<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR QUARTERLY PERIOD ENDED SEPTEMBER 30, 1996
OR
[ ] TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
COMMISSION FILE NO. 0-21440
---------------
PHYSICIAN CORPORATION OF AMERICA
(Exact name of Registrant as specified in its charter)
DELAWARE 48-1006287
(State or Other Jurisdiction of (IRS Employer
Incorporation or Organization) Identification No.)
5835 BLUE LAGOON DRIVE
MIAMI, FL 33126
(Principal Executive Offices, Including Zip Code)
Registrant's telephone number including area code: (305) 267-6633
---------------
Indicate by check mark whether the Registrant (i) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding twelve months (or for such shorter period that the Registrant was
required to file such reports), and (ii) has been subject to such filing
requirements for the past ninety days.
Yes X No
------ ------
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether Registrant has filed all documents and reports
required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act
of 1934 subsequent to the distribution of securities under a plan confirmed by a
court.
Not Applicable X
-----
APPLICABLE ONLY TO CORPORATE ISSUERS:
NUMBER OF SHARES OUTSTANDING
TITLE OF EACH CLASS AT SEPTEMBER 30, 1996
Common Stock 38,827,656
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
QUARTERLY REPORT ON FORM 10-Q
FOR QUARTER ENDED SEPTEMBER 30, 1996
TABLE OF CONTENTS
PAGE
----
PART I. Financial Information
Item 1. Financial Statements 1-9
Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations 10-14
PART II. Other Information
Item 1. Legal Proceedings 15
Item 2. Changes in Securities 15
Item 3. Defaults Upon Senior Securities 15
Item 4. Submission of Matters to a Vote of Security Holders 15
Item 5. Other Information 15
Item 6. Exhibits and Reports on Form 8-K 15
Signature Page 16
<PAGE>
PHYSICIAN CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 1996 AND DECEMBER 31, 1995
<TABLE>
<CAPTION>
(UNAUDITED)
SEPTEMBER 30, DECEMBER 31,
ASSETS 1996 1995
------ ------------- ------------
(IN THOUSANDS)
<S> <C> <C>
Current assets:
Cash and cash equivalents $ 101,307 $ 164,706
Short term investments 227,434 131,185
Accounts receivable, net of allowance of approximately
$32,716 and $7,670 at September 30, 1996 and
December 31, 1995, respectively:
Trade (health premiums and administrative service fees) 116,086 61,271
Other 18,668 11,478
Prepaid expenses, inventories and other current assets 11,337 8,449
Income taxes receivable 52,305 20,580
Deferred income tax benefit 15,153 11,301
------------- ------------
Total current assets 542,290 408,970
------------- ------------
Property and equipment, net of accumulated depreciation
of $20,314 and $22,652 at September 30, 1996 and
December 31, 1995, respectively 50,787 59,564
Long term investments 283,851 145,865
Deferred income tax benefit long-term 721 -
Statutory deposits and other assets 153,064 43,141
Intangible assets:
Goodwill, net of accumulated amortization of $18,729
and $14,742 at September 30, 1996 and December 31,
1995, respectively 151,224 164,871
Other intangible assets net of accumulated amortization of
$14,865 and $14,014 at September 30, 1996 and
December 31, 1995, respectively 18,263 27,251
------------- ------------
Total intangible assets 169,487 192,122
------------- ------------
$ 1,200,200 $ 849,662
------------- ------------
------------- ------------
</TABLE>
1
<PAGE>
PHYSICIAN CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (CONTINUED)
SEPTEMBER 30, 1996 AND DECEMBER 31, 1995
<TABLE>
<CAPTION>
(UNAUDITED)
SEPTEMBER 30, DECEMBER 31,
LIABILITIES AND STOCKHOLDERS' EQUITY 1996 1995
------------- ------------
(IN THOUSANDS, EXCEPT SHARE DATA)
<S> <C> <C>
Current liabilities:
Accounts payable, accrued expenses and other
current liabilities $ 95,427 $ 55,592
Health claims payable 169,273 171,241
Current portion of other claims payable, primarily
workers' compensation 112,056 23,629
Unearned premiums and service fees 23,144 54,398
Current portion of long-term debt and obligations
under capital leases 123,236 26,943
------------- ------------
Total current liabilities 523,136 331,803
Long-term debt and obligations under capital leases,
less current portion 10,911 157,096
Long-term portion of other claims payable, primarily
workers' compensation 494,698 138,894
Deferred income taxes - 2,068
Deferred income and other long-term liabilities 54,946 9,632
------------- ------------
Total liabilities 1,083,691 639,493
------------- ------------
Stockholders' equity:
Preferred stock, $1.00 par value, 10,000,000 shares
authorized; none issued and outstanding - -
Common stock, $.01 par value, authorized 200,000,000
shares; issued and outstanding 38,827,656 and 38,608,913
at September 30, 1996 and December 31, 1995,
respectively 388 386
Additional paid-in capital 136,453 137,826
Common stock held in treasury - at cost; 462,554 and
681,292 shares at September 30, 1996 and December 31,
1995, respectively (9,246) (12,565)
Retained earnings (accumulated deficit) (11,054) 84,058
Unrealized (loss)/gain on investments (32) 464
------------- ------------
Total stockholders' equity 116,509 210,169
Commitment and contingencies
------------- ------------
$ 1,200,200 $ 849,662
------------- ------------
------------- ------------
</TABLE>
2
<PAGE>
PHYSICIAN CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 1996 AND 1995
<TABLE>
<CAPTION>
(UNAUDITED) (UNAUDITED)
THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30,
--------------------------------- --------------------------------
1996 1995 1996 1995
------------- ------------- ------------- -------------
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<S> <C> <C> <C> <C>
Revenues:
Health premiums $ 323,539 $ 264,092 $ 966,350 $ 763,221
Workers compensation and other revenues (note D) 32,887 41,929 105,580 110,461
Investment income 5,654 4,516 17,262 12,227
------------- ------------- ------------- -------------
Total revenues 362,080 310,537 1,089,192 885,909
Operating expenses:
Medical costs 283,252 230,713 844,121 630,775
Administrative, marketing and other expenses (note D) 70,756 74,029 232,012 213,545
Loss on assumption of net workers' compensation
liabilities (note D) 130,000 - 130,000 -
Depreciation and amortization 5,439 5,971 17,408 16,627
------------ ------------ ------------ -------------
Total operating expenses 489,447 310,713 1,223,541 860,947
Operating income (loss) (127,367) (176) (134,349) 24,962
Gain on sale of subsidiaries (note E) 4,452 - 12,352 -
Interest expense (3,120) (2,420) (10,842) (6,579)
Other income (expense) 9 (50) (128) (59)
------------- ------------- ------------- -------------
Earnings (loss) before income taxes (126,026) (2,646) (132,967) 18,324
Income tax benefit (expense) 30,512 1,437 37,855 (6,450)
------------- ------------- ------------- -------------
Net earnings (loss) $ (95,514) $ (1,209) $ (95,112) $ 11,874
------------- ------------- ------------- -------------
------------- ------------- ------------- -------------
Net earnings (loss) per common and common
equivalent share $ (2.44) $ (0.03) $ (2.41) $ 0.30
------------- ------------- ------------- -------------
------------- ------------- ------------- -------------
Net earnings (loss) per common and common
equivalent share assuming full dilution $ (2.44) $ (0.03) $ (2.41) $ 0.30
------------- ------------- ------------- -------------
------------- ------------- ------------- -------------
Number of common shares used in computation of
primary earnings per share 39,206,540 39,326,358 39,406,153 39,795,666
------------- ------------- ------------- -------------
------------- ------------- ------------- -------------
Number of common shares used in computation of
fully diluted earnings per share 39,206,540 39,326,358 39,406,153 39,953,536
------------- ------------- ------------- -------------
------------- ------------- ------------- -------------
</TABLE>
3
<PAGE>
PHYSICIAN CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1996 AND 1995
<TABLE>
<CAPTION>
(UNAUDITED)
NINE MONTHS ENDED SEPTEMBER 30,
-------------------------------
1996 1995
-------------- -------------
(IN THOUSANDS)
<S> <C> <C>
Cash flows from operating activities:
Net earnings (loss) $ (95,112) $ 11,874
Adjustments to reconcile net earnings (loss) to net
cash provided by operating activities:
Depreciation and amortization 17,408 16,627
Amortization of premium/accretion of discount 1,841 -
Gain on sale of subsidiaries (12,352) -
Loss on sale of property and equipment 70 -
Loss on assumption of net workers' compensation
liabilities 100,000 -
Changes in working capital:
Accounts receivable (59,649) 5,451
Income taxes 11,135 (11,958)
Accounts payable, accrued expenses and
other current liabilities 5,818 (22,514)
Claims payable 151,020 52,392
Unearned premiums (14,510) 3,480
Deferred income taxes (8,230) 2,834
Other changes in other assets and liabilities 21,161 9,153
----------- -----------
Total adjustments 213,712 55,465
----------- -----------
Net cash provided by operating activities 118,600 67,339
----------- -----------
Cash flows from investing activities:
Purchase of investments (256,199) (209,393)
Proceeds from sale of investments 188,716 182,332
Purchase of property and equipment (9,606) (14,729)
Proceeds from sale of property and equipment 1,574 -
Statutory deposits and other assets (97,063) (21,944)
Acquisitions, net of cash acquired - (26,768)
Cash acquired from assumption of net workers'
compensation liabilities 31,318 -
Disposals, net of cash sold 8,645 -
----------- -----------
Net cash used in investing activities (132,615) (90,502)
----------- -----------
Cash flows from financing activities:
Proceeds from borrowings - 25,000
Principal payments on debt and capital leases (48,691) (4,027)
Principal payments on covenants not-to-compete (2,217) (3,250)
Proceeds from issuance of common stock 1,524 1,021
Repurchase of common stock - (18,211)
----------- -----------
Net cash (used in) provided by financing
activities (49,384) 533
----------- -----------
Net (decrease) in cash (63,399) (22,630)
Cash and cash equivalents at beginning of period 164,706 123,135
----------- -----------
Cash and cash equivalents at end of period $ 101,307 $ 100,505
----------- -----------
----------- -----------
</TABLE>
4
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
FOR QUARTER ENDED SEPTEMBER 30, 1996
(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
NOTE A:
ORGANIZATION
The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information and the instructions to Form 10-Q and Rule 10-01 of
Regulation S-X. Accordingly, they do not include all information and footnotes
required by generally accepted accounting principles for annual financial
statements. In management's opinion, all adjustments, consisting only of normal
recurring adjustments, considered necessary for a fair presentation have been
included.
The balance sheet as of December 31, 1995 was derived from the registrant's
audited financial statements.
The results for the nine months ended September 30, 1996 are not necessarily
indicative of the results to be expected for the full year.
NOTE B:
INCOME TAXES
The Company accounts for income taxes under the provisions of Statement of
Financial Accounting Standards No. 109 (SFAS 109), "Accounting for Income
Taxes." Under SFAS 109, the deferred income tax expense or benefit generally
arises from changes in differences between financial reporting and tax bases of
all assets and liabilities, and previously recorded deferred tax assets and
liabilities are adjusted upon any changes in enacted tax rates.
NOTE C:
EARNINGS PER COMMON AND COMMON EQUIVALENT SHARE
Primary earnings per share were based on the weighted average number of common
and common equivalent shares outstanding during the periods presented.
Equivalent shares consist of those shares issuable upon the assumed exercise of
stock options calculated under the treasury stock method, based on average stock
market prices in the periods.
Fully diluted earnings per share were computed using the weighted average number
of common and common equivalent shares outstanding in the periods, assuming
exercise of stock options calculated under the treasury stock method, based on
the higher of average stock prices in the periods or the stock market price at
the end of the periods.
5
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR QUARTER ENDED SEPTEMBER 30, 1996
(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
NOTE D:
WORKERS COMPENSATION AND OTHER REVENUES AND ADMINISTRATIVE, MARKETING AND OTHER
EXPENSES
In 1994 and 1995, the Company acquired four workers compensation third party
administration (TPA) companies and a property and casualty insurance (PCA P&C)
company. These subsidiaries became the Company's workers compensation division.
In 1994 and 1995 they earned the majority of their revenues and earnings from
investment earnings and TPA service fees for services provided to a number of
self insured funds and employer groups in the Southeastern United States
including three significant self insured funds; the Florida Business Mutual
Insurance Company (FBM), the Florida Auto Dealers Self Insured Fund (FADA), and
the Florida Builders and Employers Mutual Insurance Company (FBE) (collectively
the "Funds"). These Funds had been managed by the acquired TPA companies since
1978. In 1995, the assets and liabilities of FADA were assumed by the Company.
On September 30, 1996, the assets and liabilities of FBM were also assumed by
the Company.
As regulatory and legal changes occurred in Florida, competition increased in
the Florida market place and the Company evaluated its strategic options to
preserve its TPA service fee revenue base from the employer groups of these
funds. As a result of this evaluation, in January 1996, the Company, through
PCA P&C, began providing primary workers compensation insurance coverage to
employer groups in Florida who previously were self insured through the Funds.
In conjunction with providing this new risk product, the Company entered into
quota share arrangements with five reinsurers whereby a percentage of the
premiums and a percentage of the claims costs are retained by the Company and
the remaining percentage is ceded to the reinsurers. In the first quarter of
1996 these agreements included a 50% quota share arrangement; however, in the
second quarter, they were amended to a 25% quota share arrangement retroactive
to January 1, 1996. The impact to earnings of this retroactive amendment was
immaterial.
ROLLOVER OF SELF INSURED WORKERS COMPENSATION FUND ASSETS AND LIABILITIES
Throughout 1996, the Company has continued to provide TPA services to the Funds
to run off the claims liabilities remaining in the Funds. On November 1, 1996,
the Company entered into various arrangements, all of which are pending approval
from the Florida Department of Insurance (DOI), to assume, effective September
30, 1996, financial responsibility for the net liabilities of the Funds. These
agreements include an asset guaranty agreement between PCA P&C and FBE. The
Company assumed the net liabilities of the Funds as part of its evaluation of
its entire workers compensation operations in Florida and determined it was
necessary to preserve its TPA service revenue and further that it was in the
best interest of the Company and the Funds policyholders to do so.
6
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR QUARTER ENDED SEPTEMBER 30, 1996
(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
NOTE D: (CONTINUED)
A preliminary actuarial evaluation indicates that FBE's liabilities exceed its
assets by approximately $130.0 million on a pre-tax undiscounted basis as of
September 30, 1996. Accordingly, PCA has recorded a non-recurring loss on
assumption of net workers' compensation liabilities of $100.0 million (net of a
$30.0 million income tax benefit) in the third quarter of 1996, as it has
determined the future recoverability of this deficit cannot be assured. All
assets and liabilities of the FBE and FBM Funds have been consolidated with the
results of the Company in the accompanying balance sheet as of September 30,
1996. Accordingly, the Company has reported additional assets of $260.0 million
(most of which are long-term investment grade securities) and additional
liabilities of $360.0 million (most of which are long-term workers' compensation
claims) on its balance sheet as of September 30, 1996.
As a result of this $100.0 million charge, the statutory equity of PCA P&C
has been substantially depleted. Accordingly, the Company has agreed that
the DOI may exercise certain oversight functions with respect to PCA P&C's
operations until such time as PCA P&C's statutory equity surplus has been
restored. While investment earnings in PCA P&C will approximate $11.0
million in 1996, as a result of adding the long-term investments from this
transaction, the investment earnings from PCA P&C is expected to increase to
more than $17.0 million in 1997 and to decline every year thereafter as
claims liabilities are paid out. The Company is expected to earn
approximately $20.0 million in future TPA fees and more than $150.0 million
in future investment income in PCA P&C during this claims run-off period.
In response to its evaluation of the long-term prospects of the Florida workers
compensation insurance risk, the Company intends to cease writing all workers'
compensation insurance products and to focus its workers' compensation division
on providing TPA services to its current and future customer base. The Company
believes that this will eliminate the Company's exposure to workers'
compensation underwriting risks.
NOTE E:
DISPOSITIONS
In June 1996, the Company sold a wholly owned subsidiary, Physicians First, Inc.
(PFI), for $23.6 million in stock and notes to FPA Medical Management, Inc.
(FPA). As consideration, the Company received 525,000 shares of unregistered
FPA stock and a $15.0 million note from FPA. Additionally, as a condition of
the sale, PCA entered into a four-year covenant not-to-compete with FPA. This
transaction resulted in an after-tax gain on the sale of PFI of approximately
$7.9 million. After completing this transaction in June 1996, the Company made
a $9.5 million principal payment to reduce its outstanding bank debt balance.
During the third quarter of 1996, FPA paid its $15.0 million note obligation to
PCA in full and PCA used the proceeds to make an additional $15.0 million of
bank debt principal payment in the third quarter of 1996.
7
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR QUARTER ENDED SEPTEMBER 30, 1996
(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
NOTE E: (CONTINUED)
In September 1996, the Company sold its wholly owned subsidiaries, PCA Health
Plans of Georgia, Inc. (PCA/Georgia), PCA Health Plans of Alabama, Inc.
(PCA/Alabama) and Health Strategies, Inc. (Health Strategies) to Health Partners
Southeast, Inc. (HPS) for $24.5 million in cash and non-compete payments. This
transaction resulted in an after-tax gain on the sale of approximately $4.5
million. After completing this transaction in September 1996, the Company made
a $17.0 million principal payment to reduce its outstanding bank debt balance.
NOTE F:
SIGNIFICANT CONTRACTS
FLORIDA MEDICAID PROGRAM
In August 1996, the Florida Agency for Health Care Administration (AHCA)
announced its intent to utilize a competitive bidding process whereby it would
grade responses to its request for proposals (RFP) from qualified bidders using
both cost and quality of care criteria and award contracts to selected bid
winners to provide health services to Medicaid recipients in Florida. The
Company filed a protest appealing this process on the grounds it violated
existing laws and regulations. After AHCA modified its request for proposal and
provided clarifications regarding the process, the Company withdrew its protest.
The responses to the RFP are due to AHCA in November 1996, and it is anticipated
that in January or February 1997, AHCA will announce its intent to award
multi-year contracts to a number of qualifying HMOs in Florida to provide health
services to Florida Medicaid recipients.
The RFP stipulates all bids must contain proposed premiums equal to not more
than 92% of fee-for-service rates as actuarially determined. AHCA contends HMOs
in Florida are currently paid premiums equal to 95% of fee-for-service rates.
AHCA has agreed to establish a task force to review the Medicaid prepaid health
plan rate setting methodology and provide recommendations regarding the
methodology by February 1, 1997. The Company and other Florida HMOs believe the
current rates paid by AHCA to HMOs are actually less than 92% of fee-for-service
rates.
The impact of this competitive bidding process on the Company's Florida Medicaid
business, its Medicaid Premium rates or the number of Medicaid members serviced
by the Company cannot be predicted at this time. However the Company, as
Florida's largest Medicaid contractor, believes it will gain Medicaid membership
through this process.
PUERTO RICO REFORM PROGRAM
The Company's Puerto Rico HMO subsidiary currently provides health services to
approximately 266,000 Government Reform Program members pursuant to a one-year
contract which expires in December 1996. The Company expects this contract,
which is currently in a rebid stage, to be renewed for an additional annual term
at substantially similar premium rates.
8
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR QUARTER ENDED SEPTEMBER 30, 1996
(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
NOTE F: (CONTINUED)
TEXAS MEDICAID CONTRACT
During the third quarter of 1996, the Company's Texas HMO subsidiary was awarded
contracts to provide covered health care services to approximately 12,500 and
17,900 Medicaid members in Tarrent and Bexar counties, respectively, in addition
to the re-award of 22,000 Medicaid members it already services in Travis County.
NOTE G:
DEBT
As a result of recording the loss on the assumption of net workers' compensation
liabilities, at September 30, 1996, PCA was in violation of certain line of
credit facility covenants. PCA is working with its banks to obtain a waiver
from them for such violations and restructure the facility's repayment terms.
In the interim, the Company has classified all of its bank debt as a current
liability in the accompanying balance sheet as of September 30, 1996.
NOTE H:
MERGER AGREEMENT
On November 2, 1996, PCA entered into a definitive agreement to be merged with
Sierra Health Services, Inc. (Sierra). The agreement provides for an exchange
of common shares on the basis of 0.45 common shares of Sierra exchanged for
each PCA share. The transaction which is expected to be completed in early
1997, is subject to regulatory and shareholder approval and is expected to be
accounted for as a pooling-of-interests.
9
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
GENERAL
Physician Corporation of America ("the Company") is a managed health care
company that provides comprehensive health care services through its health
maintenance organizations ("HMOs") and workers compensation administrative
management services and provides primary workers compensation and reinsurance
insurance coverage through its workers compensation third party administration
and indemnity companies ("Workers Compensation Companies"). The Company
conducts all of its business in the Southeastern United States and Puerto Rico.
In the third quarter 1996, the Company continued to focus on its core markets
and execute its strategic plan to turn around its operations as evidenced by:
i) the sale of its non producing subsidiaries, PCA/ Alabama, Health Strategies
and PCA/Georgia, ii) the reduction in force of employees in its HMO and workers'
compensation subsidiaries, iii) the expansion of global risk provider contracts
in its Florida and Texas operations, and iv) the continued increase in health
premium revenue and membership growth in its health plans. The third quarter
1996 results show significant improvement over the previous three quarters prior
to a non-recurring $100 million after tax charge relating to the loss on the
assumption of net workers' compensation liabilities (see Note D to the
accompanying financial statements). The Company intends to cease writing all
workers' compensation insurance coverage (thereby eliminating the Company's
exposure to any workers' compensation underwriting related risks) in the fourth
quarter of 1996. The Company does not expect this action to have a material
impact on its financial results. The following sets forth certain financial and
operating information pertaining to the Company's results for the three and nine
months ended September 30, 1996 compared to 1995:
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------------- --------------------------
1996 1995 1996 1995
----------- ----------- ----------- -----------
(In thousands)
<S> <C> <C> <C> <C>
Health Premiums:
Commercial $138,256 $127,670 $425,349 $367,845
Medicaid 94,970 75,486 276,891 241,136
Medicare 81,462 53,563 238,184 134,902
Indemnity 8,851 7,373 25,926 19,338
----------- ----------- ----------- -----------
Total health premiums $323,539 $264,092 $966,350 $763,221
----------- ----------- ----------- -----------
----------- ----------- ----------- -----------
Workers compensation administrative
service fees and other revenues $32,887 $41,929 $105,580 $110,461
----------- ----------- ----------- -----------
----------- ----------- ----------- -----------
Operating Statistics and Data:
Medical loss ratio (1) 87.5% 87.4% 87.4% 82.6%
Health administrative, marketing
and other expenses ratio (2) 14.2% 16.0% 15.3% 17.2%
Period ending membership:
HMO:
Commercial 408,000 418,000
Medicaid 445,000 206,000
Medicare 60,000 45,000
----------- -----------
Total HMO 913,000 669,000
Health Indemnity and PPO 35,000 31,000
----------- -----------
----------- -----------
Total HMO and Insured Health Membership 948,000 700,000
----------- -----------
----------- -----------
</TABLE>
(1) Medical costs as a percentage of health premiums.
(2) Health administrative, marketing and other expenses, including
allocations of corporate overhead as a percentage of health premiums.
10
<PAGE>
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 1996 COMPARED TO THREE AND NINE MONTHS
ENDED SEPTEMBER 30, 1995
NET EARNINGS:
Net earnings for the three and nine months ended September 30, 1996 as compared
to 1995 decreased by $94.3 million to a $95.5 million net loss and by $107.0
million to a $95.1 million loss, respectively. The three and nine month
decreases were primarily due to a $2.4 million increase and a $19.6 million
decline, respectively, in profitability of the Company's HMO operations in 1996,
profits earned from the worker's compensation third party administration
companies, a third quarter 1996 $100 million after tax charge from the
assumption of net workers' compensation liabilities and a third quarter 1996
$4.5 million gain from the sale of PCA/Alabama, Health Strategies and
PCA/Georgia.
REVENUES:
Total revenues for the three and nine months ended September 30, 1996 as
compared to 1995 increased by $51.5 million or 17% and $203.3 million or 23%,
respectively. The principal components of these increases are as follows:
HEALTH PREMIUMS
Health premium revenues for the three and nine months ended September 30, 1996
as compared to 1995 increased by $59.4 million or 23% and 203.1 million or 27%,
respectively.
Of the three months increase, $114.7 million was due to a 43% increase in the
average number of members during the period offset by a $55.3 million decrease
due to a 15% decrease in the weighted average health premium rate per member.
Of the nine months increase, $334.3 million was due to a 44% increase in the
average number of members during the period offset by a $131.2 million decrease
due to a 12% decrease in the weighted average health premium per member. The
weighted average decrease in premium rates is due to: i) the 18% decrease in
the Florida Medicaid premium rates which became effective in the third quarter
of 1995, as well as ii) the Company having approximately 266,000 Medicaid
members (Puerto Rico reform program) with a lower than average premium rate
(approximately $48 per member per month) in the three and nine months ended
September 30, 1996 which began enrolling in December 1995. Total membership of
948,000 at September 30, 1996 increased by approximately 248,000 members from
700,000 members at September 30, 1995 (10,000 decrease in Commercial, 239,000
increase in Medicaid, 15,000 increase in Medicare and 4,000 increase in
indemnity and PPO members).
WORKERS COMPENSATION AND OTHER REVENUES
Workers compensation and other revenues for the three and nine months ended
September 30, 1996 decreased $9.0 million and decreased $4.9 million,
respectively. The fluctuations are due to: (i) workers compensation
administrative service fees and other revenues for the three and nine month
periods ended September 30, 1996 decreased by $13.4 million to $14.2 million
from $27.6 million and by $23.0 million to $51.8 million from $74.8 million,
respectively. These revenues were generated primarily by the Company's workers
compensation administration and indemnity operations servicing self insured
funds. In 1996, through its workers compensation indemnity subsidiary, the
Company began offering primary workers compensation coverage to these employer
groups (who were previously members of these self insured funds). Therefore,
the workers compensation services fees earned from these employers in 1995 have
been replaced in 1996 by primary workers compensation premiums; and (ii) workers
compensation premiums for the three and nine months ended September 30, 1996
increased $4.4 million and $18.1 million, respectively. The three and nine
month increase is attributable to the introduction of primary workers
compensation insurance coverage commencing January 1, 1996.
11
<PAGE>
Investment income for the three and nine months ended September 30, 1996 as
compared to 1995 increased by $1.1 million or 25% and $5.0 million or 41%,
respectively. These increases were the result of the Company investing: i) the
proceeds from the $70 million borrowed in December 1995 under the Company's bank
facility which were used to further capitalize the Company's workers
compensation and Puerto Rico HMO operations, and ii) cash generated from
operations.
MEDICAL COSTS
Medical costs for the three and nine months ended September 30, 1996 as compared
to 1995 increased by $52.5 million or 23% and $213.3 million and 34%,
respectively. Of the three months increase, $100.1 million was due to a 43%
increase in the average number of members during the period offset by a $47.6
million decrease due to a 16% decrease in the weighted average medical costs per
member. Of the nine months increase, $276.3 million was due to a 44% increase
in the average number of members in the period offset by a $63.0 million
decrease due to a 7% decrease in the weighted average medical cost per member.
These decreases in the weighted average medical costs per member were due
primarily to: (i) the shift in membership mix to proportionately more Medicaid
reform members in Puerto Rico (which have a lower than average medical cost of
approximately $42 per member per month but a higher medical loss ratio), (ii)
reduction in overall utilization by members through stronger medical utilization
management, and (iii) medical cost savings as a result of the Company's efforts
to recontract with its providers during the three and nine months ended
September 30, 1996 compared to 1995. These factors, mitigated the impact of a
lower premium rate for the Medicaid reform members in Puerto Rico, the impact of
the Florida Medicaid premium rate decrease and the increase in number of
Medicare members (which have a higher than average per member per month medical
cost), resulting in the Company's overall medical loss ratio for the three and
nine months ended September 30, 1996 increasing to 87.5% from 87.4% and to
87.4% from 82.6%, respectively for the same periods in 1995.
ADMINISTRATIVE, MARKETING AND OTHER EXPENSES
Administrative, marketing and other expenses for the three and nine months ended
September 30, 1996 as compared to 1995 decreased by $3.3 million or 4% and
increased by $18.5 million or 9%, respectively. The three month decrease in
administrative, marketing and other expenses was primarily due to administrative
cost control measures put in place. The nine month increase is attributable to
the introduction of primary workers compensation insurance coverage commencing
January 1, 1996. The Company's health administrative cost ratio for the three
and nine months ended September 30, 1996 was 14.2% and 15.3%, respectively,
compared to 16.0% and 17.2% for the same periods in 1995. This improvement was
a direct result of the Company implementing cost cutting measures while
increasing premiums.
DEPRECIATION AND AMORTIZATION
Depreciation and amortization for the three and nine months ended September 30,
1996 as compared to 1995 remained constant, as expected.
GAIN ON SALE OF SUBSIDIARIES
In June 1996, the Company sold its wholly owned subsidiary, PFI for $23.6
million in stock and notes to FPA Medical Management, Inc. (FPA). As
consideration, the Company received 525,000 shares of unregistered FPA stock and
a $15.0 million note from FPA which was received in full from FPA in the third
quarter of 1996. Additionally, as a condition of the sale, PCA entered into a
four-year covenant not-to-compete with FPA. This transaction resulted in a gain
on the sale of PFI of approximately $7.9 million being reflected in the second
quarter of 1996.
12
<PAGE>
In September 1996, the Company sold its wholly owned subsidiaries, PCA Health
Plans of Georgia, Inc. (PCA/Georgia) and PCA Health Plans of Alabama, Inc.
(PCA/Alabama) to Health Partners Southeast, Inc. (HPS) for $24.5 million in cash
and non-compete payments. This transaction resulted in a gain on the sale of
PCA/Georgia and PCA/Alabama of approximately $4.5 million.
INTEREST EXPENSE
Interest expense for the three and nine months ended September 30, 1996 as
compared to 1995 increased by $.7 million to $3.1 million and $4.3 million to
$10.8 million, respectively. These increases were due primarily to incremental
interest expense incurred relating to the $70 million borrowed under the
Company's credit facility in December 1995 to capitalize the Company's Puerto
Rico HMO and its workers compensation insurance subsidiary.
INCOME TAXES
The Company recognized an income tax benefit in the three and nine months ended
September 30, 1996 of $30.5 million and $37.9 million, respectively. This
compares with a tax benefit of $1.4 million and a tax expense of $6.5 million
for the three and nine months ended September 30, 1995, respectively. The
increase in tax benefit recognized is attributable directly to the Company
incurring a taxable loss in the three and nine months ended September 30, 1996.
The tax benefits for the three and nine months ended September 30, 1996,
respectively, are consistent with: (i) the 35% statutory rate for such periods,
(ii) the nondeductibility of goodwill amortization for income tax purposes
arising from the acquisition of the HMOs and workers compensation companies
offset by tax exempt investment income, (iii) the $30 million tax benefit
recognized with respect to the loss on assumption of net workers' compensation
liabilities, and iv) the Company incurring no income tax expense on the gains
from the sale of Physicians First, Inc., PCA/Alabama, Health Strategies and
PCA/Georgia due to the availability of capital loss carryforwards.
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 1996, the Company had working capital of $19.2 million. Cash
and cash equivalents were $101.3 million at September 30, 1996, a decrease of
$63.4 million from $164.7 million at December 31, 1995 and short term
investments were $227.4 million at September 30, 1996, an increase of $96.2
million from a $131.2 million balance at December 31, 1995. At September 30,
1996, the Company has classified approximately $140.0 million of investments
with future contractual maturities of more than one year as short-term
investments in the accompanying balance sheet based on its intent to sell the
investments to meet its obligations. The decrease in cash and cash equivalents
is the result of cash generated from operations offset by cash used in investing
and financing activities. The Company's cash and cash equivalents do not include
statutory cash deposits segregated as required by various regulatory
authorities.
Net cash provided by operating activities for the nine months ended September
30, 1996 was $118.6 million compared to cash of $67.3 million provided by
operating activities for the nine months ended September 30, 1995. The cash
provided by operating activities for 1996 was principally the result of the
following factors: (i) net loss of $95.1 million, (ii) increase in claims
payable in the amount of $151.0 million, (iii) decrease in income taxes
receivable in the amount of $11.1 million, (iv) decrease in unearned premiums in
the amount of $14.5 million, (v) $59.6 million increase in accounts receivable
resulting from the primary workers' compensation insurance written commencing
January 1996, and (vi) an increase in accounts payable, accrued expenses and
other current liabilities of $5.8 million.
13
<PAGE>
In 1996, net cash used in investment activities increased to $132.6 million,
from $90.5 million in 1995. The net cash used in investing activities was
primarily the result of the following factors: (i) $9.6 million purchase of
property and equipment, (ii) the net purchase of investments of $67.4 million,
(iii) $97.0 million increase in statutory deposits and other assets, the
majority of which relates to estimated reinsurance recoveries, and (iv) $31.3
million of cash acquired from the assumption of net workers' compensation
liabilities. The Company believes it will be able to finance all capital
expenditures for the foreseeable future from cash generated from operations and
amounts available from cash. The Company has utilized capital leases to finance
certain equipment additions in the past and expects to continue to do so in the
future.
In 1996, net cash used in financing activities for the nine months ended
September 30, 1996 was $49.4 million compared to $.5 million cash provided in
the nine months ended September 30, 1995. The cash used in financing activities
was primarily the result of $50.9 million of long-term debt principal and
covenant payments.
The Company believes that cash on hand and cash flow generated from operations
will be sufficient to fund future capital expenditures, introduction of new
products and services. The cash proceeds from the sales of Physicians First,
Inc., PCA/Georgia and PCA/Alabama were used to pay down the Company's bank debt
facility, which is provided by six banks, including Citibank, NA as agent.
As a result of the $100.0 million charge, the Company is in violation of its
bank loan covenants as of September 30, 1996. Consequently, the banks have the
right among other things, to accelerate the majority of the entire outstanding
balance of $118.5 million. Discussions are underway with the banks and while
the banks have been favorably inclined to work with the Company, there can be no
assurance that a modification/waiver agreement will be completed. In the event
that the banks were to accelerate the indebtedness, the Company would be
required to seek refinancing of such indebtedness or, if such refinancing were
unavailable, to sell assets in order to make such payments.
Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: The Statements contained in this report which are not historical facts are
forward looking. Actual results may differ materially from those projected in
such forward looking statements; such statements involve risks and
uncertainties, including but not limited to the following: completion of the
merger which is subject to various approvals including regulatory and
shareholder; Medicare and Medicaid premium rates set by state and federal
governments change unexpectedly; Texas and Puerto Rico Medicaid contracts and
renewals are awarded under a competitive bidding process and award is not
guaranteed; a Medicaid RFP process in Florida is currently underway and the full
impact on the Company is not known; completion of an actuarial study to confirm
that the liabilities of the P&C subsidiary are not understated; the outcome and
impact of present discussions with the Company's bankers regarding loan covenant
violations is uncertain; increased competition in the Company's markets or
change in product mix may unexpectedly reduce premium yield; health care costs
in any given period may be greater than expected due to incidence of major
illnesses, natural disasters, epidemics, changes in physician practice policies,
and new technologies; and, the Company may be unable to obtain acceptable
provider arrangements on satisfactory terms in key markets.
14
<PAGE>
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Not Applicable
Item 2. Changes in Securities
Not Applicable
Item 3. Defaults Upon Senior Securities
Not Applicable
Item 4. Submission of Matters to a Vote of Security Holders
Not Applicable
Item 5. Other Information
Not Applicable
Item 6. Exhibits and Reports on Form 8-K
(A) Exhibits furnished as part of the Report:
(1) Financial Statements, See PART I, Item 1
(2) Exhibits:
2.1 Agreement and Plan of Merger dated November 2, 1996
among Sierra Health Services, Inc., Sierra
Acquisition Corporation and Physician Corporation
of America.
10.1 Workers' Compensation and Employers Liability Asset
Guarantee and Indemnification Contract By and
Between Florida Builders & Employers Mutual
Insurance Company and PCA Property & Casualty
Insurance Company effective September 30, 1996.
15
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHYSICIAN CORPORATION OF AMERICA
(Registrant)
By: /s/ E. Stanley Kardatzke, M.D.
-------------------------------
E. Stanley Kardatzke, M.D.,
Chairman of the Board and CEO
(Principal Executive Officer)
By: /s/ Clifford W. Donnelly
-------------------------------
Clifford W. Donnelly
Senior Vice President of Finance
and Chief Financial Officer
By: /s/ Jay M. Grobowsky
-------------------------------
Jay M. Grobowsky
Date:November 14, 1996 Vice President of Finance
-----------------
16
<PAGE>
PHYSICIAN CORPORATION OF AMERICA
QUARTERLY REPORT ON FORM 10-Q
FOR QUARTER ENDED SEPTEMBER 30, 1996
EXHIBIT INDEX
2.1 Agreement and Plan of Merger dated November 2, 1996 among Sierra
Health Services, Inc., Sierra Acquisition Corporation and
Physician Corporation of America.
10.1 Workers' Compensation and Employers Liability Asset Guarantee and
Indemnification Contract By and Between Florida Builders &
Employers Mutual Insurance Company and PCA Property & Casualty
Insurance Company effective September 30, 1996.
<PAGE>
Exhibit 2.1
AGREEMENT AND PLAN OF MERGER
AMONG
SIERRA HEALTH SERVICES, INC.
SIERRA ACQUISITION CORP.
AND
PHYSICIAN CORPORATION OF AMERICA
<PAGE>
AGREEMENT AND PLAN OF MERGER dated as of November 2, 1996, among Sierra
Health Services, Inc., a Nevada corporation ("Sierra"), Sierra Acquisition
Corp., a Delaware corporation and a wholly owned subsidiary of Sierra ("Sierra
Sub"), and Physician Corporation of America, a Delaware corporation ("PCA").
WHEREAS, the respective Boards of Directors of Sierra, Sierra Sub and PCA
have determined that it is in the best interests of their respective
stockholders to enter into a business combination involving the merger of PCA
and Sierra Sub, pursuant to the terms and conditions of this Agreement;
WHEREAS, to effect such transaction, the respective Boards of Directors of
Sierra, Sierra Sub and PCA, and Sierra acting as the sole shareholder of Sierra
Sub, have approved the merger of PCA and Sierra Sub (the "Merger"), pursuant to
the terms and conditions of this Agreement, whereby each issued and outstanding
share of Common Stock, par value $.01 per share, of PCA ("PCA Common Stock") not
owned directly or through a wholly-owned Subsidiary by Sierra or directly by PCA
will be converted into the right to receive Common Stock, par value $.005 per
share, of Sierra ("Sierra Common Stock"), all as provided herein;
WHEREAS, Sierra, Sierra Sub and PCA desire to make certain representations,
warranties and agreements in connection with the Merger and also to prescribe
various conditions to the Merger;
WHEREAS, for Federal income tax purposes, it is intended that the Merger
shall qualify as a reorganization under the provisions of Section 368(a) of the
Internal Revenue Code of 1986, as amended (the "Code"); and for accounting
purposes, it is intended that the Merger shall be accounted for as a "pooling of
interests";
NOW, THEREFORE, in consideration of the foregoing and the respective
representations, warranties, covenants and agreements set forth in this
Agreement, the parties agree as follows:
ARTICLE I. THE MERGER
1.1. EFFECTIVE TIME OF THE MERGER. Subject to the provisions of this
Agreement, the officers' certificate of PCA required by Section 251 of the
Delaware General Corporation Law (the "DGCL") shall be duly prepared, executed
and acknowledged by PCA (such document and any other documents necessary to
effect the Merger in accordance with the DGCL shall be referred to as the
"Merger Filings") and shall be delivered by the Surviving Corporation (as
defined in Section 1.3) to the Secretary of State of the State of Delaware for
filing. The Merger shall become effective upon the filing of the Merger Filings
with the Secretary of State of the State of Delaware (the "Effective Time").
<PAGE>
1.2. CLOSING. The closing of the Merger (the "Closing") will begin at
10:00 a.m. local time on a date to be specified by the parties, which shall be
no later than the fifth business day after satisfaction of the latest to occur
of the conditions set forth in Sections 6.1, 6.2(b) (other than the delivery of
the officers' certificates referred to therein), 6.2(e), 6.3(b) (other than the
delivery of the officers' certificates referred to therein) and 6.3(d) (provided
that the other closing conditions set forth in Article VI have been met or
waived as provided in Article VI at or prior to the Closing) (the "Closing
Date"), at the offices of Morgan, Lewis & Bockius LLP, 5300 First Union
Financial Center, 200 South Biscayne Boulevard, Miami, Florida 33131-2339,
unless another date or place is agreed to in writing by the parties hereto.
1.3. EFFECTS OF THE MERGER.
(a) At the Effective Time, (i) the separate existence of Sierra Sub
shall cease and Sierra Sub shall be merged with and into PCA (Sierra Sub
and PCA are sometimes referred to herein as the "Constituent Corporations"
and PCA is sometimes referred to herein as the "Surviving Corporation"),
(ii) the Certificate of Incorporation of PCA shall be amended by filing a
Certificate of Merger pursuant to Section 251 of the DGCL, substantially in
the form attached as Exhibit 1.3(a)(ii), so that (A) Article Fourth of such
Certificate of Incorporation shall read in its entirety as follows: "The
corporation is authorized to issue only one class of shares of stock which
shall be designated as "Common Stock;" and the total number of shares which
this Corporation is authorized to issue is one thousand (1,000)" and (B)
Article Eleventh of such Certificate of Incorporation shall be deleted in
its entirety, and, as so amended, the Certificate of Incorporation shall be
the Certificate of Incorporation of the Surviving Corporation (until
further amended) and (iii) the Bylaws of PCA as in effect immediately prior
to the Effective Time shall be the Bylaws of the Surviving Corporation
(until further amended).
(b) At and after the Effective Time, in accordance with Section 259
of the DGCL, the Surviving Corporation shall possess all the rights and
property of the Constituent Corporations and be subject to all the debts
and liabilities of the Constituent Corporations as if the Surviving
Corporation had itself incurred them; all rights of creditors and all liens
upon any property of either of the Constituent Corporations shall be
preserved unimpaired, provided that such liens upon property of a
disappearing corporation shall be limited to the property affected thereby
immediately prior to the Effective Time; and any action or proceeding
pending by or against any disappearing corporation may be prosecuted to
judgment, which shall bind the Surviving Corporation, or the Surviving
Corporation may be proceeded against or substituted in its place.
-2-
<PAGE>
ARTICLE II. EFFECT OF THE MERGER ON
THE CAPITAL STOCK OF THE CONSTITUENT
CORPORATIONS; EXCHANGE OF CERTIFICATES
2.1. EFFECT ON CAPITAL STOCK. As of the Effective Time, by virtue of the
Merger and without any action on the part of the holder of any shares of PCA
Common Stock or capital stock of Sierra Sub:
(a) CAPITAL STOCK OF SIERRA SUB. Each issued and outstanding share
of the capital stock of Sierra Sub shall be converted into and become one
fully paid and nonassessable share of common stock, par value $.01 per
share, of the Surviving Corporation.
(b) CANCELLATION OF SIERRA-OWNED STOCK. All shares of PCA Common
Stock that are owned by Sierra, Sierra Sub or any other wholly-owned
Subsidiary of Sierra shall be canceled and retired and shall cease to exist
and no stock of Sierra or other consideration shall be delivered in
exchange therefor. As used in this Agreement, the word "Subsidiary" means
any corporation or other organization, whether incorporated or
unincorporated, of which a party to this Agreement or any other Subsidiary
of such a party (i) is a general partner (in the case of a partnership), or
(ii) holds directly or indirectly at least a majority of the securities or
other interests having by their terms ordinary voting power to elect a
majority of the Board of Directors or others performing similar functions
with respect to such corporation or other organization.
(c) EXCHANGE RATIO FOR PCA COMMON STOCK. Subject to Section 2.2(f),
each issued and outstanding share of PCA Common Stock together with the
rights (the "PCA Rights") granted under the Rights Agreement, dated
January 13, 1995 (the "PCA Rights Agreement"), between PCA and the Rights
Agent (as defined therein), (other than shares to be canceled in accordance
with Section 2.1(b)) shall be converted into the right to receive .45 (the
"Conversion Number") of a fully paid and nonassessable share of Sierra
Common Stock, including the corresponding percentage of a right (the
"Right") to purchase shares of Series A Junior Participating Preferred
Stock of Sierra (the "Sierra Series A Preferred") pursuant to the Rights
Agreement dated as of June 14, 1994, between Sierra and Continental Stock
Transfer & Trust Company, as Rights Agent (the "Rights Agreement"). All
references in this Agreement to the PCA Common Stock to be received
pursuant to the Merger shall be deemed to include the PCA Rights. Prior to
the Distribution Date (as defined in the Rights Agreement) all references
in this Agreement to the Sierra Common Stock to be received pursuant to the
Merger shall be deemed to include the Rights. All such shares of PCA
Common Stock shall no longer be outstanding and shall automatically be
canceled and retired and shall cease to exist, and each holder of a
certificate representing any such shares shall cease to have any rights
with respect thereto, except the right to receive the shares of Sierra
Common Stock
-3-
<PAGE>
to be issued in consideration therefor upon the surrender of such
certificate in accordance with Section 2.2, without interest.
(d) SHARES OF DISSENTING HOLDERS.
(i) Notwithstanding anything to the contrary contained in this
Agreement, any holder of PCA Common Stock with respect to which
dissenters' rights, if any, are granted by reason of the Merger under
the DGCL and who does not vote in favor of the Merger and who
otherwise complies with Subchapter IX of the DGCL ("PCA Dissenting
Shares"), shall not be entitled to receive shares of Sierra Common
Stock pursuant to Section 2.1(c) hereof, unless such holder fails to
perfect, effectively withdraws or loses his right to dissent from the
Merger under the DGCL. Such holder shall be entitled to receive only
the payment provided for by Subchapter IX of the DGCL. If any such
holder so fails to perfect, effectively withdraws or loses his
dissenters' rights under the DGCL, his PCA Dissenting Shares shall
thereupon be deemed to have been converted, as of the Effective Time,
into the right to receive shares of Sierra Common Stock pursuant to
Section 2.1(c).
(ii) Any payments relating to PCA Dissenting Shares shall be made
solely by the Surviving Corporation and no funds or other property
have been or will be provided by Sierra Sub or any of its other direct
or indirect Subsidiaries for such payment.
2.2. EXCHANGE OF CERTIFICATES.
(a) EXCHANGE AGENT. As of the Effective Time, Sierra shall deposit
with Continental Stock Transfer & Trust Company, or another bank or trust
company designated by Sierra and reasonably acceptable to PCA (the
"Exchange Agent"), for the benefit of the holders of shares of PCA Common
Stock, for exchange in accordance with this Article II, through the
Exchange Agent: (i) certificates representing the appropriate number of
shares of Sierra Common Stock and (ii) cash to be paid in lieu of
fractional shares of Sierra Common Stock (such shares of Sierra Common
Stock and such cash are hereinafter referred to as the "Exchange Fund")
issuable pursuant to Section 2.1 in exchange for outstanding shares of PCA
Common Stock.
(b) EXCHANGE PROCEDURES. As soon as reasonably practicable after the
Effective Time, the Exchange Agent shall mail to each holder of record of a
certificate or certificates which immediately prior to the Effective Time
represented outstanding shares of PCA Common Stock (the "Certificates")
whose shares were converted into the right to receive shares of Sierra
Common Stock pursuant to Section 2.1 and whose shares are not PCA
Dissenting Shares: (i) a letter of transmittal (which shall specify that
-4-
<PAGE>
delivery shall be effected, and risk of loss and title to the Certificates
shall pass, only upon delivery of the Certificates to the Exchange Agent
and shall be in such form and have such other provisions as Sierra and PCA
may reasonably specify) and (ii) instructions for use in effecting the
surrender of the Certificates in exchange for certificates representing
shares of Sierra Common Stock. Upon surrender of a Certificate for
cancellation to the Exchange Agent or to such other agent or agents as may
be appointed by Sierra and Sierra Sub, together with such letter of
transmittal, duly executed, the holder of such Certificate shall be
entitled to receive in exchange therefor a certificate representing that
number of whole shares of Sierra Common Stock and, if applicable, a check
representing the cash consideration to which such holder may be entitled on
account of a fractional share of Sierra Common Stock, which such holder has
the right to receive pursuant to the provisions of this Article II, and the
Certificate so surrendered shall forthwith be canceled. In the event of a
transfer of ownership of PCA Common Stock which is not registered in the
transfer records of PCA, a certificate representing the proper number of
shares of Sierra Common Stock may be issued to a transferee if the
Certificate representing such PCA Common Stock is presented to the Exchange
Agent, accompanied by all documents required to evidence and effect such
transfer and by evidence that any applicable stock transfer taxes have been
paid. Until surrendered as contemplated by this Section 2.2, each
Certificate shall be deemed at any time after the Effective Time to
represent only the right to receive upon such surrender the certificate
representing shares of Sierra Common Stock and cash in lieu of any
fractional shares of Sierra Common Stock as contemplated by this Section
2.2.
(c) DISTRIBUTIONS WITH RESPECT TO UNEXCHANGED SHARES. No dividends
or other distributions declared or made after the Effective Time with
respect to Sierra Common Stock with a record date after the Effective Time
shall be paid to the holder of any unsurrendered Certificate with respect
to the shares of Sierra Common Stock represented thereby and no cash
payment in lieu of fractional shares shall be paid to any such holder
pursuant to Section 2.2(f) until the holder of record of such Certificate
shall surrender such Certificate. Subject to the effect of applicable
laws, following surrender of any such Certificate, there shall be paid to
the holder of the certificates representing whole shares of Sierra Common
Stock issued in exchange therefor, without interest, (i) at the time of
such surrender, the amount of any cash payable in lieu of a fractional
share of Sierra Common Stock to which such holder is entitled pursuant to
Section 2.2(f) and the amount of dividends or other distributions with a
record date after the Effective Time theretofore paid with respect to such
whole shares of Sierra Common Stock, and (ii) at the appropriate payment
date, the amount of dividends or other distributions with a record date
after the Effective Time but prior to surrender and a payment date
subsequent to surrender payable with respect to such whole shares of Sierra
Common Stock.
(d) LOST, STOLEN OR DESTROYED CERTIFICATES. In the event that any
certificate for PCA Common Stock shall have been lost, stolen or destroyed,
the Exchange Agent
-5-
<PAGE>
shall issue in exchange therefor, upon the making of an affidavit of that
fact by the holder thereof such shares of Sierra Common Stock and cash in
lieu of fractional shares, if any, as may be required pursuant to this
Agreement provided, however, that Sierra may, in its discretion, require
the delivery of a suitable bond or indemnity.
(e) NO FURTHER OWNERSHIP RIGHTS IN PCA COMMON STOCK. All shares of
Sierra Common Stock issued upon the surrender for exchange of shares of PCA
Common Stock in accordance with the terms hereof (including any cash paid
pursuant to Section 2.2(c) or 2.2(f)) shall be deemed to have been issued
in full satisfaction of all rights pertaining to such shares of PCA Common
Stock, subject, however, to the Surviving Corporation's obligation to pay
any dividends or make any other distributions with a record date prior to
the Effective Time which may have been declared or made by PCA on such
shares of PCA Common Stock in accordance with the terms of this Agreement
or prior to the date hereof and which remain unpaid at the Effective Time,
and there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation of the shares of PCA Common
Stock which were outstanding immediately prior to the Effective Time. If,
after the Effective Time, Certificates are presented to the Surviving
Corporation for any reason, they shall be canceled and exchanged as
provided in this Article II.
(f) NO FRACTIONAL SHARES. No fractions of a share of Sierra Common
Stock shall be issued in the Merger, but in lieu thereof each holder of
shares of PCA Common Stock otherwise entitled to a fraction of a share of
Sierra Common Stock shall, upon surrender of his certificate or
certificates, be entitled to receive an amount of cash (without interest)
determined by multiplying the closing price for Sierra Common Stock as
reported on the New York Stock Exchange ("NYSE") Composite Transactions on
the business day two days prior to the Effective Date by the fractional
share interest to which such holder would otherwise be entitled. The
parties acknowledge that payment of the cash consideration in lieu of
issuing fractional shares was not separately bargained for consideration
but merely represents a mechanical rounding off for purposes of simplifying
the corporate and accounting problems which would otherwise be caused by
the issuance of fractional shares.
(g) TERMINATION OF EXCHANGE FUND. Any portion of the Exchange Fund
which remains undistributed to the stockholders of PCA for six months after
the Effective Time shall be delivered to Sierra, upon demand, and any
stockholders of PCA who have not theretofore complied with this Article II
shall thereafter look only to Sierra for payment of their claim for Sierra
Common Stock, as the case may be, any cash in lieu of fractional shares of
Sierra Common Stock and any dividends or distributions with respect to
Sierra Common Stock.
-6-
<PAGE>
(h) NO LIABILITY. Neither Sierra nor PCA shall be liable to any
holder of shares of PCA Common Stock, or Sierra Common Stock, as the case
may be, for such shares (or dividends or distributions with respect
thereto) or cash from the Exchange Fund delivered to a public official
pursuant to any applicable abandoned property, escheat or similar law.
ARTICLE III. REPRESENTATIONS AND WARRANTIES
3.1. REPRESENTATIONS AND WARRANTIES OF PCA. PCA represents and warrants to
Sierra and Sierra Sub as follows:
(a) ORGANIZATION, STANDING AND POWER. Each of PCA and its
Subsidiaries is a corporation, duly organized, validly existing and in good
standing under the laws of its jurisdiction of organization, has all
requisite corporate power and authority to own, lease and operate its
properties and to carry on its business, including those Subsidiaries
engaged in the insurance business (the "Insurance Subsidiaries"), as now
being conducted, and is duly qualified and in good standing to do business
in each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary except when
the failure to be so qualified would not have a Material Adverse Effect (as
defined below) on PCA. As used in this Agreement, "Material Adverse
Effect" means any change in or effect on the referenced entity that is or
will be materially adverse to the financial condition, businesses, assets
or liabilities of such entity and its Subsidiaries taken as a whole, but
shall not include (i) the effects of changes that are generally applicable
in (A) the health care industry, (B) the United States economy, or (C) the
United States securities markets or (ii) with respect to PCA, any default
in or the acceleration of the maturity or due date of any indebtedness of
PCA.
(b) CAPITAL STRUCTURE. As of the date hereof, the authorized capital
stock of PCA consists of 200,000,000 shares of PCA Common Stock and
10,000,000 shares of preferred stock, $1.00 par value ("PCA Preferred
Stock"). At the close of business on October 31, 1996: (i) 38,828,456
shares of PCA Common Stock were outstanding, 3,784,860 shares of PCA Common
Stock were reserved for issuance upon the exercise of outstanding stock
options (3,449,047 shares of which are subject to outstanding stock
options) or pursuant to PCA's other benefit plans (such stock options and
such benefit plans, collectively, the "PCA Stock Plans"), (ii) no shares of
PCA Common Stock were reserved for issuance upon exercise of the PCA
Rights, (iii) no shares of PCA Common Stock were held by its wholly-owned
Subsidiaries, (iv) no shares of PCA Preferred Stock were outstanding and
(v) except as set forth on Schedule 3.1(b), no warrants, bonds, debentures,
notes or other indebtedness or other security having the right to vote (or
convertible into or exercisable for securities having the right to vote) on
any matters on which stockholders may vote ("Voting Debt"), were issued or
outstanding; since September 30, 1996 there has been no material change in
such share information. All
-7-
<PAGE>
outstanding shares of PCA capital stock are validly issued, fully paid
and nonassessable and not subject to preemptive rights. As of the date
of this Agreement, except for this Agreement, the PCA Stock Options (as
defined in Section 5.7) and the PCA Rights, there are no options,
warrants, calls, rights, or agreements to which PCA or any Subsidiary of
CA is a party or by which it or any such Subsidiary is bound obligating
PCA or any Subsidiary of PCA to issue, deliver or sell, or cause to be
issued, delivered or sold, any shares of capital stock or any Voting Debt
of PCA or of any Subsidiary of PCA or obligating PCA or any Subsidiary of
PCA to grant, extend or enter into any such option, warrant, call, right
or agreement. Assuming compliance by Sierra with Section 5.7 after the
Effective Time, there will be no option, warrant, call, right or agreement
obligating PCA or any Subsidiary of PCA to issue, deliver or sell, or cause
to be issued, delivered or sold, any shares of capital stock or any Voting
Debt of PCA or any Significant Subsidiary of PCA, or obligating PCA or any
Subsidiary of PCA to grant, extend or enter into any such option, warrant,
call, right or agreement.
(c) AUTHORITY. PCA has all requisite corporate power and authority
to enter into this Agreement and subject to approval of this Agreement and
the Merger by the stockholders of PCA, to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby have been duly
authorized by all necessary corporate action on the part of PCA, subject to
such approval of this Agreement by the stockholders of PCA. This Agreement
has been duly executed and delivered by PCA and, subject to such approval
of this Agreement by the stockholders of PCA, constitutes a valid and
binding obligation of PCA enforceable against it in accordance with its
terms. The execution and delivery of this Agreement does not, and the
consummation of the transactions contemplated hereby will not, conflict
with, or result in any violation of, or default (with or without notice or
lapse of time, or both) under, or give rise to a right of termination,
cancellation or acceleration of any obligation or the loss of a material
benefit under, or the creation of a lien, pledge, security interest or
other encumbrance on assets (any such conflict, violation, default, right
of termination, cancellation or acceleration, loss or creation, a
"Violation"), pursuant to any provision of the Certificate of Incorporation
or Bylaws of PCA or any Subsidiary of PCA or, except (i) as set forth on
SCHEDULE 3.1(C) hereto or (ii) as contemplated by the next sentence hereof,
result in any Violation of any loan or credit agreement, note, mortgage,
indenture, lease, Designated Plan (as defined in Section 3.1(o)) or other
agreement, obligation, instrument, permit, concession, franchise, license,
judgment, order, decree, statute, law, ordinance, rule or regulation
applicable to PCA or any Subsidiary of PCA or their respective properties
or assets which Violation would have a Material Adverse Effect on PCA. No
consent, approval, order or authorization of, or registration, declaration
or filing with, any court, administrative agency or commission or other
governmental authority or instrumentality, domestic or foreign (a
"Governmental Entity"), is required by or with respect to PCA or any of its
Subsidiaries in connection with the execution and delivery of this
Agreement
-8-
<PAGE>
by PCA, or the consummation by PCA of the transactions contemplated
hereby, the failure to obtain which would have a Material Adverse Effect
on PCA, except for (i) the filing of a premerger notification report by
PCA under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (the "HSR Act"), (ii) the filing with the Securities and Exchange
Commission (the "SEC") of (A) a proxy statement in definitive form
relating to the meeting of PCA's stockholders, and a meeting of Sierra's
shareholders, to be held in connection with the Merger (the "Proxy
Statement") and (B) such reports under Sections 13(a), 13(d) and 16(a)
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
as may be required in connection with this Agreement and the transactions
contemplated hereby, (iii) the filing of the Merger Filings and
appropriate documents with the relevant authorities of other states in
which PCA is qualified to do business, (iv) such filings, authorizations,
orders and approvals (the "State Approvals") as may be required by foreign,
state or local governmental authorities including those in connection with
PCA's insurance business and those required by the federal Health
Maintenance Organization Act of 1973 and the rules and regulations
thereunder (the "Federal HMO Act"), the applicable provisions of the
Florida, Texas and Puerto Rico laws regulating health maintenance
organizations and prepaid health clinics, and the rules and regulations
thereunder (the "HMO Act"), the applicable provisions of the Florida, Texas
and Puerto Rico Insurance Code and the rules and regulations thereunder
relating to the regulation of domestic insurers, third-party benefits
administrators and to Insurance Holding Company Systems in the State of
Florida (collectively the "Insurance Laws"), the applicable provisions of
Title XVIII of the Social Security Act and the regulations promulgated
thereunder (the "Medicare Laws"), the applicable provisions of Title XIX of
the Social Security Act and the regulations promulgated thereunder and the
Florida and Texas laws and regulations implementing the Medicaid Program
(the "Medicaid Laws"), the Puerto Rico Healthcare Reform Act and the
regulations promulgated thereunder, the applicable provisions of Florida,
Texas and Puerto Rico laws regulating home health agencies and pharmacies
and the regulations promulgated thereunder and the applicable provisions of
the Drug Enforcement Administration laws and regulations regulating
controlled substances (the "Facility Licensing Laws"), and the applicable
provisions of Florida, Texas and Puerto Rico laws respecting certificates
of need and the regulations promulgated thereunder (the "CON Laws") and
(v) such filings, authorizations, orders and approvals (the "State Takeover
Approvals") as may be required by state takeover laws.
(d) SEC DOCUMENTS. PCA has delivered or made available to Sierra a
true and complete copy of each material report, schedule, registration
statement and definitive proxy statement filed by PCA with the SEC since
January 1, 1992 (as such documents have since the time of their filing been
amended, the "PCA SEC Documents") which are all the documents (other than
preliminary material) that PCA has been required to file with the SEC since
such date. As of their respective dates, the PCA SEC Documents complied in
all material respects with the requirements of the Securities Act of 1933,
as
-9-
<PAGE>
amended (the "Securities Act"), or the Exchange Act, as the case may be,
and the rules and regulations of the SEC thereunder applicable to such PCA
SEC Documents and at the time of its filing none of the PCA SEC Documents
contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were
made, not misleading. The consolidated financial statements of PCA
included in the PCA SEC Documents comply as to form in all material
respects with applicable accounting requirements and with the published
rules and regulations of the SEC with respect thereto, have been prepared
in accordance with generally accepted accounting principles applied on a
consistent basis during the periods involved (except as may be indicated in
the notes thereto or, in the case of the unaudited statements, as permitted
by Form 10-Q of the SEC) and fairly present in all material respects
(subject, in the case of the unaudited statements, to normal, recurring
audit adjustments) the consolidated financial position of PCA and its
consolidated Subsidiaries as at the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended.
(e) INFORMATION SUPPLIED. None of the information supplied or to be
supplied by PCA for inclusion or incorporation by reference in (i) the
registration statement on Form S-4 to be filed with the SEC by Sierra in
connection with the issuance of shares of Sierra Common Stock in the Merger
(the "S-4") will, at the time the S-4 is filed with the SEC and at the time
it becomes effective under the Securities Act, contain any untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading, and
(ii) the Proxy Statement will, at the date mailed to stockholders of PCA
and shareholders of Sierra and at the times of the meetings of stockholders
of PCA and shareholders of Sierra to be held in connection with the Merger,
contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they are
made, not misleading. The Proxy Statement will comply as to form in all
material respects with the provisions of the Exchange Act and the rules and
regulations thereunder.
(f) COMPLIANCE WITH APPLICABLE LAWS. Except as set forth on
SCHEDULE 3.1(f), the businesses of PCA and each of its Subsidiaries have
been and are being conducted in compliance in all material respects with
all applicable laws, rules, ordinances, regulations, licenses, judgments,
orders or decrees of federal, state, local and foreign governmental
authorities, except for possible violations which individually or in the
aggregate do not, and, insofar as reasonably can be foreseen, in the future
will not, have a material adverse effect on PCA and its Subsidiaries taken
as a whole. PCA and each of its Subsidiaries hold all certificates of
authority, franchises, grants, permits, licenses, easements, consents,
certificates, variances, exemptions, orders and approvals from all
Governmental Entities (collectively, "PCA Permits") which are necessary to
own, lease and operate the assets and properties they currently own, lease
and operate
-10-
<PAGE>
and to conduct their respective businesses and operations in the manner
heretofore conducted and as proposed to be conducted, except for those
PCA Permits, the absence of which would not have a Material Adverse Effect
on PCA. SCHEDULE 3.1(f) contains a list of all PCA Permits the violation
of which would have a Material Adverse Effect on PCA, including the
jurisdictions in which PCA or one or more of its Subsidiaries holds a
license or are otherwise authorized to conduct insurance business and the
types or lines of insurance which PCA or one or more of its Subsidiaries is
permitted to write in such jurisdictions. Except as set forth on SCHEDULE
3.1(F), no notice has been received and, after due inquiry of management,
no investigation or review is pending or, to PCA's knowledge, threatened by
any Governmental Entity with regard to (i) any alleged violation by PCA or
any of its Subsidiaries of any law, rule, regulation, ordinance, PCA
Permit, judgment, order or decree or (ii) any alleged failure to have or
any violation of any PCA Permit, which violation or failure would have a
Material Adverse Effect on PCA. Neither PCA nor any of its Subsidiaries
nor to PCA's knowledge any of its or their respective executive officers,
directors or employees (in their capacities as such) has engaged in any
activity constituting fraud or abuse under the laws relating to health
care, insurance or the regulation of professional corporations.
(g) FINANCIAL STATEMENTS.
(i) PCA has delivered, or (if not yet available) will promptly
deliver when available (and in any event prior to the Effective Time), to
Sierra complete and correct copies of (i) the consolidated balance sheets
of PCA and each of its then-existing Subsidiaries as at December 31, 1995,
1994, 1993, 1992, 1991, and the related audited statements of income and
stockholders' equity and cash flows, for the fiscal years ended on those
dates, together with all footnotes and (ii) the unaudited consolidated
interim financial statements for PCA and each of its Subsidiaries as at,
and for the fiscal periods ended on September 30, 1996 and 1995 and each
subsequent quarterly reporting date. All of such financial statements
fairly present or when delivered will fairly present, as the case may be
(subject, in the case of unaudited interim financial statements, to normal,
recurring adjustments which are not expected to be, individually or in the
aggregate, materially adverse to PCA and its Subsidiaries taken as a
whole), in all material respects, the financial position, results of
operations and cash flows of PCA and each of its Subsidiaries as at the
respective dates of such balance sheets and for each of the respective
periods then ended, in conformity with (A) generally accepted accounting
principles prevailing in the United States ("U.S. GAAP") and (B) in the
case of each of the Insurance Subsidiaries, statutory or other accounting
practices prescribed or permitted by the insurance regulatory authorities
in the States of Florida and Texas or in Puerto Rico, as appropriate, in
each case applied on a basis consistent throughout the reported periods.
-11-
<PAGE>
(ii) Except as set forth on SCHEDULE 3.1(g), neither such financial
statements nor the financial statements of PCA included in the PCA SEC
Documents (i) contain or when delivered will contain, as the case may be,
any item of extraordinary or non-recurring income or expense (except as
specified therein); (ii) reflect or when delivered will reflect, as the
case may be, uncollectible accounts receivable without a reserve fairly
stated for uncollectible amounts; and (iii) reflect or when delivered will
reflect, as the case may be, any write-off or revaluation of assets (except
as specified therein). As at the respective dates of the balance sheets
included in all such financial statements, there was no liability,
indebtedness or obligation of any nature or in any amount that should
properly be reflected or provided for in financial statements prepared in
conformity with U.S. GAAP or statutory accounting practices prescribed or
permitted by the applicable insurance regulatory authorities, whichever is
appropriate, applied on a basis consistent with that for prior periods,
which was not fully reflected in such financial statements.
(iii) Except as set forth on SCHEDULE 3.1(g), the reserves
recorded in the accounting records of each of the Insurance Subsidiaries
for insurance policy benefits, losses, claims and expenses and any other
reserves are reasonable and adequate and were prepared in accordance with
the statutory or other accounting practices prescribed or permitted by the
applicable insurance regulatory authorities and of all the jurisdictions in
which the Insurance Subsidiaries are licensed to transact an insurance
business and make good and sufficient provisions for all insurance
obligations of PCA and its Subsidiaries. Such reserves have been opined
upon as reasonable and adequate as of December 31, 1995, by Towers Perrin
Integrated Health Systems Consulting and Insurance Industry Consultants,
Inc., each a duly qualified actuarial firm that, as of the date of its
report, was a member in good standing in the American Academy of Actuaries.
William M. Mercer, Incorporated ("Mercer"), a duly qualified actuarial firm
that is a member in good standing in the American Academy of Actuaries, has
evaluated the unpaid loss and loss adjustment expense liabilities of PCA's
property and casualty Subsidiary, PCA Property & Casualty Insurance Company
("PCA P&C"), as of September 30, 1996, with respect to certain "blocks" of
business (the "Workers' Compensation Business"), a draft report with
respect to which has been provided to Sierra.
(h) LITIGATION. Except (i) as set forth on SCHEDULE 3.1(h), (ii) as
disclosed in the SEC Documents and (iii) for actions and suits arising in
the ordinary course of the insurance business, none of which is reasonably
expected to have a Material Adverse Effect on PCA, there is no action,
suit, proceeding or investigation, either at law or in equity, at or before
any commission or other administrative authority in any domestic or foreign
jurisdiction, of any kind now pending or, to PCA's knowledge, threatened,
involving PCA, any of its Subsidiaries or any of the respective properties
or assets of PCA or any Subsidiary of PCA that (i) if asserted is
reasonably expected to have a
-12-
<PAGE>
Material Adverse Effect on PCA, (ii) questions the validity of this
Agreement or (iii) seeks to delay, prohibit or restrict in any manner the
Merger or any action taken or to be taken by PCA or any of its Subsidiaries
under this Agreement. Except as set forth on SCHEDULE 3.1(h), none of PCA
nor any of its Subsidiaries, nor any of their respective properties or
assets, is subject to any continuing order of, consent decree, settlement
agreement or other similar written agreement (other than agreements related
to the settlement of insurance claims in the ordinary course of business),
continuing investigation (other than regularly scheduled audits) by any
court, Governmental Entity, or any judicial, administrative or arbitral
judgment, order, writ, decree, injunction, restraint, or award of any
court, Governmental Entity or arbitrator, including without limitation
cease-and-desist or other orders. Neither PCA nor any of its Subsidiaries
has agreed to, or is bound by, any extension or waiver of the statute of
limitations relating to any pending or potential action, suit, claim,
proceeding or investigation involving PCA or any of its Subsidiaries
(other than extensions or waivers in connection with the settlement of
insurance claims in the ordinary course of business).
(i) LABOR AND EMPLOYMENT MATTERS. Neither PCA nor any of its
Subsidiaries has employees who are represented by a labor union or
organization, no labor union or organization has been certified or
recognized as a representative of any such employees, and neither PCA nor
any of its Subsidiaries is a party to or has any obligation under any
collective bargaining agreement or other contract or agreement with any
labor union or organization. There are no pending or, to PCA's knowledge,
threatened, representation campaigns, elections or proceedings or questions
concerning union representation involving any employees of either PCA or
any of its Subsidiaries. Neither PCA nor any of its Subsidiaries has any
knowledge of any activities or efforts of any labor union or organization
(or representatives thereof) to organize any of its employees, any demands
for recognition or collective bargaining, any strikes, slowdowns, work
stoppages or lock-outs of any kind, or threats thereof, by or with respect
to any employees of PCA or any of its Subsidiaries, and no such activities,
efforts, demands, strikes, slowdowns, work stoppages or lock-outs occurred
during a three-year period preceding the date hereof. Neither PCA nor any
of its Subsidiaries has engaged in, admitted committing, or been held in
any administrative or judicial proceeding to have committed any unfair
labor practice under the National Labor Relations Act, as amended. Except
as set forth on SCHEDULE 3.1(i), neither PCA nor any of its Subsidiaries is
involved in any industrial or trade dispute or any dispute or negotiation
regarding a claim of material importance with any labor union or
organization concerning its employees, and there are no controversies,
claims, demands or grievances of material importance pending or, so far as
PCA is aware, threatened, between PCA or any of its Subsidiaries and any of
their respective employees.
(j) ABSENCE OF CERTAIN CHANGES. Since December 31, 1995 and except
(i) as set forth in SCHEDULE 3.1(j), (ii) for the execution and delivery of
this Agreement and
-13-
<PAGE>
changes in its properties or business attributable to the transactions
contemplated by this Agreement, (iii) as disclosed in PCA's financial
statements or in the PCA SEC Reports previously delivered or made available
to Sierra and Sierra Sub and (iv) sales and purchases of investment
securities in the ordinary course, neither PCA nor any of its Subsidiaries:
(i) had any change in its financial condition or businesses,
assets or liabilities, other than changes which have not had,
individually or in the aggregate, a Material Adverse Effect on PCA;
(ii) suffered any damage, destruction or loss of physical property
(not adequately covered by insurance) that, individually or in the
aggregate, has had a Material Adverse Effect on PCA;
(iii) issued, sold or otherwise disposed of, or, since October 31,
1996, redeemed, purchased or otherwise acquired, or agreed to issue,
sell or otherwise dispose of, redeem, purchase or otherwise acquire,
any capital stock or any other security of PCA or any of its
Subsidiaries or granted or agreed to grant any option warrant or other
right to subscribe for or to purchase any capital stock or any other
security of PCA or any of its Subsidiaries;
(iv) incurred or agreed to incur any material indebtedness for
borrowed money;
(v) paid or obligated itself to pay in excess of $500,000 in the
aggregate for any fixed assets;
(vi) [intentionally omitted];
(vii) sold, transferred, leased or otherwise disposed of, or
agreed to sell, transfer, lease or otherwise dispose of, (A) any
properties or assets to any director or officer of PCA or of any
Subsidiary of PCA or any member of the family or any other affiliate
of any of the foregoing or (B) any properties or assets having a fair
market value of $250,000 or agreed to sell, transfer, lease or
otherwise dispose of, any assets (other than securities) having a fair
market value at the time of sale, transfer or disposition of $250,000;
(viii) mortgaged, pledged or subjected to any material charge,
lien, claim or encumbrance, or agreed to mortgage, pledge or subject
to any material charge, lien, claim or encumbrance any of its material
properties or assets;
-14-
<PAGE>
(ix) declared, set aside or paid any dividend or made any
distribution (whether in cash, property or stock) with respect to any
of its capital stock;
(x) (A) increased, or agreed to increase, the compensation or
bonuses or special compensation of any kind of any of its directors,
officers or employees (other than insurance agents or independent
contractors) over the rate being paid to them on December 31, 1995, as
set forth in PCA's Proxy Statement for the 1996 Annual Meeting of
Stockholders ("PCA's 1996 Proxy Statement"), other than normal merit
and cost-of-living increases pursuant to customary arrangements
consistently followed, or (B) since July 1, 1996, paid any bonus or
similar compensation to any director, officer or employee of PCA or
any Subsidiary of PCA in excess of $100,000, or (C) entered into any
employment, consulting or severance agreement or arrangement with any
director, officer or employee (other than any agent or independent
contractor) or adopted or increased any benefit under any insurance,
pension or other employee benefit plan, payment or arrangement made
to, for or with any director, officer or employee (other than any
agent or independent contractor);
(xi) has terminated, or been notified in writing of the likely
termination of, a material contract with a hospital or other provider,
a self-insured employer, a union or other association, a government
agency or a national insurance carrier or any other material contract
regarding managed care services or insurance services;
(xii) neither PCA nor any of its Subsidiaries has entered into a
contract or arrangement with an individual or entity (including a
network of health care providers) providing for the rendering of
professional health care services by such person as an employee of or
contractor to PCA (other than a provider of in-patient care) under
which, during the last 12 months, PCA was obligated or became
committed to pay in excess of $500,000 or under which, during the next
12 months, PCA is reasonably expected to pay or to become obligated to
pay in excess of $500,000, except for such contracts that are
terminable by PCA upon 90 days advance notice without penalty;
(xiii) except as otherwise required or provided for in this
Agreement and except in the ordinary course of business, made or
permitted any material amendment or termination of any material
contract, lease, concession, franchise, license, indenture,
instrument, mortgage, note, loan or credit agreement or other
obligation to which it is a party;
(xiv) had any resignation or termination of employment of any
of its key officers or employees, or become aware of any impending or
threatened
-15-
<PAGE>
termination of employment, that would, individually or in the
aggregate, have a Material Adverse Effect on PCA;
(xv) had any labor trouble or concerted work stoppage or knows of
any impending or threatened labor trouble or concerted work stoppage;
(xvi) canceled, or agreed to cancel, any debts or claims over
$500,000 in the aggregate or $250,000 individually other than in the
ordinary course of business;
(xvii) made any material change in its accounting methods or
practices with respect to its condition, operations, business,
properties, assets or liabilities;
(xviii) entered into any material transaction not in the ordinary
course of its business;
(xix) made any charitable or political contribution or pledge in
excess of $100,000 in the aggregate;
(xx) agreed or committed to do, or authorized or approved any
action looking to, any of the foregoing;
(xxi) paid aggregate commissions to insurance agents and
independent contractors for policies issued in 1995 and with normal
anniversary dates of January 1, 1995 or subsequent thereto in excess
of 15% of direct premiums written or;
(xxii) made any material cash payments to insurance agents,
independent contractors or brokers other than pursuant to a Producer
Profit Share Agreement.
(k) MATERIAL CONTRACTS. Except as set forth in SCHEDULE 3.1(k),
neither PCA nor any of its Subsidiaries is a party to any written or oral:
(i) employment or consulting contract or other contract for
services involving a payment of more than $250,000 annually and that
is not terminable without cost upon thirty (30) days' prior written
notice;
(ii) material lease, franchise or concession providing for a
payment by any person of more than $500,000 annually;
-16-
<PAGE>
(iii) loan agreement, mortgage, indenture, promissory note, financing
lease or other instrument relating to any debt (in excess of $250,000 and
which, in the aggregate, do not amount to more than $1,000,000);
(iv) contract of purchase or sale involving more than $500,000 and
that is not in the ordinary course of business;
(v) partnership, joint venture, material license or similar
agreement;
(vi) stand-by letter of credit, guarantee or performance bond;
(vii) contract restricting the ability of any person from freely
engaging in any business or competing anywhere in the world;
(viii) material contract with a hospital or other provider, a
self-insured employer, a union or other association, a governmental
agency or a national insurance carrier or any other material contract
regarding managed care services or insurance services;
(ix) contract or arrangement with an individual or entity (including
a network of health care providers) providing for the rendering of
professional health care services by such person as an employee of or
contractor to PCA (other than a provider of in-patient care) under which,
during the last 12 months, PCA was obligated or became committed to pay in
excess of $1,000,000 except for such contracts that are terminable by PCA
upon 90 days advance notice without penalty; or
(x) other material contract or commitment not made in the ordinary
course of business.
Each contract or other agreement listed in SCHEDULE 3.1(k) is in full force and
effect and is valid and enforceable by PCA or a Subsidiary of PCA, as the case
may be, in accordance with its terms. Except as set forth on SCHEDULE 3.1(k),
neither PCA nor any of its Subsidiaries is in default in the observance or the
performance of any term or obligation to be performed by it under any contract
listed in SCHEDULE 3.1(k) except for such defaults the effect of which singly
or in the aggregate would not have a Material Adverse Effect on PCA. To the
knowledge of PCA without investigation, no other person is in default in the
observance or the performance of any term or obligation to be performed by it
under any material contract listed in SCHEDULE 3.1(k). There is currently no
outstanding bid or contract proposal by PCA or any of its Subsidiaries which,
if accepted or entered into, might reasonably be expected to result in a
material loss to either PCA or any of its Subsidiaries, except with respect to
losses occurring in the
-17-
<PAGE>
ordinary course of business. PCA has delivered or made available to Sierra
and Sierra Sub copies of all contracts listed in the schedules hereto.
(l) OFFICERS AND DIRECTORS AND EMPLOYEES. PCA's 1996 Proxy Statement, as
modified by SCHEDULE 3.1(l), sets forth a list of:
(i) The names of all directors and officers of PCA and each of its
Subsidiaries;
(ii) The name and current annual rate of compensation (including
bonuses and other forms of compensation) paid by PCA and its Subsidiaries
to each of its respective officers, directors and employees whose annual
rate of base compensation exceeded $100,000 for the year ended
December 31, 1995; and
(iii) The names of all persons who have written employment,
consulting or severance agreements or arrangements with PCA or any of
its Subsidiaries if such agreement or arrangement provides for payment
to such persons resulting from such person's resignation, from a
change-in-control of PCA or any of its Subsidiaries or from a change
in such person's responsibilities following a change-in-control,
complete and correct copies of such agreements have been completed to
Sierra.
(m) TITLE TO AND CONDITION OF PROPERTIES AND ASSETS.
(i) PCA and its Subsidiaries have good and defensible title to,
or valid leasehold interests in, their respective material properties
and assets, whether owned or leased, including, without limitation,
(i) those used in their respective businesses, and (ii) those
reflected in the consolidated balance sheet of PCA as of September 30,
1996 most recently delivered to Sierra (except as since sold or
otherwise disposed of in the ordinary course of business and except
for minor defects in title, easements, restrictive covenants and
similar encumbrances or impediments that, individually or in the
aggregate, do not and will not materially interfere with the ability
of PCA and its Subsidiaries to use their properties or to conduct
their businesses as currently conducted), in each case subject to no
mortgage, pledge, conditional sales contract, lien, security interest,
right of possession in favor of any third party, claim or other
encumbrance (collectively "Liens"), except for (w) the lien of current
Taxes (as hereinafter defined) not yet due and payable, (x) with
respect to leased property, the provisions of such leases, (y) Liens
granted to PCA's lenders under that certain Revolving Credit Agreement
(the "PCA Credit Facility") between PCA and Citibank, N.A. dated
October 27, 1994, as amended on September 22, 1995 and March 29, 1996
and (z) liens, that, individually or in the aggregate, do not and will
not materially
-18-
<PAGE>
interfere with the ability of PCA or any of its Subsidiaries to conduct
business as currently conducted. Except as described on SCHEDULE 3.1(m),
subsequent to December 31, 1995, neither PCA nor any of its Subsidiaries
has sold or disposed of any of their respective properties or assets or
obligated themselves to do so except in the ordinary course of business.
The facilities, machinery, furniture, office and other equipment of PCA
and each of its Subsidiaries that are used in their respective businesses
are in good operating condition and repair, subject to the ordinary wear
and tear of those businesses.
(ii) All of the real property owned or leased by PCA or any of
its Subsidiaries has been maintained by PCA in compliance with all
federal, state and local environmental protection, occupational,
health and safety or similar laws, ordinances, restrictions, licenses
and regulations, except where the failure to so maintain the property
would not have a Material Adverse Effect on PCA.
(n) PATENTS, COPYRIGHTS, SERVICE MARKS AND TRADEMARKS. Neither PCA
nor any of its Subsidiaries own or licenses any patent, copyright, service
mark, trademark or other intellectual property right, other than such
patents, copyrights, service marks, trademarks and other intellectual
property rights as are described in SCHEDULE 3.1(n), except for such
intellectual property rights the loss of which singly or in the aggregate
would not have a Material Adverse Effect on PCA. Except as set forth on
SCHEDULE 3.1(n) and other than such as would have a Material Adverse Effect
on PCA: (i) PCA and its Subsidiaries own or license all patents,
copyrights, service marks, trademarks and other intellectual property
rights that are necessary to the conduct of their respective businesses,
(ii) all names under which PCA or any of its Subsidiaries currently
conducts business are set forth in SCHEDULE 3.1(n), (iii) no claim has been
made, and to PCA's knowledge no basis for any such claim exists, that PCA
or any of its Subsidiaries has infringed any patent, copyright, service
mark, trademark or other intellectual property right of any other person
and (iv) no claim has been made, and to PCA's knowledge no basis for any
such claim exists, that any person has infringed on any patent, copyright,
service mark, trademark or other intellectual property right of PCA or any
of its Subsidiaries.
(o) EMPLOYEE BENEFIT PLANS.
(i) LIST OF PLANS. SCHEDULE 3.1(o) includes a complete and
accurate list of all employee benefit plans ("Plans"), as defined in
Section 3(3) of the Employee Retirement Income Security Act of 1974,
as amended ("ERISA"), and material benefit arrangements that are not
Plans ("Benefit Arrangements"), including, but not limited to any (A)
employment or consulting agreements, (B) incentive bonus or deferred
bonus arrangements, (C) arrangements providing termination allowance,
severance or similar benefits, (D) equity compensation
-19-
<PAGE>
plan, and (E) deferred compensation plans, (F) cafeteria plans, (G)
employee assistance programs, (H) bonus programs, (I) scholarship programs,
(J) vacation policies, and (K) stock option plans that are currently
in effect or were maintained within three years of the Effective Time,
or have been approved before the Effective Time but are not yet
effective, for the benefit of directors, officers, employers or former
employees (or their beneficiaries) of PCA or a Controlled Company
("Designated Plans"). For purposes of this Section 3.1(o), "Controlled
Company" shall mean any entity that, together with PCA as of the relevant
determination date under ERISA, is or was required to be treated as a
single employer under Section 414 of the Code and any reference to PCA in
this Section 3.1(o) shall also include a reference to a Controlled Company.
(ii) NO TITLE IV PLANS OR VEBAS. Neither PCA nor any entity
(whether or not incorporated) that was at any time during the six
years before the Effective Time treated as a single employer together
with PCA under Section 414 of the Code has ever maintained, had any
obligation to contribute to or incurred any liability with respect to
a pension plan that is or was subject to the provisions of Title IV of
ERISA or Section 412 of the Code. Neither PCA nor any entity (whether
or not incorporated) that was at any time during the six years before
the Effective Time treated as a single employer together with PCA
under Section 414 of the Code has ever maintained, had an obligation
to contribute to, or incurred any liability with respect to a
multiemployer pension plan as defined in Section 3(37) of ERISA.
During six years before the Effective Time, PCA has not maintained,
had an obligation to contribute to or incurred any liability with
respect to a voluntary employees beneficiary association that is or
was intended to satisfy the requirements of Section 501(c)(9) of the
Code.
(iii) DISCLOSED PLANS. With respect to each Designated Plan,
PCA has delivered to Sierra, as applicable, true and complete copies
of (A) all written documents comprising such Plan or each Benefit
Arrangement (including amendments and individual agreements relating
thereto); (B) the trust, group annuity contract or other document that
provides for the funding of the Designated Plan or the payment of
Designated Plan benefits, (C) the three most recent annual Form 5500,
990 and 1041 reports (including all schedules thereto) filed with
respect to the Designated Plan; (D) the most recent actuarial report,
valuation statement or other financial statement; (E) the most recent
Internal Revenue Service determination letter ("IRS") and all rulings
or determinations requested from the IRS after the date of that
determination letter; (F) the summary plan description currently in
effect and all material modifications thereto; and (G) all other
correspondence from the IRS or Department of Labor received that
relate to one or more of the Designated Plans with respect to any
matter, audit or inquiry that is still pending. All information
provided by PCA and its
-20-
<PAGE>
Subsidiaries to the individuals who prepared any such financial
statements was true, correct and complete in all material respects.
Each financial or other report delivered to Sierra pursuant hereto is
accurate in all material respects, and there has been no material
adverse change in the financial status of any Designated Plan since
the date of the most recent report provided with respect thereto.
(iv) COMPLIANCE WITH LAW. Except as set forth in SCHEDULE 3.1(o),
PCA has operated, and has caused its appointees and nominees to
operate, each Designated Plan in a manner which is in material
compliance with the terms thereof and with all applicable law,
regulations and administrative agency rulings and requirements
applicable thereto, the violation of which would not have a material
adverse effect on PCA and its Subsidiaries taken as a whole. Except
as otherwise disclosed in SCHEDULE 3.1(o), with respect to each
Designated Plan that is a Plan (A) the Plan is in compliance with
ERISA in all material respects, including but not limited to all
reporting and disclosure requirements of Part 1 of Subtitle B of
Title I of ERISA; (B) the appropriate Form 5500 has been timely filed,
for each year of its existence; (C) there has been no transaction
described in sections 406 or 407 of ERISA or section 4975 of the Code
relating to the Plan unless exempt under section 408 of ERISA or
section 4975 of the Code, as applicable; and (D) the bonding
requirements of section 412 of ERISA have been satisfied.
(v) CONTRIBUTIONS. Full payment has been made of all amounts
which PCA or a Controlled Company is required, under applicable law or
under any Designated Plan or any agreement related to any Designated
Plan to which PCA or a Controlled Company is a party, to have paid as
contributions thereto as of the last day of the most recent fiscal
year of each Designated Plan ended prior to the date hereof. Benefits
under all Designated Plans are as represented in the governing
instruments provided pursuant to (i) above, and have not been
increased subsequent to the date as of which documents have been
provided.
(vi) TAX QUALIFICATION. Each Designated Plan, as amended to date,
that is intended to be qualified under Section 401(a) and 501(a) of
the Code has been determined to be so qualified by the IRS, has been
submitted to the IRS for a determination with respect to such
qualified status or the remedial amendment period established under
Section 402(b) of the Code with respect to the Designated Plan will
not have expired prior to the Effective Time. Except as disclosed on
SCHEDULE 3.1(o), no facts have occurred which if known by the IRS
could cause disqualification of any such Plan.
(vii) TAX OR CIVIL LIABILITY. Neither PCA nor a Controlled
Company has participated in, or is aware of, any conduct that could
result in the imposition
-21-
<PAGE>
upon PCA of any excise tax under Sections 4971 through 4980B of the
Code or civil liability under Section 502(i) of ERISA with respect to
any Designated Plan.
(viii) CLAIMS LIABILITY. There is no action, claim or demand of
any kind (other than routine claims for benefits) that has been
brought or, to PCA's knowledge, threatened against, or relating to,
any Designated Plan, and PCA has no knowledge of any pending
investigation or administrative review by any Governmental Entity
relating to any Designated Plan.
(ix) RETIREE WELFARE COVERAGE. Except as set forth in
SCHEDULE 3.1(o), no Designated Plan provides any health, life or other
welfare coverage to employees of PCA or a Controlled Company beyond
termination of their employment with PCA or a Controlled Company by
reason of retirement or otherwise, other than coverage as may be
required under Section 4980B of the Code or Part 6 of ERISA, or under
the continuation of coverage provisions of the laws of any state or
locality.
(x) NO EXCESS PARACHUTE PAYMENTS. No amount that could be
received (whether in cash or property or the vesting of property) as a
result of any of transactions contemplated by this Agreement by any
employee, officer or director of PCA or a Controlled Company who is a
"disqualified individual" (as such term is defined in proposed
Treasury Regulation Section 1.280G-1) under any employment, severance
or termination agreement, other compensation arrangement or Designated
Plan currently in effect would be characterized as an "excess
parachute payment" (as such term is defined in Section 280G(b)(1) of
the Code).
(p) TRANSACTIONS WITH OFFICERS, DIRECTORS AND OTHERS. Except as set
forth on SCHEDULE 3.1(p), no director, officer or affiliate of PCA, or any
member of the immediate family or any other affiliate of any of the
foregoing, is a party to business arrangements or relationships of any kind
with PCA or its Subsidiaries in which the amount involved exceeds $60,000,
or, to the knowledge of PCA, owns or has an ownership interest in any
corporation (in excess of 5% of any publicly traded corporation) or other
entity that is a party to, or in any property which is the subject of any
such business arrangements.
(q) INSURANCE MATTERS--REINSURANCE AND COINSURANCE. SCHEDULE 3.1(q)
contains a list of all reinsurance or coinsurance treaties or agreements to
which PCA or any of its Subsidiaries is a party. All such treaties or
agreements as set forth in such Schedule are valid, binding and in full
force and effect in accordance with their terms (except as the
enforceability thereof may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting creditors'
rights generally or
-22-
<PAGE>
by the principles governing the availability of equitable remedies); and
neither PCA nor its Insurance Subsidiaries nor, to PCA's knowledge, any
other party thereto is in default as to any provision thereof, except for
such defaults the effect of which singly or in the aggregate would not have
a Material Adverse Effect on PCA, and none of such agreements contains any
provision (A) providing that any other party thereto may terminate such
agreement or declare a default or seek damages thereunder by reason of the
transactions contemplated by this Agreement or (B) which would be altered
or otherwise become applicable by reason of such transactions. PCA does
not know of any facts or events that could cause the financial condition of
any party to any such agreement to be impaired to such an extent that a
default thereunder may be reasonably anticipated.
(r) TAXES.
(i) DEFINITIONS. For purposes of this Agreement:
(A) "Code" means the Internal Revenue Code of 1986, as
amended.
(B) "Returns" means any returns, reports or statements
(including any information returns) required to be filed for
purposes of a particular Tax.
(C) "Tax" or "Taxes" means all federal, state, local or
foreign net or gross income, gross receipts, net proceeds,
premium, capital, sales, use, ad valorem, value added, franchise,
withholding, payroll, employment, disability, workers'
compensation, excise, property, alternative or add-on minimum,
environmental or other taxes, assessments, duties, fees,
levies or other governmental charges of any nature whatever,
whether disputed or not, together with any interest,
penalties, additions to tax or additional amounts with respect
thereto.
(D) "Taxing Authority" means any governmental agency,
board, bureau, body, department or authority of any United
States federal, state or local jurisdiction, or any foreign
jurisdiction, having or purported to exercise jurisdiction with
respect to any Tax.
(ii) TAX REPRESENTATIONS. Except as set forth in SCHEDULE 3.1(r):
(A) All Returns required to have been filed on or before
the date hereof by or with respect to PCA or any of its Subsidiaries
or any affiliated, combined, consolidated, unitary or similar group
of which PCA
-23-
<PAGE>
or its Subsidiaries is or was a member (a "Relevant Group") with any
Taxing Authority have been duly and timely filed, and each such
Return correctly and completely reports all material information
required to be reported thereon. All Taxes of PCA or its
Subsidiaries or any member of a Relevant Group (whether or not shown
on any Return) with respect to any period ending on or before the
date hereof have been paid or are duly reserved for in the financial
statements of PCA and its Subsidiaries for such period.
(B) Neither PCA nor any of its Subsidiaries has waived any
statute of limitations in respect of Taxes or agreed to any
extension of time with respect to any Tax assessment or deficiency.
(C) PCA is not currently under audit by any Taxing
Authority with respect to any material Return. PCA's consolidated
federal income tax returns have been audited through
December 31, 1992. No claim is pending by any Taxing Authority in
a jurisdiction in which PCA or any of its Subsidiaries does not file
Returns, that it is subject to Taxation in that jurisdiction.
(D) Other than agreements among PCA and its Subsidiaries,
neither PCA nor any of its Subsidiaries is a party to any tax
allocation or tax sharing agreement.
(E) Neither PCA nor any of its Subsidiaries is a
"consenting corporation" within the meaning of Section 341(f)(1) of
the Code or comparable provisions of any state statute, and none of
the assets of PCA or its Subsidiaries is subject to any election
under Section 341(f) of the Code or comparable provisions of any
state statutes.
(F) Neither PCA nor any of its Subsidiaries has received
or requested any ruling of a Taxing Authority relating to Taxes or
entered into any material written or legally binding agreement
with a Taxing Authority relating to Taxes.
(G) Neither PCA nor any of its Subsidiaries (1) has or is
projected to have a material amount includible in its income for the
current taxable year under Section 951 of the Code, (2) has been a
passive foreign investment company within the meaning of Section 1296
of the Code, and neither PCA nor any of its Subsidiaries is a
shareholder, directly or indirectly in any passive foreign investment
company, or (3) has a material unrecaptured overall foreign loss
within the meaning of Section 940(f) of the Code.
-24-
<PAGE>
(H) Neither PCA nor any of its Subsidiaries is, or at any
time has been, subject to (1) the dual consolidated loss provisions
of Section 1503(d) of the Code, (2) the overall foreign loss
provisions of Section 904(f) of the Code, or (3) the
recharacterization provisions of Section 952(c)(2) of the Code.
(I) None of the assets of PCA or any of its Subsidiaries
constitutes tax-exempt bond financed property or tax-exempt use
property, within the meaning of Section 168 of the Code.
Neither PCA nor any of its Subsidiaries is a party to any "safe
harbor lease" that is subject to the provisions of Section 168(f)(3)
of the Internal Revenue Code as in effect prior to the Tax Reform Act
of 1986, or to any "long-term contract" within the meaning of
Section 460 of the Code.
(J) Neither PCA nor any of its Subsidiaries has any
material (1) deferred gain or loss arising out of any deferred
intercompany transaction or (2) income which will be reportable in a
period ending after the Closing Date which is attributable to a
transaction occurring in, or a change in accounting method made for,
a period ending on or prior to the Closing Date.
(K) Neither PCA nor any of its Subsidiaries is a party
to any written, oral or implied agreement or obligation to provide any
"covered employee," as defined in Section 162(m)(3) of the Code, with
remuneration in excess of $1 million, that would be disallowed as a
deduction for Federal income tax purposes pursuant to Section 162(m)
of the Code.
(iii) REPRESENTATIONS RELATING TO TAX-FREE REORGANIZATION.
(A) In the Merger, shares of PCA Common Stock representing
control of PCA, as defined in Section 369(c) of the Code, will be
exchanged solely for voting stock of Sierra.
(B) PCA is not an investment company within the meaning of
Section 368(a)(2)(F)(iii) of the Code.
(C) Neither PCA nor any of its Subsidiaries is under the
jurisdiction of a court in a Title 11 or similar case within the
meaning of Section 368(a)(3)(A) of the Code.
(D) To the knowledge of PCA there is no plan or intention on
the part of PCA stockholders to sell, exchange or otherwise dispose
of a number of shares of Sierra Common Stock received by them for
shares of PCA Common Stock pursuant to the Merger, nor to enter
into any puts, calls, straddles, spreads or
-25-
<PAGE>
similar transactions, that would reduce PCA stockholders' ownership
for U.S. federal income tax purposes of Sierra's Common Stock to a
number of shares having a value, as of the Effective Time, of less
than 50 percent of the value of all of the formerly outstanding stock
of PCA as of the same date. For purposes of this representation,
shares of PCA Common Stock surrendered by dissenters or exchanged for
cash in lieu of fractional shares of Sierra Common Stock are treated
as outstanding shares of PCA Common Stock at the Effective Time.
Moreover, shares of PCA Common Stock and shares of Sierra Common Stock
held by PCA stockholders and otherwise sold, redeemed or disposed of
prior to or subsequent to the Merger will be considered in making
this representation.
(E) At the Effective Time, the fair market value of the assets
of PCA will exceed the sum of its liabilities, plus the amount of
liabilities, if any, to which such assets are subject.
(F) At the Effective Time, PCA will not have outstanding any
warrants, options, convertible securities, or any other type of right
pursuant to which any person could acquire stock in PCA that, if
exercised or converted, would affect Sierra's acquisition or retention
of control of PCA as defined in Section 368(c)(1) of the Code.
(G) At the Effective Time there will not be any intercorporate
indebtedness existing between Sierra and PCA or between Sierra Sub and
PCA.
(H) PCA, PCA stockholders and Subsidiaries will pay their own
respective expenses, if any, incurred in connection with the Merger.
(I) As of the Effective Time, PCA will hold at least 90% of the
fair market value of its net assets and at least 70% of the fair
market value of its gross assets held immediately before the
commencement of the negotiations of the transaction as contemplated
herein or hereby. For purposes of this representation, amounts paid
by PCA to dissenters, amounts paid by PCA to stockholders who receive
cash and other property, amounts used by PCA to pay reorganization
expenses and all redemptions and distributions (except for regular,
normal dividends) made by PCA will be included as assets of PCA
immediately prior to the transaction.
(J) PCA will not make any extraordinary dividend payments to
its stockholders prior to the Effective Time, or in contemplation
of the Merger.
(s) OPINION OF FINANCIAL ADVISOR. PCA has received the opinion of
Bear, Stearns & Co. dated the date hereof, to the effect that the Merger is
fair, from a financial
-26-
<PAGE>
point of view, to the stockholders of PCA. PCA has delivered a true and
complete copy of this opinion to Sierra.
(t) VOTE REQUIRED. The affirmative vote of a majority of the votes
that holders of the outstanding shares of PCA Common Stock are entitled to
cast is the only vote of the holders of any class or series of PCA capital
stock or Voting Debt necessary to approve this Agreement and the
transactions contemplated hereby (assuming the accuracy of the
representations contained in Sections 3.2(b) and 3.2(u), without giving
effect to the knowledge qualification thereof).
(u) ACCOUNTING MATTERS. Neither PCA nor to the best of its
knowledge, any of its affiliates, has through the date of this Agreement,
taken or agreed to take any action that would prevent Sierra from
accounting for the business combination to be effected by the Merger as a
pooling of interests.
(v) INVESTMENT COMPANY ACT. Neither PCA nor any of its Subsidiaries
is an "investment company", or a company "controlled" by an "investment
company", within the meaning of the Investment Company Act of 1940, as
amended.
(w) APPLICABILITY OF DGCL 203. The provisions of Section 203 of the
DGCL will not, assuming the accuracy of the representations contained in
Section 3.2(u) (without giving effect to the knowledge qualification
thereof), apply to this Agreement or any of the transactions contemplated
hereby.
(x) OWNERSHIP OF SIERRA COMMON STOCK. As of the date hereof, neither
PCA nor, to the best of its knowledge, any of its affiliates or associates
is an "interested stockholder" of Sierra within the meaning of Section 203
of the DGCL.
3.2. REPRESENTATIONS AND WARRANTIES OF SIERRA AND SIERRA SUB. Sierra and
Sierra Sub represent and warrant to PCA as follows:
(a) ORGANIZATION; STANDING AND POWER. Each of Sierra and Sierra Sub
and any other Subsidiary of Sierra is a corporation duly organized, validly
existing and in good standing under the laws of its state of incorporation
or organization and has all requisite corporate power and authority to own,
lease and operate its properties and to carry on its business as now being
conducted, and is duly qualified and in good standing to do business in
each jurisdiction in which the nature of its business or the ownership of
leasing of its properties makes such qualification necessary, except where
the failure to be so qualified would not have a Material Adverse Effect on
Sierra.
(b) CAPITAL STRUCTURE. As of the date hereof, the authorized capital
stock of Sierra consists of 40,000,000 shares of Sierra Common Stock and
1,000,000 shares of
-27-
<PAGE>
Sierra Series A Preferred Stock. As of the close of business on
October 31, 1996: (i) 17,874,403 shares of Sierra Common Stock were
outstanding, (ii) 3,086,153 shares of Sierra Common Stock were reserved
for issuance pursuant to the Sierra stock option plans and Sierra
restricted stock plans (collectively, "Sierra Stock Plans"), (iii) 100,200
shares of Sierra Common Stock were held by Sierra in its treasury, (iv)
209,606 shares of Sierra Series A Preferred were reserved for issuance upon
exercise of the Rights and (v) no Voting Debt of Sierra or any of its
Subsidiaries was issued or outstanding; since September 30, 1996 there has
been no material change in such share information. Between September 30,
1996 and the date of this Agreement Sierra has granted stock options
pursuant to the Sierra Stock Plans as set forth on SCHEDULE 3.2(b). All
outstanding shares of Sierra capital stock are, and the shares of Sierra
Common Stock (x) to be issued pursuant to or as specifically contemplated
by this Agreement, and (y) when issued in accordance with this Agreement,
upon exercise of PCA Stock Options, in accordance with actions permitted by
Section 4.1(c), will be, validly issued, fully paid and nonassessable and
not subject to preemptive rights. As of the date of this Agreement, except
for this Agreement, the Sierra Stock Plans, and the Rights Agreement, there
are no options, warrants, calls, rights or agreements to which Sierra or
any Subsidiary of Sierra is a party or by which it or any such Subsidiary
is bound obligating Sierra or any Subsidiary of Sierra to issue, deliver or
sell, or cause to be issued, delivered or sold, additional shares of
capital stock or any Voting Debt of Sierra or of any Subsidiary of Sierra
or obligating Sierra or any Subsidiary of Sierra to issue, deliver or sell,
or cause to be issued, delivered or sold, additional shares of capital
stock of Sierra or of any Subsidiary of Sierra to grant, extend or enter
into any such option, warrant, call, right or agreement. As of the date
hereof, the authorized capital stock of Sierra Sub consists of 1,000 shares
of Common Stock, par value $.01 per share, of which 100 shares are issued
and outstanding.
(c) AUTHORITY. Sierra and Sierra Sub have all requisite corporate
power and authority to enter into this Agreement and to consummate the
transactions contemplated hereby. The execution and delivery of this
Agreement and the consummation of the transactions contemplated hereby have
been duly authorized by all necessary corporate action on the part of
Sierra and Sierra Sub, except that the approval of Sierra's shareholders of
this Agreement and the Merger and the transactions contemplated hereby may
be required. This Agreement has been duly executed and delivered by Sierra
and Sierra Sub and constitutes a valid and binding obligation of Sierra and
Sierra Sub enforceable against each in accordance with its terms. The
execution and delivery of this Agreement does not, and the consummation of
the transactions contemplated hereby will not, conflict with, or result in
any Violation pursuant to any provision of the Articles of Incorporation or
Bylaws of Sierra, except (i) as set forth on SCHEDULE 3.2(c) hereto or
(ii) as contemplated by the next sentence hereof, result in any Violation
of any loan or credit agreement, note, mortgage, indenture, lease,
Designated Plan or other agreement, obligation, instrument, permit,
concession, franchise, license, judgment, order, decree,
-28-
<PAGE>
statute, law, ordinance, rule or regulation applicable to Sierra or any
Subsidiary of Sierra or their respective properties or assets, which
Violation would have a Material Adverse Effect on Sierra. No consent,
approval, order or authorization of, or registration, declaration or
filing with, any Governmental Entity is required by or with respect to
Sierra or any of its Subsidiaries in connection with the execution and
delivery of this Agreement by Sierra and Sierra Sub or the consummation
by Sierra and Sierra Sub of the transactions contemplated hereby, the
failure to obtain which would have a Material Adverse Effect on Sierra,
except for (i) the filing of a premerger notification report by Sierra
under the HSR Act, (ii) the filing with the SEC of the S-4, the Proxy
Statement (if the approval of Sierra's shareholders is required) and such
reports under Sections 13(a), 13(d) and 16(a) of the Exchange Act, as may
be required in connection with this Agreement, and the transactions
contemplated hereby and the obtaining from the SEC of such orders as may
be so required, (iii) the filing of such documents with, and the obtaining
of such orders from, the various state authorities, including state
securities authorities, that are required in connection with the
transactions contemplated by this Agreement, (iv) the filing of the Merger
Filings with the Secretary of State of the State of Delaware and
appropriate documents with the relevant authorities of other states in
which Sierra is qualified to do business and (v) the State Approvals and
State Takeover Approvals.
(d) SEC DOCUMENTS. Sierra has delivered or made available to PCA a
true and complete copy of each material report, schedule, registration
statement and definitive proxy statement filed by Sierra with the SEC since
January 1, 1992 (as such documents have since the time of their filing been
amended, the "Sierra SEC Documents") which are all the documents (other
than preliminary material) that Sierra was required to file with the SEC
since such date. As of their respective dates, the Sierra SEC Documents
complied in all material respects with the requirements of the Securities
Act or the Exchange Act, as the case may be, and the rules and regulations
of the SEC thereunder applicable to such Sierra SEC Documents, and at the
time of its filing none of the Sierra SEC Documents contained any untrue
statement of a material fact or omitted to state a material fact required
to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading. The
consolidated financial statements of Sierra and its consolidated
Subsidiaries included in the Sierra SEC Documents comply as to form in all
material respects with applicable accounting requirements and with the
published rules and regulations of the SEC with respect thereto, have been
prepared in accordance with generally accepted accounting principles
applied on a consistent basis during the periods involved (except as may be
indicated in the notes thereto or, in the case of the unaudited statements,
as permitted by Form 10-Q of the SEC) and fairly present in all material
respects (subject, in the case of the unaudited statements, to normal,
recurring audit adjustments) the consolidated financial position of Sierra
and its consolidated Subsidiaries as at the dates thereof and the
consolidated results of their operations and cash flows for the periods
then ended.
-29-
<PAGE>
(e) INFORMATION SUPPLIED. None of the information supplied or to be
supplied by Sierra or Sierra Sub for inclusion or incorporation by
reference in (i) the S-4 will, at the time the S-4 is filed with the SEC
and at the time it becomes effective under the Securities Act, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein
not misleading and (ii) the Proxy Statement will, at the date mailed to
shareholders and at the times of the meeting or meetings of shareholders to
be held in connection with the Merger, contain any untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in light of
the circumstances under which they are made, not misleading. The Proxy
Statement will comply as to form in all material respects with the
provisions of the Exchange Act and the rules and regulations thereunder,
and the S-4 will comply as to form in all material respects with the
provisions of the Securities Act and the rules and regulations thereunder.
(f) COMPLIANCE WITH APPLICABLE LAWS. Except as set forth on
SCHEDULE 3.2(f), the businesses of Sierra and each of its Subsidiaries have
been and are being conducted in compliance with all applicable laws, rules,
ordinances, regulations, licenses, judgments, orders or decrees of federal,
state, local and foreign governmental authorities, except for possible
violations which individually or in the aggregate do not, and, insofar as
reasonably can be foreseen, in the future will not, have a material adverse
effect on Sierra and its Subsidiaries taken as a whole. Sierra and each
Subsidiary of Sierra hold all certificates of authority, franchises,
grants, permits, licenses, easements, consents, certificates, variances,
exemptions, orders and approvals from all Governmental Entities
(collectively, "Sierra Permits") which are necessary to own, lease and
operate the assets and properties they currently own, lease and operate and
to conduct their respective businesses and operations in the manner
heretofore conducted and as proposed to be conducted, except for those
Sierra Permits, the absence of which would not have a Material Adverse
Effect on Sierra. SCHEDULE 3.2(f) contains a list of all Sierra Permits
the violation of which would have a Material Adverse Effect on Sierra,
including the jurisdictions in which Sierra or one or more of its
Subsidiaries holds a license or are otherwise authorized to conduct
insurance business and the types or lines of insurance which Sierra or one
or more of its Subsidiaries is permitted to write in such jurisdictions.
No notice has been received and, after due inquiry of management, no
investigation or review is pending or, to Sierra's knowledge, threatened by
any Governmental Entity with regard to (i) any alleged violation by Sierra
or any of its Subsidiaries of any law, rule, regulation, ordinance, Sierra
Permit, judgment, order or decree or (ii) any alleged failure to have or
any violation of any Sierra Permit which violation or failure would have a
Material Adverse Effect on Sierra. Neither Sierra nor any of its
Subsidiaries nor to Sierra's knowledge any of its or their respective
executive officers, directors or employees (in their capacities as such)
has engaged in any activity constituting fraud or
-30-
<PAGE>
abuse under the laws relating to health care, insurance or the regulation
of professional corporations.
(g) FINANCIAL STATEMENTS.
(i) Sierra has delivered, or (if not yet available) will
promptly deliver when available (and in any event prior to the
Effective Time), to PCA complete and correct copies of (i) the balance
sheets of Sierra and each of its then-existing Subsidiaries as at
December 31, 1995, 1994, 1993, 1992, 1991, and the related audited
statements of income and shareholders' equity and cash flows, for the
fiscal years ended on those dates, together with all footnotes and
(ii) the unaudited interim financial statements for Sierra and each of
its Subsidiaries as at, and for the fiscal periods ended on
September 30, 1996 and 1995 and each subsequent quarterly reporting
date. All of such financial statements fairly present or when
delivered will fairly present, as the case may be (subject, in the
case of unaudited interim financial statements, to normal, recurring
adjustments which are not expected to be, individually or in the
aggregate, materially adverse to Sierra and its Subsidiaries taken as
a whole), in all material respects, the financial position, results of
operations and cash flows of Sierra and each of its Subsidiaries as at
the respective dates of such balance sheets and for each of the
respective periods then ended, in conformity with (A) U.S. GAAP and
(B) in the case of each of the Insurance Subsidiaries, statutory or
other accounting practices prescribed or permitted by the applicable
insurance regulatory authorities in each case applied on a basis
consistent throughout the reported periods.
(ii) Except as set forth on SCHEDULE 3.2(g), neither such
financial statements nor the financial statements of Sierra included
in the Sierra SEC Documents (i) contain or when delivered will
contain, as the case may be, any item of extraordinary or
non-recurring income or expense (except as specified therein);
(ii) reflect or when delivered will reflect, as the case may be,
uncollectible accounts receivable without a reserve fairly stated for
uncollectible amounts; and (iii) reflect or when delivered will
reflect, as the case may be, any write-off or revaluation of assets
(except as specified therein). As at the respective dates of the
balance sheets included in all such financial statements, there was no
liability, indebtedness or obligation of any nature or in any amount
that should properly be reflected or provided for in financial
statements prepared in conformity with U.S. GAAP or statutory
accounting practices prescribed or permitted by the applicable
insurance regulatory authorities, whichever is appropriate, applied on
a basis consistent with that for prior periods, which was not fully
reflected in such financial statements.
-31-
<PAGE>
(iii) The reserves recorded in the accounting records of each
of the Insurance Subsidiaries for insurance policy benefits, losses,
claims and expenses and any other reserves are reasonable and adequate
and were prepared in accordance with the statutory or other accounting
practices prescribed or permitted by the applicable insurance
regulatory authorities and of all the jurisdictions in which the
Insurance Subsidiaries are licensed to transact an insurance business
and make good and sufficient provisions for all insurance obligations
of Sierra and its Subsidiaries. Such reserves have been opined upon
as reasonable and adequate as of December 31, 1995, for Sierra Health
& Life Insurance Company, Inc. by Towers Perrin Integrated Health
Systems Consulting, a duly qualified actuarial firm that is a member
in good standing in the American Academy of Actuaries. For Health
Plan of Nevada, Inc. and HMO Texas, L.C. such reserves have been
opined upon as reasonable and adequate as of December 31, 1995 by
Marlin Mueller, a duly qualified actuary who is a member in the
American Academy of Actuaries. For California Indemnity Insurance
Company and Commercial Casualty Insurance Company such reserves have
been opined upon as resonable and adequate as of December 31, 1995 by
Timothy B. Perr, a duly qualified actuary who is a member in good
standing in the American Academy of Actuaries.
(h) LITIGATION. Except (i) as set forth on SCHEDULE 3.2(h), (ii) as
disclosed in the Sierra SEC Documents and (iii) for actions and suits
arising in the ordinary course of business, none of which is reasonably
expected to have a Material Adverse Effect on Sierra, there is no action,
suit, proceeding or investigation, either at law or in equity, at or before
any commission or other administrative authority in any domestic or foreign
jurisdiction, of any kind now pending or, to the best of Sierra's or Sierra
Sub's knowledge, threatened, involving Sierra, Sierra Sub or any other
Subsidiary of Sierra, or any of the respective properties or assets of
Sierra or Sierra Sub that (i) if asserted is reasonably expected to have a
Material Adverse Effect on Sierra, (ii) questions the validity of this
Agreement, or (iii) seeks to delay, prohibit or restrict in any manner any
action taken or to be taken by Sierra or Sierra Sub under this Agreement.
None of Sierra nor any Subsidiary of Sierra, nor any of their respective
properties or assets is subject to any continuing order of, consent decree,
settlement agreement or other similar written agreement (other than
agreements related to the settlement of insurance claims in the ordinary
course of business), continuing investigation (other than regularly
scheduled audits) by any court, Governmental Entity, or any judicial
administrative or arbitral judgment, order, writ, decree, injunction,
restraint, or award of any court, Governmental Entity or arbitrator,
including without limitation cease-and-desist or other orders. Neither
Sierra nor any of its Subsidiaries has agreed to, or is bound by, any
extension or waiver of the statute of limitations relating to any pending
or potential action, suit, claim, proceeding or investigation involving
Sierra or any of its Subsidiaries (other than
-32-
<PAGE>
extensions or waivers in connection with the settlement of insurance
claims in the ordinary course of business).
(i) LABOR AND EMPLOYMENT MATTERS. Neither Sierra nor any of its
Subsidiaries has employees who are represented by a labor union or
organization, no labor union or organization has been certified or
recognized as a representative of any such employees, and neither Sierra
nor any of its Subsidiaries is a party to or has any obligation under any
collective bargaining agreement or other contract or agreement with any
labor union or organization. There are no pending or, to Sierra's
knowledge, threatened, representation campaigns, elections or proceedings
or questions concerning union representation involving any employees of
either Sierra or any of its Subsidiaries. Neither Sierra nor any of its
Subsidiaries has any knowledge of any activities or efforts of any labor
union or organization (or representatives thereof) to organize any of its
employees, any demands for recognition or collective bargaining, any
strikes, slowdowns, work stoppages or lock-outs of any kind, or threats
thereof, by or with respect to any employees of Sierra or any of its
Subsidiaries, and no such activities, efforts, demands, strikes, slowdowns,
work stoppages or lock-outs occurred during a three-year period preceding
the date hereof. Neither Sierra nor any of its Subsidiaries has engaged
in, admitted committing, or been held in any administrative or judicial
proceeding to have committed any unfair labor practice under the National
Labor Relations Act, as amended. Except as set forth on SCHEDULE 3.2(i),
neither Sierra nor any of its Subsidiaries is involved in any industrial or
trade dispute or any dispute or negotiation regarding a claim of material
importance with any labor union or organization concerning its employees,
and there are no controversies, claims, demands or grievances of material
importance pending or, so far as Sierra is aware, threatened, between
Sierra or any of its Subsidiaries and any of their respective employees.
(j) ABSENCE OF CERTAIN CHANGES OR EVENTS. Since December 31, 1995
and except (i) as set forth in SCHEDULE 3.2(j), (ii) for the execution and
delivery of this Agreement and changes in its properties or business
attributable to the transactions contemplated by this Agreement, (iii) as
disclosed in the Sierra SEC Documents filed prior to the date of this
Agreement or in the audited consolidated balance sheets of Sierra and its
Subsidiaries and the related consolidated statements of income,
shareholders' equity and cash flows as of and for the period ended
December 31, 1995 (the "Sierra 1995 Financials"), true and correct copies
of which have been delivered to PCA, and (iv) sales and purchases of
investment securities in the ordinary course, neither Sierra nor any of its
Subsidiaries:
(i) had any change in its financial condition businesses, assets
or liabilities, other than changes which have not had, individually or
in the aggregate, a Material Adverse Effect on Sierra;
-33-
<PAGE>
(ii) suffered any damage, destruction or loss of physical
property (not adequately covered by insurance) that, individually or
in the aggregate, has had a Material Adverse Effect on Sierra;
(iii) issued, sold or otherwise disposed of, or, since
October 31, 1996, redeemed, purchased or otherwise acquired, or agreed
to issue, sell or otherwise dispose of, redeem, purchase or otherwise
acquire, any capital stock or any other security of Sierra or any of
its Subsidiaries or granted or agreed to grant any option warrant or
other right to subscribe for or to purchase any capital stock or any
other security of Sierra or any of its Subsidiaries;
(iv) incurred or agreed to incur any material indebtedness for
borrowed money;
(v) paid or obligated itself to pay in excess of $500,000 in
the aggregate for any fixed assets;
(vi) sold, transferred, leased or otherwise disposed of, or
agreed to sell, transfer, lease or otherwise dispose of, (A) any
properties or assets to any director or officer of Sierra or of any
Subsidiary of Sierra or any member of the family or any other
affiliate of any of the foregoing or (B) any properties or assets
having a fair market value of $250,000 or agreed to sell, transfer,
lease or otherwise dispose of, any assets (other than securities)
having a fair market value at the time of sale, transfer or
disposition of $250,000;
(vii) mortgaged, pledged or subjected to any material charge,
lien, claim or encumbrance, or agreed to mortgage, pledge or subject
to any material charge, lien, claim or encumbrance any of its material
properties or assets;
(viii) declared, set aside or paid any dividend or made any
distribution (whether in cash, property or stock) with respect to any
of its capital stock;
(ix) (A) increased, or agreed to increase, the compensation or
bonuses or special compensation of any kind of any of its directors,
officers or employees (other than insurance agents or independent
contractors) over the rate being paid to them on December 31, 1995, as
set forth in Sierra's Proxy Statement for the 1996 Annual Meeting of
Shareholders ("Sierra's 1996 Proxy Statement"), other than normal
merit and cost-of-living increases pursuant to customary arrangements
consistently followed, or (B) since July 1, 1996, paid any bonus or
similar compensation to any director, officer or employee of Sierra or
any Subsidiary of Sierra in excess of $100,000, or (C) entered into
any employment, consulting or severance agreement or arrangement with
any director, officer or employee (other
-34-
<PAGE>
than any agent or independent contractor) or adopted or increased any
benefit under any insurance, pension or other employee benefit plan,
payment or arrangement made to, for or with any director, officer or
employee (other than any agent or independent contractor);
(x) has terminated, or been notified in writing of the likely
termination of, a material contract with a hospital or other provider,
a self-insured employer, a union or other association, a government
agency or a national insurance carrier or any other material contract
regarding managed care services or insurance services;
(xi) neither Sierra nor any of its Subsidiaries has entered
into a contract or arrangement with an individual or entity (including
a network of health care providers) providing for the rendering of
professional health care services by such person as an employee of or
contractor to Sierra (other than a provider of in-patient care) under
which, during the last 12 months, Sierra was obligated or became
committed to pay in excess of $500,000 or under which, during the next
12 months, Sierra is reasonably expected to pay or to become obligated
to pay in excess of $500,000, except for such contracts that are
terminable by Sierra upon 90 days advance notice without penalty;
(xii) except as otherwise required or provided for in this
Agreement and except in the ordinary course of business, made or
permitted any material amendment or termination of any material
contract, lease, concession, franchise, license, indenture,
instrument, mortgage, note, loan or credit agreement or other
obligation to which it is a party;
(xiii) had any resignation or termination of employment of any
of its key officers or employees, or become aware of any impending or
threatened termination of employment, that would, individually or in
the aggregate, have a Material Adverse Effect on Sierra;
(xiv) had any labor trouble or concerted work stoppage or
knows of any impending or threatened labor trouble or concerted work
stoppage;
(xv) canceled, or agreed to cancel, any debts or claims over
$500,000 in the aggregate or $250,000 individually other than in the
ordinary course of business;
(xvi) made any material change in its accounting methods or
practices with respect to its condition, operations, business,
properties, assets or liabilities;
-35-
<PAGE>
(xvii) made any charitable or political contribution or pledge
in excess of $100,000 in the aggregate;
(xviii) agreed or committed to do, or authorized or approved
any action looking to, any of the foregoing;
(xix) paid aggregate commissions to insurance agents and
independent contractors for policies issued in 1995 and with normal
anniversary dates of January 1, 1995 or subsequent thereto in excess
of 15% of direct premiums written;
(xx) made any material cash payments to insurance agents,
independent contractors or brokers other than pursuant to a Producer
Profit Share Agreement; or
(xxi) entered into any material transaction not in the
ordinary course of its business.
(k) MATERIAL CONTRACTS. Except as set forth in SCHEDULE 3.2(k),
neither Sierra nor any of its Subsidiaries is a party to any written or
oral:
(i) employment or consulting contract or other contract for
services involving a payment of more than $250,000 annually and that
is not terminable without cost upon thirty (30) days' prior written
notice;
(ii) material lease, franchise or concession providing for a
payment by any person of more than $500,000 annually;
(iii) loan agreement, mortgage, indenture, promissory note,
financing lease or other instrument relating to any debt (in excess of
$250,000 and which, in the aggregate, do not amount to more than
$1,000,000);
(iv) contract of purchase or sale involving more than $500,000
and that is not in the ordinary course of business;
(v) partnership, joint venture, material license or similar
agreement;
(vi) stand-by letter of credit, guarantee or performance bond;
(vii) material contract with a hospital or other provider, a
self-insured employer, a union or other association, a governmental
agency or a national
-36-
<PAGE>
insurance carrier or any other material contract
regarding managed care services or insurance services;
(viii) contract restricting the ability of any person from
freely engaging in any business or competing anywhere in the world;
(ix) contract or arrangement with an individual or entity
(including a network of health care providers) providing for the
rendering of professional health care services by such person as an
employee of or contractor to Sierra (other than a provider of
in-patient care) under which, during the last 12 months, Sierra was
obligated or became committed to pay in excess of $1,000,000 except
for such contracts that are terminable by Sierra upon 90 days advance
notice without penalty; or
(x) other material contract or commitment not made in the
ordinary course of business.
Each contract or other agreement listed in SCHEDULE 3.2(k) is in full force
and effect and is valid and enforceable by Sierra or a Subsidiary of
Sierra, as the case may be, in accordance with its terms. Neither Sierra
nor any of its Subsidiaries is in default in the observance or the
performance of any term or obligation to be performed by it under any
material contract listed in SCHEDULE 3.2(k). To the knowledge of Sierra
without investigation, no other person is in default in the observance or
the performance of any term or obligation to be performed by it under any
material contract listed in SCHEDULE 3.2(k). There is currently no
outstanding bid or contract proposal by Sierra or any of its Subsidiaries
which, if accepted or entered into, might reasonably be expected to result
in a material loss to either Sierra or any of its Subsidiaries, except with
respect to losses occurring in the ordinary course of business. Sierra has
delivered or made available to PCA copies of all contracts listed in the
schedules hereto.
(l) OFFICERS AND DIRECTORS AND EMPLOYEES. Sierra's 1996 Proxy
Statement, as modified by SCHEDULE 3.2(l), sets forth a list of:
(i) The names of all directors and officers of Sierra and
each of its material Subsidiaries;
(ii) The name and current annual rate of compensation
(including bonuses and other forms of compensation) paid by Sierra and
its Subsidiaries to each of its respective officers, directors and
employees whose annual rate of base compensation exceeded $100,000 for
the year ended December 31, 1995; and
-37-
<PAGE>
(iii) The names of all persons who have written employment,
consulting or severance agreements or arrangements with Sierra or
any of its Subsidiaries if such agreement or arrangement provides
for payment to such persons resulting from such person's
resignation, from a change-in-control of Sierra or any of its
Subsidiaries or from a change in such person's responsibilities
following a change-in-control; and Sierra has provided complete and
correct copies of such agreements to PCA.
(m) TITLE TO AND CONDITION OF PROPERTIES AND ASSETS.
(i) Sierra and its Subsidiaries have good and defensible title
to, or valid leasehold interests in, their respective material
properties and assets, whether owned or leased, including,
without limitation, (A) those used in their respective
businesses, and (B) those reflected in the consolidated balance
sheet of Sierra as of September 30, 1996 most recently delivered
to PCA (except as since sold or otherwise disposed of in the
ordinary course of business and except for minor defects in
title, easements, restrictive covenants and similar encumbrances
or impediments that, individually or in the aggregate, do not
and will not materially interfere with the ability of Sierra and
its Subsidiaries to use their properties or to conduct their
businesses as currently conducted), in each case subject to no
Liens, except for (x) the lien of current Taxes (as hereinafter
defined) not yet due and payable, (y) with respect to leased
property, the provisions of such leases and (z) liens, that,
individually or in the aggregate, do not and will not materially
interfere with the ability of Sierra or any of its Subsidiaries
to conduct business as currently conducted. Except as described
on SCHEDULE 3.2(m), subsequent to December 31, 1995, neither
Sierra nor any of its Subsidiaries has sold or disposed of any
of their respective properties or assets or obligated themselves
to do so except in the ordinary course of business. The
facilities, machinery, furniture, office and other equipment of
Sierra and each of its Subsidiaries that are used in their
respective businesses are in good operating condition and
repair, subject to the ordinary wear and tear of those
businesses.
(ii) All of the real property owned or leased by Sierra or any of
its Subsidiaries has been maintained by Sierra in compliance with all
federal, state and local environmental protection, occupational,
health and safety or similar laws, ordinances, restrictions,
licenses and regulations, except where the failure to so
maintain the property would not have a Material Adverse Effect
on Sierra.
(n) PATENTS, COPYRIGHTS, SERVICE MARKS AND TRADEMARKS. Neither Sierra
nor any of its Subsidiaries own or licenses any patent, copyright, service
mark, trademark or other intellectual property right, other than such patents,
copyrights, service marks, trademarks and other intellectual property rights as
are described in SCHEDULE 3.2(n),
-38-
<PAGE>
except for such intellectual property rights the loss of which singly or in
the aggregate would not have a Material Adverse Effect on Sierra. Except as
set forth on SCHEDULE 3.2(n) and other than such as would have a Material
Adverse Effect on Sierra: (i) Sierra and its Subsidiaries own or license
all patents, copyrights, service marks, trademarks and other intellectual
property rights that are necessary to the conduct of their respective
businesses, (ii) all names under which Sierra or any of its Subsidiaries
currently conducts business are set forth in SCHEDULE 3.2(n), (iii) no
claim has been made, and to Sierra's knowledge no basis for any such
claim exists, that Sierra or any of its Subsidiaries has infringed any patent,
copyright, service mark, trademark or other intellectual property right of any
other person and (iv) no claim has been made, and to Sierra's knowledge no basis
for any such claim exists, that any person has infringed on any patent,
copyright, service mark, trademark or other intellectual property right of
Sierra or any of its Subsidiaries.
(o) EMPLOYEE BENEFIT PLANS.
(i) LIST OF PLANS. SCHEDULE 3.2(o) includes a complete and
accurate list of all employee benefit plans ("Plans"), as
defined in Section 3(3) of ERISA and material benefit
arrangements that are not Plans ("Benefit Arrangements"),
including, but not limited to any (A) employment or consulting
agreements, (B) incentive bonus or deferred bonus arrangements,
(C) arrangements providing termination allowance, severance or
similar benefits, (D) equity compensation plan, and (E) deferred
compensation plans, (F) cafeteria plans, (G) employee assistance
programs, (H) bonus programs, (I) scholarship programs, (J)
vacation policies, and (K) stock option plans that are currently
in effect or were maintained within three years of the Effective
Time, or have been approved before the Effective Time but are
not yet effective, for the benefit of directors, officers,
employers or former employees (or their beneficiaries) of Sierra
or a Controlled Company ("Designated Plans"). For purposes of
this Section 3.2(o), "Controlled Company" shall mean any entity
that, together with Sierra as of the relevant determination date
under ERISA, is or was required to be treated as a single
employer under Section 414 of the Code and any reference to
Sierra in this Section 3.2(o) shall also include a reference to
a Controlled Company.
(ii) NO TITLE IV PLANS OR VEBAS. Neither Sierra nor any
entity (whether or not incorporated) that was at any time during
the six years before the Effective Time treated as a single
employer together with Sierra under Section 414 of the Code has
ever maintained, had any obligation to contribute to or incurred
any liability with respect to a pension plan that is or was
subject to the provisions of Title IV of ERISA or Section 412 of
the Code. Neither Sierra nor any entity (whether or not
incorporated) that was at any time during the six years before
the Effective Time treated as a single employer together with
Sierra
-39-
<PAGE>
under Section 414 of the Code has ever maintained, had an
obligation to contribute to, or incurred any liability with
respect to a multiemployer pension plan as defined in Section
3(37) of ERISA. During six years before the Effective Time,
Sierra has not maintained, had an obligation to contribute
to or incurred any liability with respect to a voluntary
employees beneficiary association that is or was intended
to satisfy the requirements of Section 501(c)(9) of the
Code.
(iii) DISCLOSED PLANS. With respect to each Designated
Plan, Sierra has delivered to Sierra, as applicable, true and
complete copies of (A) all written documents comprising such
Plan or each Benefit Arrangement (including amendments and
individual agreements relating thereto); (B) the trust, group
annuity contract or other document that provides for the funding
of the Designated Plan or the payment of Designated Plan
benefits, (C) the three most recent annual Form 5500, 990 and
1041 reports (including all schedules thereto) filed with
respect to the Designated Plan; (D) the most recent actuarial
report, valuation statement or other financial statement; (E)
the most recent Internal Revenue Service determination letter
("IRS") and all rulings or determinations requested from the IRS
after the date of that determination letter; (F) the summary
plan description currently in effect and all material
modifications thereto; and (G) all other correspondence from the
IRS or Department of Labor received that relate to one or more
of the Designated Plans with respect to any matter, audit or
inquiry that is still pending. All information provided by
Sierra and its Subsidiaries to the individuals who prepared any
such financial statements was true, correct and complete in all
material respects. Each financial or other report delivered to
Sierra pursuant hereto is accurate in all material respects, and
there has been no material adverse change in the financial
status of any Designated Plan since the date of the most recent
report provided with respect thereto.
(iv) COMPLIANCE WITH LAW. Except as set forth in SCHEDULE
3.2(O), Sierra has operated, and has caused its appointees and
nominees to operate, each Designated Plan in a manner which is
in material compliance with the terms thereof and with all
applicable law, regulations and administrative agency rulings
and requirements applicable thereto, the violation of which
would not have a material adverse effect on Sierra and its
Subsidiaries taken as a whole. Except as otherwise disclosed in
SCHEDULE 3.2(o), with respect to each Designated Plan that is a
Plan (A) the Plan is in compliance with ERISA in all material
respects, including but not limited to all reporting and
disclosure requirements of Part 1 of Subtitle B of Title I of
ERISA; (B) the appropriate Form 5500 has been timely filed, for
each year of its existence; (C) there has been no transaction
described in sections 406 or 407 of ERISA or section 4975 of the
Code relating to the Plan unless exempt under section 408 of
ERISA or section 4975 of the Code, as
-40-
<PAGE>
applicable; and (D) the bonding requirements of section 412 of
ERISA have been satisfied.
(v) CONTRIBUTIONS. Full payment has been made of all
amounts which Sierra or a Controlled Company is required, under
applicable law or under any Designated Plan or any agreement
related to any Designated Plan to which Sierra or a Controlled
Company is a party, to have paid as contributions thereto as of
the last day of the most recent fiscal year of each Designated
Plan ended prior to the date hereof. Benefits under all
Designated Plans are as represented in the governing instruments
provided pursuant to (i) above, and have not been increased
subsequent to the date as of which documents have been provided.
(vi) TAX QUALIFICATION. Each Designated Plan, as amended to
date, that is intended to be qualified under Section 401(a) and
501(a) of the Code has been determined to be so qualified by the
IRS, has been submitted to the IRS for a determination with
respect to such qualified status or the remedial amendment
period established under Section 402(b) of the Code with respect
to the Designated Plan will not have expired prior to the
Effective Time. Except as disclosed on SCHEDULE 3.2(o), no
facts have occurred which if known by the IRS could cause
disqualification of any such Plan.
(vii) TAX OR CIVIL LIABILITY. Neither Sierra nor a
Controlled Company has participated in, or is aware of, any
conduct that could result in the imposition upon Sierra of any
excise tax under Sections 4971 through 4980B of the Code or
civil liability under Section 502(i) of ERISA with respect to
any Designated Plan.
(viii) CLAIMS LIABILITY. There is no action, claim or
demand of any kind (other than routine claims for benefits) that
has been brought or, to Sierra's knowledge, threatened against,
or relating to, any Designated Plan, and Sierra has no knowledge
of any pending investigation or administrative review by any
Governmental Entity relating to any Designated Plan.
(ix) RETIREE WELFARE COVERAGE. Except as set forth in
SCHEDULE 3.2(o), no Designated Plan provides any health, life or
other welfare coverage to employees of Sierra or a Controlled
Company beyond termination of their employment with Sierra or a
Controlled Company by reason of retirement or otherwise, other
than coverage as may be required under Section 4980B of the Code
or Part 6 of ERISA, or under the continuation of coverage
provisions of the laws of any state or locality.
(x) NO EXCESS PARACHUTE PAYMENTS. No amount that could be
received (whether in cash or property or the vesting of
property) as a result of any
-41-
<PAGE>
of transactions contemplated by this Agreement by any employee,
officer or director of Sierra or a Controlled Company who is a
"disqualified individual" (as such term is defined in proposed
Treasury Regulation Section 1.280G-1) under any employment,
severance or termination agreement, other compensation
arrangement or Designated Plan currently in effect would be
characterized as an "excess parachute payment" (as such term is
defined in Section 280G(b)(1) of the Code).
(p) TRANSACTIONS WITH OFFICERS, DIRECTORS AND OTHERS. Except as set
forth on SCHEDULE 3.2(p), no director, officer or affiliate of Sierra, or
any member of the immediate family or any other affiliate of any of the
foregoing, is a party to business arrangements or relationships of any kind
with Sierra or its Subsidiaries in which the amount involved exceeds
$60,000, or, to the knowledge of Sierra, owns or has an ownership interest
in any corporation (in excess of 5% of any publicly traded corporation) or
other entity that is a party to, or in any property which is the subject of
any such business arrangements.
(q) INSURANCE MATTERS--REINSURANCE AND COINSURANCE. SCHEDULE 3.2(q)
contains a list of all reinsurance or coinsurance treaties or agreements to
which Sierra or any of its Subsidiaries is a party. All such treaties or
agreements as set forth in such Schedule are valid, binding and in full
force and effect in accordance with their terms (except as the
enforceability thereof may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting creditors'
rights generally or by the principles governing the availability of
equitable remedies); and neither Sierra nor its Insurance Subsidiaries nor,
to Sierra's knowledge, any other party thereto is in default as to any
provision thereof, except for such defaults the effect of which singly or
in the aggregate would not have a Material Adverse Effect on Sierra, and
none of such agreements contains any provision (A) providing that any other
party thereto may terminate such agreement or declare a default or seek
damages thereunder by reason of the transactions contemplated by this
Agreement or (B) which would be altered or otherwise become applicable by
reason of such transactions. Sierra does not know of any facts or events
that could cause the financial condition of any party to any such agreement
to be impaired to such an extent that a default thereunder may be
reasonably anticipated.
(r) TAXES.
(i) TAX REPRESENTATIONS. Except as set forth in SCHEDULE 3.2(r):
(A) All Returns required to have been filed on or before the
date hereof by or with respect to Sierra or any of its Subsidiaries
or any affiliated, combined, consolidated, unitary or similar group
of which Sierra
-42-
<PAGE>
or its Subsidiaries is or was a member (a "Relevant Group") with any
Taxing Authority have been duly and timely filed, and each such
Return correctly and completely reports all material information
required to be reported thereon. All Taxes of Sierra or its
Subsidiaries or any member of a Relevant Group (whether or not shown
on any Return) with respect to any period ending on or before the date
hereof have been paid or are duly reserved for in the financial
statements of Sierra and its Subsidiaries for such period.
(B) Neither Sierra nor any of its Subsidiaries has waived any
statute of limitations in respect of Taxes or agreed to any extension
of time with respect to any Tax assessment or deficiency.
(C) PCA is not currently under audit by any Taxing Authority
with respect to any material Return. PCA's consolidated federal
income tax returns have been audited through December 31, 1992. No
claim is pending by any Taxing Authority in a jurisdiction in which
PCA or any of its Subsidiaries does not file Returns, that it is
subject to Taxation in that jurisdiction.
(D) Other than agreements among Sierra and its Subsidiaries,
neither Sierra nor any of its Subsidiaries is a party to any tax
allocation or tax sharing agreement.
(E) Neither Sierra nor any of its Subsidiaries is a
"consenting corporation" within the meaning of Section 341(f)(1)
of the Code or comparable provisions of any state statute, and
none of the assets of Sierra or its Subsidiaries is subject to
any election under Section 341(f) of the Code or comparable
provisions of any state statutes.
(F) Neither Sierra nor any of its Subsidiaries has received
or requested any ruling of a Taxing Authority relating to Taxes
or entered into any material written or legally binding agreement
with a Taxing Authority relating to Taxes.
(G) Neither Sierra nor any of its Subsidiaries (1) has or
is projected to have a material amount includible in its income
for the current taxable year under Section 951 of the Code, (2)
has been a passive foreign investment company within the meaning
of Section 1296 of the Code, and neither Sierra nor any of its
Subsidiaries is a shareholder, directly or indirectly in any
passive foreign investment company, or (3) has a material
-43-
<PAGE>
unrecaptured overall foreign loss within the meaning of Section
940(f) of the Code.
(H) Neither Sierra nor any of its Subsidiaries is, or at
any time has been, subject to (1) the dual consolidated loss
provisions of Section 1503(d) of the Code, (2) the overall
foreign loss provisions of Section 904(f) of the Code, or (3) the
recharacterization provisions of Section 952(c)(2) of the Code.
(I) None of the assets of Sierra or any of its Subsidiaries
constitutes tax-exempt bond financed property or tax-exempt use
property, within the meaning of Section 168 of the Code. Neither
Sierra nor any of its Subsidiaries is a party to any "safe harbor
lease" that is subject to the provisions of Section 168(f)(3) of
the Internal Revenue Code as in effect prior to the Tax Reform
Act of 1986, or to any "long-term contract" within the meaning of
Section 460 of the Code.
(J) Neither Sierra nor any of its Subsidiaries has any
material (1) deferred gain or loss arising out of any deferred
intercompany transaction or (2) income which will be reportable
in a period ending after the Closing Date which is attributable
to a transaction occurring in, or a change in accounting method
made for, a period ending on or prior to the Closing Date.
(K) Neither Sierra nor any of its Subsidiaries is a party
to any written, oral or implied agreement or obligation to
provide any "covered employee," as defined in Section 162(m)(3)
of the Code, with remuneration in excess of $1 million, that
would be disallowed as a deduction for Federal income tax
purposes pursuant to Section 162(m) of the Code.
(ii) REPRESENTATIONS RELATING TO TAX-FREE REORGANIZATION. Prior
to and at the Effective Time, Sierra will be in "control" of Sierra
Sub within the meaning of Section 368(C) of the Code and Sierra has no
plan or intention to cause PCA to issue additional shares of capital
stock following the Effective Time that would result in Sierra losing
"control" (as so defined) of PCA; Sierra has no plan or intention to
reacquire any of its stock issued pursuant to the Merger; Sierra has
no plan or intention to liquidate PCA, to merge PCA with or into
another corporation including Sierra or its affiliates, to sell,
distribute or otherwise dispose of any of the capital stock of PCA or
to cause PCA to sell or otherwise dispose of any of its assets, except
for dispositions made in the ordinary course of business; neither
Sierra nor Sierra Sub is an "investment company"
-44-
<PAGE>
within the meaning of Section 368(a)(2)(F)(iii) of the Code; neither
Sierra nor Sierra Sub is under the jurisdiction of a court in a Title 11
or similar case within the meaning of Section 368(a)(3)(A) of the Code;
the liabilities of Sierra Sub assumed by PCA and the liabilities to which
the transferred assets of Sierra Sub are subject were incurred by Sierra
Sub in the ordinary course of its business; following the Effective Time,
Sierra shall cause PCA to either continue the historic business of PCA or
use a significant portion of PCA's historic business assets in a business;
any amounts paid with respect to PCA Dissenting Shares will be paid by PCA
solely from PCA's pre-merger assets and without reimbursement therefor by
Sierra or Sierra Sub; neither Sierra nor any affiliate of Sierra owns, or
has owned during the past five (5) years, directly or indirectly, any
shares of PCA's capital stock or the right to acquire or vote any such
shares; no shareholder is acting as agent for Sierra in connection with the
Merger or the approval thereof; and assuming the accuracy of PCA's
representation contained in Section 3.1(r)(iii)(I), following the Merger
PCA will hold at least 90% of the fair market value of its net assets and
at least 70% of the fair market value of its gross assets and at least 90%
of the fair market value of Sierra Sub's net assets and at least 70% of the
fair market value of Sierra Sub's gross assets, held immediately before the
Merger, taking into account any merger expenses and any distributions other
than regular dividends.
(s) OPINION OF FINANCIAL ADVISOR. Sierra has received the opinion of
Salomon Brothers Inc, dated the date hereof, to the effect that the
consideration to be received in the Merger by Sierra's shareholders is fair
to Sierra and its shareholders from a financial point of view. Sierra has
delivered a true and complete copy of this opinion to PCA.
(t) ACCOUNTING MATTERS. Neither Sierra nor, to the best of its
knowledge, any of its affiliates, has through the date of this Agreement
taken or agreed to take any action that would prevent Sierra from accounting
for the business combination to be effected by the Merger as a pooling of
interests.
(u) OWNERSHIP OF PCA COMMON STOCK. As of the date hereof, neither
Sierra nor, to the best of its knowledge, any of its affiliates or
associates, (i) (A) beneficially owns, directly or indirectly, or (B) are
parties to any agreement, arrangement or understanding for the purpose of
acquiring, holding, voting or disposing of, in each case, shares of capital
stock of PCA, which in the aggregate, represent 10% or more of the
outstanding shares of capital stock of PCA entitled to vote generally in the
election of directors, nor (ii) is an "interested stockholder" of PCA within
the meaning of Section 203 of the DGCL.
-45-
<PAGE>
(v) INTERIM OPERATIONS OF SIERRA SUB. Sierra Sub was formed solely
for the purpose of engaging in the transactions contemplated hereby, has
engaged in no other business activities and has conducted its operations
only as contemplated hereby.
(w) INVESTMENT COMPANY ACT. Neither Sierra nor Sierra Sub is an
"investment company", or a company "controlled" by an "investment company",
within the meaning of the Investment Company Act of 1940, as amended.
(x) VOTE REQUIRED. The affirmative vote of a majority of the votes
that holders of the outstanding shares of Sierra Common Stock are entitled
to cast is the only vote of the holders of any class or series of Sierra
capital stock or Voting Debt necessary to approve this Agreement and the
transactions contemplated hereby.
(y) APPLICABILITY OF DGCL 203. The provisions of Section 203 of the
DGCL will not, assuming the accuracy of the representations contained in
Section 3.1 (x) (without giving effect to the knowledge qualification
thereof), apply to this Agreement or any of the transactions contemplated
hereby.
ARTICLE IV. COVENANTS RELATING TO CONDUCT OF BUSINESS
4.1. COVENANTS OF PCA. During the period from the date of this Agreement
and continuing until the Effective Time, PCA agrees as to itself and its
Subsidiaries that (except as expressly contemplated or permitted by this
Agreement, or to the extent that the other party shall otherwise consent in
writing and except with respect to employment and compensation arrangements
entered into by PCA):
(a) ORDINARY COURSE. PCA and its Subsidiaries shall carry on their
respective businesses in the usual, regular and ordinary course in
substantially the same manner as heretofore conducted and use all
reasonable efforts to preserve intact their present business organizations,
keep available the services of their present officers and employees and
preserve their relationships with customers, suppliers and others having
business dealings with them to the end that their goodwill and ongoing
businesses shall not be impaired in any material respect at the Effective
Time.
(b) DIVIDENDS; CHANGES IN STOCK. PCA shall not, nor shall it permit
any of its Subsidiaries to, nor shall PCA propose to, (i) declare or pay
any dividends on or make other distributions in respect of any of its
capital stock, except for dividends by a wholly-owned Subsidiary of PCA or
such Subsidiary, (ii) split, combine or reclassify any of its capital stock
or issue or authorize or propose the issuance of any other securities in
respect of, in lieu of or in substitution for shares of its capital stock
or (iii) repurchase or otherwise acquire, or permit any Subsidiary to
purchase or otherwise acquire, any shares of its capital stock.
-46-
<PAGE>
(c) ISSUANCE OF SECURITIES. PCA shall not, nor shall PCA permit any
of its Subsidiaries to, issue, deliver or sell, or authorize or propose the
issuance, delivery or sale of, any shares of its capital stock or any
securities convertible into, or any rights, warrants or options to acquire,
any such shares, or convertible securities, other than the issuance of PCA
Common Stock upon the exercise of outstanding stock options or stock grants
under PCA Stock Plans in each case in accordance with their present terms.
(d) GOVERNING DOCUMENTS. PCA shall not amend nor shall it permit its
Subsidiaries (except, with the consent of Sierra, to the extent required by
relevant authorities to become admitted to engage in the insurance business
in the jurisdictions in which PCA and its Subsidiaries are currently
admitted) to amend or propose to amend its Certificate of Incorporation or
Bylaws.
(e) NO ACQUISITIONS. PCA shall not, nor shall PCA permit any of its
Subsidiaries to, acquire or agree to acquire by merging or consolidating
with, or by purchasing a substantial equity interest in or a substantial
portion of the Assets of, or by any other manner, any business or any
corporation, partnership, association or other business organization or
division thereof or otherwise acquire or agree to acquire any assets in
each case which are material, individually or in the aggregate, to PCA and
its Subsidiaries taken as a whole.
(f) NO DISPOSITIONS. Other than (i) as may be required by law to
consummate the transactions contemplated hereby or (ii) in the ordinary
course of business consistent with prior practice, PCA shall not, nor shall
PCA permit any of its Subsidiaries to, without the prior consent of Sierra,
sell, lease, encumber or otherwise dispose of, or agree to sell, lease,
encumber or otherwise dispose of, any of its assets, which are material,
individually or in the aggregate, to PCA and its Subsidiaries taken as a
whole. The transaction described in clause (i) above is not in
contemplation of the Merger and the Merger is not dependent upon the
consummation of such transaction.
(g) INDEBTEDNESS. PCA shall not, nor shall PCA permit any of its
Subsidiaries to, incur (which shall not be deemed to include entering into
credit agreements, lines of credit or similar arrangements until borrowings
are made under such arrangements) any indebtedness for borrowed money or
guarantee any such indebtedness or issue or sell any debt securities or
warrants or rights to acquire any debt securities of such party or any of
its Subsidiaries or guarantee any debt securities of others other than (i)
in each case in the ordinary course of business consistent with prior
practice and (ii) refinancing, amendments to or modifications of existing
credit lines and borrowings thereunder.
(h) OTHER ACTIONS. PCA shall not, nor shall PCA permit any of its
Subsidiaries to, take any action that would or is reasonably likely to
result in any of its representations and warranties set forth in this
Agreement being untrue as of the date
-47-
<PAGE>
made (to the extent so limited), or in any of the conditions to the Merger
set forth in Article VI not being satisfied.
(i) ADVICE OF CHANGES; SEC FILINGS. PCA shall confer with Sierra on
a regular and frequent basis and report on operational matters and promptly
advise Sierra of any change or event having a Material Adverse Effect on
PCA. PCA shall promptly provide Sierra (or its counsel) copies of all
filings made by such party with any state or federal Governmental Entity in
connection with this Agreement and the transactions contemplated hereby.
(j) ACCESS TO INFORMATION. Upon reasonable notice, PCA shall (and
shall cause its Subsidiaries to) afford to the officers, employees,
accountants, counsel and other representatives of Sierra, access, during
normal business hours during the period prior to the Effective Time, to all
its properties, books, contracts, commitments and records and, during such
period, PCA shall (and shall cause its Subsidiaries to) furnish promptly to
Sierra (a) a copy of each report, schedule, registration statement and
other document filed or received by it during such period pursuant to the
requirements of Federal securities laws and (b) all other information
concerning its business, properties and personnel as such other party may
reasonably request. Unless otherwise required by law, Sierra will hold any
such information which is nonpublic in confidence until such time as such
information otherwise becomes publicly available through no wrongful act of
either party, and in the event of termination of this Agreement for any
reason Sierra shall promptly return all nonpublic documents obtained from
PCA or its Subsidiaries, and any copies made of such documents, to PCA.
(k) AFFILIATES. Prior to the Closing Date, PCA shall deliver to
Sierra a letter identifying all persons who are, at the time this Agreement
is submitted for approval to the stockholders of PCA, "affiliates" of PCA
for purposes of Rule 145 under the Securities Act. PCA shall use its best
efforts to cause each such person to deliver to Sierra on or prior to the
Closing Date a written agreement, substantially in the form attached as
EXHIBIT 4.1(k) hereto.
4.2. COVENANTS OF SIERRA AND SIERRA SUB. During the period from the date
of this Agreement and continuing until the Effective Time, Sierra Sub agrees and
Sierra agrees as to itself and its Subsidiaries that (except (i) as described on
EXHIBIT 4.2, (ii) as expressly contemplated or permitted by this Agreement,
(iii) to the extent that the other party shall otherwise consent in writing and
(iv) with respect to employment and compensation arrangements entered into by
Sierra):
(a) ORDINARY COURSE. Sierra and its Subsidiaries shall carry on
their respective businesses in the usual, regular and ordinary course in
substantially the same manner as heretofore conducted and use all
reasonable efforts to preserve intact their
-48-
<PAGE>
present business organizations, keep available the services of their
present officers and employees and preserve their relationships with
customers, suppliers and others having business dealings with them to
the end that their goodwill and ongoing businesses shall not be impaired
in any material respect at the Effective Time.
(b) DIVIDENDS; CHANGES IN STOCK. Sierra shall not, nor shall it
permit any of its Subsidiaries to, nor shall Sierra propose to, (i) declare
or pay any dividends on or make other distributions in respect of any of
its capital stock, except for dividends by a wholly-owned Subsidiary of
Sierra or such Subsidiary, (ii) split, combine or reclassify any of its
capital stock or issue or authorize or propose the issuance of any other
securities in respect of, in lieu of or in substitution for shares of its
capital stock or (iii) repurchase or otherwise acquire, or permit any
Subsidiary to purchase or otherwise acquire, any shares of its capital
stock.
(c) ISSUANCE OF SECURITIES. Sierra shall not, nor shall Sierra
permit any of its Subsidiaries to, issue, deliver or sell, or authorize or
propose the issuance, delivery or sale of, any shares of its capital stock
or any securities convertible into, or any rights, warrants or options to
acquire, any such shares, or convertible securities, other than the
issuance of Sierra Common Stock upon the exercise of outstanding stock
options or stock grants under Sierra Stock Plans in each case in accordance
with their present terms.
(d) GOVERNING DOCUMENTS. Except as contemplated by this Agreement,
Sierra shall not amend nor shall it permit its Subsidiaries (except, with
the consent of PCA, to the extent required by relevant authorities to
become admitted to engage in the insurance business in the jurisdictions in
which Sierra and its Subsidiaries are currently admitted) to amend or
propose to amend its Articles of Incorporation or Bylaws.
(e) NO ACQUISITIONS. Sierra shall not, nor shall Sierra permit any
of its Subsidiaries to, acquire or agree to acquire by merging or
consolidating with, or by purchasing a substantial equity interest in or a
substantial portion of the Assets of, or by any other manner, any business
or any corporation, partnership, association or other business organization
or division thereof or otherwise acquire or agree to acquire any assets in
each case which are material, individually or in the aggregate, to Sierra
and its Subsidiaries taken as a whole.
(f) NO DISPOSITIONS. Other than (i) as may be required by law to
consummate the transactions contemplated hereby or (ii) in the ordinary
course of business consistent with prior practice, Sierra shall not, nor
shall Sierra permit any of its Subsidiaries to, without the prior consent
of PCA, sell, lease, encumber or otherwise dispose of, or agree to sell,
lease, encumber or otherwise dispose of, any of its assets, which are
material, individually or in the aggregate, to Sierra and its Subsidiaries
taken as a whole. The
-49-
<PAGE>
transaction described in clause (i) above is not in contemplation of the
Merger and the Merger is not dependent upon the consummation of such
transaction.
(g) INDEBTEDNESS. Sierra shall not, nor shall Sierra permit any of
its Subsidiaries to, incur (which shall not be deemed to include entering
into credit agreements, lines of credit or similar arrangements until
borrowings are made under such arrangements) any indebtedness for borrowed
money or guarantee any such indebtedness or issue or sell any debt
securities or warrants or rights to acquire any debt securities of such
party or any of its Subsidiaries or guarantee any debt securities of others
other than (i) in each case in the ordinary course of business consistent
with prior practice, (ii) refinancing of existing credit lines and
borrowings thereunder and (iii) to enable Sierra to pay when due all
indebtedness for borrowed money of PCA.
(h) OTHER ACTIONS. Sierra shall not, nor shall Sierra permit any of
its Subsidiaries to, take any action that would or is reasonably likely to
result in any of its representations and warranties set forth in this
Agreement being untrue as of the date made (to the extent so limited), or
in any of the conditions to the Merger set forth in Article VI not being
satisfied.
(i) ADVICE OF CHANGES; SEC FILINGS. Sierra shall confer with PCA on
a regular and frequent basis and report on operational matters and promptly
advise PCA of any change or event having a Material Adverse Change. Sierra
shall promptly provide PCA (or its counsel) copies of all filings made by
such party with any state or federal Governmental Entity in connection with
this Agreement and the transactions contemplated hereby.
(j) ACCESS TO INFORMATION. Upon reasonable notice, Sierra shall (and
shall cause its Subsidiaries to) afford to the officers, employees,
accountants, counsel and other representatives of PCA, access, during
normal business hours during the period prior to the Effective Time, to all
its properties, books, contracts, commitments and records and, during such
period, Sierra shall (and shall cause its Subsidiaries to) furnish promptly
to PCA (a) a copy of each report, schedule, registration statement and
other document filed or received by it during such period pursuant to the
requirements of Federal securities laws and (b) all other information
concerning its business, properties and personnel as such other party may
reasonably request. Unless otherwise required by law, PCA will hold any
such information which is nonpublic in confidence until such time as such
information otherwise becomes publicly available through no wrongful act of
either party, and in the event of termination of this Agreement for any
reason PCA shall promptly return all nonpublic documents obtained from
Sierra or its Subsidiaries, and any copies made of such documents, to
Sierra.
-50-
<PAGE>
ARTICLE V. ADDITIONAL AGREEMENTS
5.1. PREPARATION OF S-4 AND THE PROXY STATEMENT. Sierra and PCA shall
promptly prepare and file with the SEC the Proxy Statement and Sierra shall
prepare and file with the SEC the S-4, in which the Proxy Statement will be
included as a prospectus. Each of Sierra and PCA shall use its best efforts to
have the S-4 declared effective under the Securities Act as promptly as
practicable after such filing. Sierra shall also take any action (other than
qualifying to do business in any jurisdiction in which it is now not so
qualified) required to be taken under any applicable state securities laws in
connection with the issuance of Sierra Common Stock in the Merger and upon the
exercise of PCA Stock Options (as defined in Section 5.7), and PCA shall furnish
all information concerning PCA and the holders of PCA Common Stock as may be
reasonably requested in connection with any such action.
5.2. LETTER OF PCA'S ACCOUNTANTS. PCA shall use its best efforts to cause
to be delivered to Sierra a letter of KPMG Peat Marwick LLP, PCA's independent
auditors, dated a date within two business days before the date on which the S-4
shall become effective and addressed to Sierra, in form and substance reasonably
satisfactory to Sierra and customary in scope and substance for letters
delivered by independent public accountants in connection with registration
statements similar to the S-4.
5.3. MEETINGS. Each of PCA and Sierra shall call a meeting of its
respective stockholders and shareholders to be held as promptly as practicable
for the purpose of voting upon this Agreement and related matters (including,
with respect to Sierra, the approval of an amendment to the Articles of
Incorporation of Sierra to increase its authorized capital stock from 40,000,000
shares of Sierra Common Stock to 100,000,000 shares). PCA, Sierra Sub and
Sierra will, through their respective Boards of Directors, subject to their
fiduciary duties to their shareholders under applicable law, recommend to their
respective stockholders and shareholders approval of such matters. PCA and
Sierra shall coordinate and cooperate with respect to the timing of such
meetings and shall use their best efforts to hold such meetings on the same day
and as soon as practicable after the date hereof.
5.4. LEGAL CONDITIONS TO MERGER. Each of PCA, Sierra and Sierra Sub will
take all reasonable actions necessary to comply promptly with all legal
requirements which may be imposed on itself with respect to the Merger
(including furnishing all information required under the HSR Act, in connection
with the Approvals and in connection with approvals of or filings with any other
Governmental Entity) and will promptly cooperate with and furnish information to
each other in connection with any such requirements imposed upon any of them or
any of their Subsidiaries in connection with the Merger. Each of PCA, Sierra
and Sierra Sub will, and will cause its Subsidiaries to, take all reasonable
actions necessary to obtain (and will cooperate with each other in obtaining)
any consent, authorization, order or approval of, or any exemption by, any
Governmental Entity or other public or private third party, required to be
obtained or
-51-
<PAGE>
made by Sierra, PCA or any of their Subsidiaries in connection with the
Merger or the taking of any action contemplated thereby or by this Agreement.
5.5. STOCK EXCHANGE LISTING. Sierra shall use all reasonable efforts to
cause the shares of Sierra Common Stock to be issued in the Merger and the
shares of Sierra Common Stock to be reserved for issuance upon exercise of PCA
Stock Options to be approved for listing on the NYSE, subject to official notice
of issuance, prior to the Closing Date.
5.6. EMPLOYEE BENEFIT PLANS. PCA agrees to take all necessary steps at or
prior to the Closing to terminate effective as of the Closing, the following
Designated Plans (as disclosed on SCHEDULE 3.1(o)): (i) the 1986 Incentive Stock
Option Plan, (ii) the 1986 Non-Qualified Stock Option Plan and (iii) the 1993
Stock Option Plan. PCA also agrees that, on or after the date of this
Agreement, it will not issue any stock option or any other award pursuant to the
1993 Stock Option Plan, the 1986 Incentive Stock Option Plan and the 1986
Non-Qualified Stock Option Plan (collectively, the "PCA Plans") and PCA agrees
that the remaining Designated Plans, if any, will continue subsequent to the
Closing, but may be terminated at any time thereafter provided that at such time
the employees of the Surviving Corporation or its Subsidiaries are either
covered under a Plan, if any, providing benefits of the same nature that is
maintained by either Sierra or a Subsidiary for its employees or by a Plan
comparable to any such Plan.
5.7. STOCK OPTIONS.
(a) At the Effective Time, each outstanding option to purchase shares
of PCA Common Stock (a "PCA Stock Option" or collectively, "PCA Stock
Options") issued pursuant to PCA Plans, issued to Jackson Memorial
Foundation and to The University of Miami, and issued to employees of PCA
not pursuant to the PCA Plans or any other stock option plan, whether
vested or unvested, shall be assumed by Sierra. Each PCA Stock Option
shall be deemed to constitute an option to acquire, on the same terms and
conditions as were applicable under such PCA Stock Option, the same number
of shares of Sierra Common Stock as the holder of such PCA Stock Option
would have been entitled to receive pursuant to the Merger had such holder
exercised such option in full immediately prior to the Effective Time, at a
price per share equal to (y) the aggregate exercise price for the shares of
PCA Common Stock otherwise purchasable pursuant to such PCA Stock Option
divided by (z) the number of full shares of Sierra Common Stock deemed
purchasable pursuant to such PCA Stock Option; provided, however, that in
the case of any option to which section 421 of the Code applies by reason
of its qualification under section 422 of the Code ("incentive stock
options"), the option price, the number of shares purchasable pursuant to
such option and the terms and conditions of exercise of such option shall
be determined in order to comply with section 424(a) of the Code.
(b) As soon as practicable after the Effective Time, Sierra shall
deliver to the holders of PCA Stock Options appropriate notices setting
forth such holders' rights
-52-
<PAGE>
pursuant to the respective PCA Plans and the agreements evidencing the
grants of such Options shall continue in effect on the same terms and
conditions (subject to the adjustments required by this Section 5.7 after
giving effect to the Merger). Sierra shall comply with the terms of the
PCA Plans and ensure, to the extent required by, and subject to the
provisions of, such Plans, that PCA Stock Options which qualified as
incentive stock options prior to the Effective Time continue to qualify
as qualified stock options after the Effective Time.
(c) Sierra shall take all corporate action necessary to reserve for
issuance a sufficient number of shares of Sierra Common Stock for delivery
upon exercise of PCA Stock Options assumed in accordance with this Section
5.7. As soon as practicable after the Effective Time, Sierra shall file a
registration statement on Form S-3 or Form S-8, as the case may be (or any
successor or other appropriate forms), or another appropriate form with
respect to the shares of Sierra Common Stock subject to such options and
shall use its best efforts to maintain the effectiveness of such
registration statement or registration statements (and maintain the current
status of the prospectus or prospectuses contained therein) for so long as
such options remain outstanding. With respect to those individuals who
subsequent to the Merger will be subject to the reporting requirements
under Section 16(a) of the Exchange Act, where applicable, Sierra shall
administer PCA Plans assumed pursuant to this Section 5.7 in a manner that
complies with Rule 16b-3 promulgated under the Exchange Act to the extent
the applicable PCA Plan complied with such rule prior to the Merger.
5.8. BROKERS OR FINDERS. Each of Sierra and PCA represents, as to itself,
its Subsidiaries and its affiliates, that no agent, broker, investment banker,
financial advisor or other firm or person is or will be entitled to any broker's
or finder's fee or any other commission or similar fee in connection with any of
the transactions contemplated by this Agreement, except Bear, Stearns & Co.,
whose fees and expenses will be paid by PCA in accordance with PCA's agreement
with such firm (copies of which have been delivered by PCA to Sierra prior to
the date of this Agreement), and Salomon Brothers Inc, whose fees and expenses
will be paid by Sierra in accordance with Sierra's agreement with such firm
(copies of which have been delivered by Sierra to PCA prior to the date of this
Agreement), and each of Sierra and PCA respectively agree to indemnify and hold
the other harmless from and against any and all claims, liabilities or
obligations with respect to any other fees, commissions or expenses asserted by
any person on the basis of any act or statement alleged to have been made by
such party or its affiliate.
5.9. ACCESS TO SIERRA RECORDS. Upon reasonable notice, Sierra shall (and
shall cause its Subsidiaries to) afford to the officers, employees, accountants,
counsel and other representatives of PCA, access, during normal business hours
during the period prior to the Effective Time, to all its properties, books,
contracts, commitments and records and, during such period, Sierra shall (and
shall cause its Subsidiaries to) furnish promptly to PCA (a) a copy
-53-
<PAGE>
of each report, schedule, registration statement and other document filed or
received by it during such period pursuant to the requirements of Federal
securities laws and (b) all other information concerning its business,
properties and personnel as such other party may reasonably request. Unless
otherwise required by law, PCA will hold any such information which is
nonpublic in confidence until such time as such information otherwise becomes
publicly available through no wrongful act of either party, and in the event
of termination of this Agreement for any reason PCA shall promptly return all
nonpublic documents obtained from Sierra or its Subsidiaries, and any copies
made of such documents, to Sierra.
5.10. EMPLOYMENT AGREEMENTS. Sierra shall, as of or prior to the
Effective Time, have offered to, which offer has not been revoked or rescinded,
to enter into employment contracts with the persons set forth on EXHIBIT 5.10 on
the terms set forth in the forms of Employment Agreements attached hereto as
EXHIBIT 5.10.
5.11. INDEMNIFICATION; DIRECTORS' AND OFFICERS' INSURANCE.
(a) From and after the Effective Time, Sierra and the Surviving
Corporation shall, jointly and severally indemnify, defend and hold
harmless each person who is now, or has been at any time prior to the date
hereof or who becomes prior to the Effective Time, an officer, director or
employee of PCA or any of its Subsidiaries (the "Indemnified Parties")
against (i) all losses, claims, damages, costs, expenses (including
attorney's fees), liabilities or judgments or amounts that are paid in
settlement (which settlement shall require the prior written consent of
Sierra, which consent shall not be unreasonably withheld) of or in
connection with any claim, action, suit, proceeding or investigation (a
"Claim") in which an Indemnified Party is, or is threatened to be made, a
party or a witness based in whole or in part on or arising in whole or in
part out of the fact that such person is or was an officer, director or
employee of PCA or any of its Subsidiaries, whether such Claim pertains to
any matter or fact arising, existing or occurring at or prior to the
Effective Time (including, without limitation, the Merger and other
transactions contemplated by this Agreement), regardless of whether such
Claim is asserted or claimed prior to, at or after the Effective Time (the
"Indemnified Liabilities"), and (ii) all Indemnified Liabilities based in
whole or in part on, or arising in whole or in part out of, or pertaining
to this Agreement or the transactions contemplated hereby, in each case to
the full extent PCA would have been permitted under Delaware law and its
Certificate of Incorporation and Bylaws to indemnify such person (and
Sierra shall pay expenses in advance of the final disposition of any such
action or proceeding to each Indemnified Party to the full extent permitted
by law and under such Certificate of Incorporation or Bylaws, upon receipt
of any undertaking required by such Certificate of Incorporation, Bylaws or
applicable law). Any Indemnified Party wishing to claim indemnification
under this Section 5.11(a), upon learning of any Claim, shall notify Sierra
(but the failure so to notify Sierra shall not relieve it from any
liability which Sierra may have under this Section 5.11(a) except to
-54-
<PAGE>
the extent such failure prejudices Sierra) and shall deliver to Sierra any
undertaking required by such Certificate of Incorporation, Bylaws or
applicable law. Each of Sierra and Surviving Corporation shall, jointly and
severally use its best efforts to assure, to the extent permitted under
applicable law, that all limitations of liability existing in favor of the
Indemnified Parties as provided in PCA's Certificate of Incorporation and
Bylaws, as in effect as of the date hereof, with respect to claims or
liabilities arising from facts or events existing or occurring prior to the
Effective Time (including, without limitation, the transactions
contemplated by this Agreement), shall survive the Merger. The obligations
of Sierra and Surviving Corporation described in this Section 5.11(a) shall
continue in full force and effect, without any amendment thereto, for a
period of not less than six years from the Effective Time; provided,
however, that all rights to indemnification in respect of any Claim
asserted or made within such period shall continue until the final
disposition of such Claim; and provided further that nothing in this
Section 5.11(a) shall be deemed to modify applicable Delaware
Indemnification of former officers and directors. The Indemnified Parties
as a group may retain only one law firm at the expense of Sierra to
represent them with respect to each such matter unless there is, under
applicable standards of professional conduct, a conflict on any significant
issue between the positions of any two or more Indemnified Parties.
(b) Sierra and the Surviving Corporation shall cause to be maintained
in effect for not less than six years from the Effective Time the current
policies of directors' and officers' liability insurance maintained by PCA
and its Subsidiaries (provided that Sierra and the Surviving Corporation
may substitute therefor policies of at least the same coverage containing
terms and conditions which are no less advantageous to the Indemnified
Parties in all material respects so long as no lapse in coverage occurs as
a result of such substitution) with respect to all matters, including the
transactions contemplated hereby, occurring prior to, and including, the
Effective Time, provided that, in the event that any Claim is asserted or
made within such six-year period, such insurance shall be continued in
respect of any such Claim until final disposition of any and all such
Claims. Notwithstanding anything to the contrary contained elsewhere
herein, Sierra's and Surviving Corporation's agreement set forth above
shall be limited to cover claims only to the extent that those claims are
not covered under PCA's directors' and officers' insurance policies (or any
substitute policies permitted by this Section 5.11(b)).
(c) The obligations of Sierra and the Surviving Corporation under
this Section 5.11 are intended to benefit, and be enforceable against
Sierra and the Surviving Corporation directly by, the Indemnified Parties,
and shall be binding on all respective successors of Sierra and the
Surviving Corporation.
5.12. ADDITIONAL AGREEMENTS; REASONABLE EFFORTS. Subject to the terms
and conditions of this Agreement, each of the parties hereto agrees to use all
reasonable efforts to take, or cause
-55-
<PAGE>
to be taken, all action and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations to consummate and
make effective the transactions contemplated by this Agreement, subject to
the appropriate vote of shareholders of Sierra and of stockholders of PCA
described in Section 6.1(a), including cooperating fully with the other
party, including by provision of information and making of all necessary
filings in connection with, among other things the HSR Act. In case at any
time after the Effective Time any further action is necessary or desirable to
carry out the purposes of this Agreement or to vest the Surviving Corporation
with full title to all properties, assets, rights, approvals, immunities and
franchises of either of the Constituent Corporations, the proper officers and
directors of each party to this Agreement shall take all such necessary
action.
5.13. POOLING. Sierra and PCA each agrees that it will not knowingly
take any action which would have the effect of jeopardizing the treatment of the
Merger as a "pooling-of-interests" for accounting purposes.
5.14. NO ACTIONS INCONSISTENT WITH TAX-FREE REORGANIZATION. PCA and
each of its Subsidiaries, Sierra and Sierra Sub shall (and, following the
Effective Time, Sierra shall cause the Surviving Corporation to) take no action
with respect to the capital stock, assets or liabilities of the Surviving
Corporation that would cause the Merger not to qualify as a "reorganization"
within the meaning of Sections 368(a)(1)(A) and (a)(2)(E) of the Code.
5.15. SIERRA'S BOARD OF DIRECTORS.
(a) The Board of Directors of Sierra will take action prior to the
Effective Time to cause the number of directors comprising the full Board
of Directors of Sierra at the Effective Time to be increased to nine
persons, and the three persons listed on EXHIBIT 5.15 as the PCA designees
to the Board of Directors of Sierra shall be elected to the Board of
Directors of Sierra by the Sierra Board of Directors effective at the
Effective Time, such increase in number and such election to be subject to
the Closing. The Sierra Board of Directors will also take action prior to
the Effective Time to cause the committees of the Board of Directors of
Sierra at the Effective Time to be the committees listed on EXHIBIT 5.15,
having the membership noted on such Exhibit, such action to be subject to
the Closing. Following the Effective Time, the Board of Directors of
Sierra will take action to cause one person to be designated by mutual
agreement of the PCA designees and the Sierra designees to be elected to
the Board of Directors of Sierra. If prior to the Effective Time, any PCA
designee for director set forth on EXHIBIT 5.15, or if during the two years
after the Effective Time, any PCA designated director shall decline or be
unable to serve as a director of Sierra, the other PCA designees or the
remaining PCA designated directors, as the case may be, shall designate
another person to serve in such person's stead, subject to the approval of
a majority of the Sierra designated directors at that time, which approval
shall not be unreasonably withheld. If during the two years after the
Effective Time, any Sierra designated director
-56-
<PAGE>
shall decline or be unable to serve as a director of Sierra, the remaining
Sierra designated directors shall designate another person to serve in such
person's stead. Sierra agrees that, during the two year period after the
Effective Time, it shall cause at least one PCA designee listed on
EXHIBIT 5.16 (or his successor chosen pursuant to this Section 5.15(a)) to
be a member of each of the Committees set forth on EXHIBIT 5.16 of the
Board of Directors of Sierra. Sierra shall take all appropriate action for
two years after the Effective Time to assist in the nomination for election
as directors of the PCA designees listed on EXHIBIT 5.15 (or any successor
chosen pursuant to this Section 5.15(a)).
(b) Each person designated by PCA to serve on the Board of Directors
of Sierra, and any person subsequently appointed to the Board of Directors
of Sierra by such designees pursuant to Section 5.15(a), shall be covered
by the 1995 Employee Directors Stock Plan and the prior service of any such
person on the PCA Board of Directors shall count as service on the Board of
Directors of Sierra for all purposes under such plan.
5.16. APPOINTMENT OF DIRECTORS TO COMMITTEES. Sierra's Board of
Directors shall take the requisite action to appoint at the Effective Time those
individuals set forth on EXHIBIT 5.16 as members of the executive and operating
committees of the Board of Directors of Sierra as set forth on such EXHIBIT
5.16.
5.17. ELECTION OF OFFICERS OF SIERRA. Sierra's Board of Directors
shall take the requisite action to elect at the Effective Time those individuals
set forth on EXHIBIT 5.10 to the offices set forth in their respective
Employment Agreement, understanding that such individuals will be entitled to
all rights under their existing employment contracts with PCA.
5.18. HEADQUARTERS. PCA and Sierra agree that commencing at the
Effective Time the headquarters of the Surviving Corporation shall be located in
Las Vegas, Nevada.
ARTICLE VI. CONDITIONS PRECEDENT
6.1. CONDITIONS TO EACH PARTY'S OBLIGATION TO EFFECT THE MERGER. The
respective obligation of each party to effect the Merger shall be subject to the
satisfaction prior to the Closing Date of the following conditions:
(a) APPROVAL. This Agreement and the Merger shall have been approved
and adopted by the affirmative vote of a majority of the votes that the
holders of the outstanding shares of PCA Common Stock are entitled to cast
and shall have been approved by the affirmative vote of [a majority of the
votes that the holders of the outstanding shares of Sierra Common Stock are
entitled to cast]. Not more than ten percent (10%) of the holders of the
outstanding shares of PCA Common Stock shall have
-57-
<PAGE>
delivered to PCA written demands for appraisal of such shares prior to the
taking of the vote by the stockholders of PCA on the Merger.
(b) NYSE LISTING. The shares of Sierra Common Stock issuable to PCA
stockholders pursuant to this Agreement and such other shares required to
be reserved for issuance in connection with the Merger shall have been
authorized for listing on the NYSE upon official notice of issuance.
(c) OTHER APPROVALS. The filings provided for by Section 1.1 and the
State Takeover Approvals and all authorizations, consents, orders or
approvals (including State Approvals) of, or declarations or filings with,
or expirations of waiting periods imposed by, any Governmental Entity the
absence of which would have a Material Adverse Effect on Sierra or the
Surviving Corporation shall have been filed, have occurred or been
obtained.
(d) S-4. The S-4 shall have become effective under the Securities
Act and shall not be the subject of any stop order or proceedings seeking a
stop order.
(e) NO INJUNCTIONS OR RESTRAINTS. No temporary restraining order,
preliminary or permanent injunction or other order issued by any court of
competent jurisdiction or other legal restraint or prohibition (an
"Injunction") preventing the consummation of the Merger shall be in effect.
(f) POOLING. The independent public accountants of each of PCA and
Sierra shall have issued an opinion, addressed to them that the Merger will
qualify for "pooling of interests" accounting treatment under applicable
accounting rules, including, without limitation, applicable SEC accounting
standards.
6.2. CONDITIONS TO OBLIGATIONS OF SIERRA AND SIERRA SUB. The obligations
of Sierra and Sierra Sub to effect the Merger are subject to the satisfaction of
the following conditions unless waived by Sierra and Sierra Sub:
(a) REPRESENTATIONS AND WARRANTIES. The representations and
warranties of PCA set forth in this Agreement shall be true and correct in
all material respects as of the date of this Agreement and (except to the
extent such representations and warranties speak as of an earlier date) as
of the Closing Date as though made on and as of the Closing Date, except
(i) as otherwise contemplated by this Agreement or (ii) to the extent that
any omission or misrepresentation would not have a Material Adverse Effect
on PCA. Sierra shall have received a certificate signed on behalf of PCA
by the chief executive officer and by the chief financial officer of PCA to
such effect.
-58-
<PAGE>
(b) PERFORMANCE OF OBLIGATIONS OF PCA. PCA shall have performed in
all material respects all obligations required to be performed by it under
this Agreement at or prior to the Closing Date where the failure to do so
would have a Material Adverse Effect on PCA, and Sierra shall have received
a certificate signed on behalf of PCA by the Chief Executive Officer and by
the Chief Financial Officer of PCA to such effect.
(c) LETTER FROM PCA AFFILIATES. Sierra shall have received from each
person named in the letter referred to in Section 4.1(k) an executed copy
of an agreement substantially in the form of EXHIBIT 4.1(K).
(d) TAX OPINION. The opinion of Morgan, Lewis & Bockius LLP, counsel
to Sierra, to the effect that the Merger will be treated for Federal income
tax purposes as a reorganization within the meaning of Section 368(a) of
the Code, and that Sierra, Sierra Sub and PCA will each be a party to that
reorganization within the meaning of Section 368(b) of the Code, dated on
or about the date that is two business days prior to the date the Proxy
Statement is first mailed to stockholders of PCA and to the shareholders of
Sierra, shall not have been withdrawn or modified in any material respect.
(e) CONSENTS UNDER AGREEMENTS. PCA shall have obtained the consent
or approval of each person (other than Sierra and its Subsidiaries and
affiliates) whose consent or approval shall be required in order to permit
the succession by the Surviving Corporation pursuant to the Merger to any
obligation, right or interest of PCA or any Subsidiary of PCA under any
loan or credit agreement, note, mortgage, indenture, lease or other
agreement or instrument, except those for which failure to obtain such
consents and approvals would not have a Material Adverse Effect on Sierra
following the Merger, including the Surviving Corporation and its
Subsidiaries.
(f) NO REPEAL OF RESOLUTIONS. Except as permitted by the terms of
this Agreement, neither the Board of Directors of PCA nor any committee
thereof shall have rescinded or repealed, or amended to change the terms of
this Agreement, the resolutions adopted by the Board of Directors on
November 2, 1996 (accurate and complete copies of which will be provided to
Sierra).
6.3. CONDITIONS OF OBLIGATIONS OF PCA. The obligation of PCA to effect the
Merger is subject to the satisfaction of the following conditions unless waived
by PCA:
(a) REPRESENTATIONS AND WARRANTIES. The representations and
warranties of Sierra and Sierra Sub set forth in this Agreement shall be
true and correct in all material respects as of the date of this Agreement
and (except to the extent such representations speak as of an earlier date)
as of the Closing Date as though made on and as of the Closing Date, except
(i) as otherwise contemplated by this Agreement or (ii) to the extent
-59-
<PAGE>
that any omission or misrepresentation would not have a Material Adverse
Effect on Sierra. PCA shall have received a certificate signed on behalf
of Sierra by the Chief Executive Officer or the President or the Vice
Chairman or and by the chief financial officer of Sierra to such effect.
(b) PERFORMANCE OF OBLIGATIONS OF SIERRA AND SIERRA SUB. Sierra and
Sierra Sub shall have performed in all material respects all obligations
required to be performed by them under this Agreement at or prior to the
Closing Date where the failure to do so would have a Material Adverse
Effect on Sierra, and PCA shall have received a certificate signed on
behalf of Sierra by the Chief Executive Officer or the President or the
Vice Chairman and by the chief financial officer of Sierra to such effect.
(c) TAX OPINION. The opinion of Fulbright & Jaworski L.L.P., counsel
to PCA, to the effect that the Merger will be treated for Federal income
tax purposes as a reorganization within the meaning of Section 368(a) of
the Code, and that Sierra, Sierra Sub and PCA will each be a party to that
reorganization within the meaning of Section 368(b) of the Code, dated on
or about the date that is two business days prior to the date the Proxy
Statement is first mailed to stockholders of PCA and of Sierra, shall not
have been withdrawn or modified in any material respect.
(d) CONSENTS UNDER AGREEMENTS. Sierra shall have obtained the
consent or approval of each person (other than PCA and its Subsidiaries and
affiliates) whose consent or approval shall be required in connection with
the transactions contemplated hereby under any loan or credit agreement,
note, mortgage, indenture, lease or other agreement or instrument, except
those for which failure to obtain such consents and approvals would not
have a Material Adverse Effect on Sierra following the Merger, including
the Surviving Corporation and its Subsidiaries.
(e) NO REPEAL OF RESOLUTIONS. Except as permitted by the terms of
this Agreement, neither the Board of Directors of Sierra nor any committee
thereof shall have rescinded or repealed, or amended to change the terms of
this Agreement, the resolutions adopted by the Board of Directors at a
meeting duly called and held on November 1, 1996 (accurate and complete
copies of which will be provided to PCA).
ARTICLE VII. TERMINATION AND AMENDMENT
7.1. TERMINATION. This Agreement may be terminated at any time prior to
the Effective Time, whether before or after approval of the matters presented in
connection with the Merger by the stockholders of PCA or by the shareholders of
Sierra:
(a) by mutual consent of Sierra and PCA;
-60-
<PAGE>
(b) by
(i) Sierra if there has been a breach of any representation,
warranty, covenant or agreement on the part of PCA set forth in this
Agreement that would have a Material Adverse Effect on PCA so that the
conditions set forth in Section 6.2(a) or (b) would be incapable of
being satisfied within forty-five (45) days of notice of such breach;
provided that in any case, a wilful breach shall be deemed to cause
such conditions to be incapable of being satisfied for purposes of
this Section 7.1(b),
(ii) PCA if there has been a breach of any representation,
warranty, covenant or agreement on the part of Sierra or Sierra Sub
set forth in this Agreement that would have a Material Adverse Effect
on Sierra so that the conditions set forth in Section 6.3(a) or (b)
would be incapable of being satisfied within sixty (60) days of notice
of such breach provided that in any case, a wilful breach shall be
deemed to cause such conditions to be incapable of being satisfied for
purposes of this Section 7.1(b), or
(iii) either Sierra or PCA if any permanent injunction or
other order of a court or other competent authority preventing the
consummation of the Merger shall have become final and non-appealable;
(c) by either Sierra or PCA if the Merger shall not have been
consummated on or before March 31, 1997, unless the failure to consummate
the Merger is the result of a material breach of this Agreement by the
party seeking to terminate this Agreement;
(d) by either Sierra or PCA if any required approval of the
stockholders of PCA or shareholders of Sierra shall not have been obtained
by reason of the failure to obtain the required affirmative vote at a duly
held meeting of shareholders of Sierra or stockholders of PCA or at any
adjournment thereof;
(e) by either Sierra or PCA to the extent permitted under Section 8.2
or 8.3.; or
(f) by Sierra (i) within three business days of the receipt by Sierra
of a final report by Mercer with respect to the Workers' Compensation
Business which concludes that the reasonable and adequate reserves for the
Workers' Compensation Business with respect to those certain "blocks" has
increased from the Mercer draft report referred to in Section 3.1(g)(iii)
of $317.3 million and exceeds the $362.6 million reserve accrued on the
financial books and records of PCA, or (ii) on or before 5:00 p.m. Miami
time on November 18, 1996, in the event that the Florida Department of
Insurance shall not
-61-
<PAGE>
have approved on or before November 15, 1996, the transfer to ZC Insurance
Company of Florida Workers' Compensation policies currently being written
by PCA P&C.
7.2. EFFECT OF TERMINATION. In the event of termination of this Agreement
by either PCA or Sierra as provided in Section 7.1, this Agreement shall
forthwith become void and there shall be no liability or obligation on the part
of Sierra, Sierra Sub or PCA or their respective officers or directors except
(y) with respect to the last sentence of Sections 4.1(j) and 5.9, and Sections
5.8, 7.5, 8.2, 8.3 and 8.4 and (z) to the extent that such termination results
from the willful breach by a party hereto of any of its representations,
warranties, covenants or agreements set forth in this Agreement except as
provided in Section 9.7.
7.3. AMENDMENT. This Agreement may be amended by the parties hereto, by
action taken or authorized by their respective Boards of Directors, at any time
before or after approval of the matters presented in connection with the Merger
by the stockholders of PCA or, the shareholders of Sierra, but, after any such
approval, no amendment shall be made which by law requires further approval by
such stockholders or shareholders without such further approval. This Agreement
may not be amended except by an instrument in writing signed on behalf of each
of the parties hereto.
7.4. EXTENSION; WAIVER. At any time prior to the Effective Time, the
parties hereto, by action taken or authorized by their respective Board of
Directors, may, to the extent legally allowed, (a) extend the time for the
performance of any of the obligations or other acts of the other parties hereto,
(b) waive any inaccuracies in the representations and warranties contained
herein or in any document delivered pursuant hereto and (c) waive compliance
with any of the agreements or conditions contained herein. Any agreement on the
part of a party hereto to any such extension or waiver shall be valid only if
set forth in a written instrument signed on behalf of such party.
7.5. FEES AND EXPENSES.
(a) All costs and expenses incurred in connection with this Agreement
and the transactions contemplated hereby shall be paid by the party
incurring such expense, and, in connection therewith, each of Sierra and
PCA shall pay, with its own funds and not with funds provided by the other
party, any and all property or transfer taxes imposed on such party or any
real property tax imposed on any holder of shares in such party resulting
from the Merger, except that expenses incurred in connection with printing
and mailing the Proxy Statement and the S-4 shall be shared equally by
Sierra and PCA.
(b) PCA agrees that if Sierra terminates this Agreement pursuant to
Section 7.1(b), then on the Payment Date (as defined below), PCA shall pay
to Sierra an amount equal to $3,000,000 plus all of Sierra's Expenses,
including Sierra's share of the Expenses described in Section 7.5(a), which
sum PCA and Sierra agree is reasonable
-62-
<PAGE>
under the circumstances since it would be impracticable and extremely
difficult to fix the actual damage to Sierra in the case of such a
termination. For purposes of this Section 7.5(b), the "Payment Date" is
the date not less than 10 days following the termination of this Agreement
by Sierra giving rise to payment under this Section 7.5(b), and not later
than two business days after the date of delivery of a notice of demand
pursuant to Section 7.5(e). PCA shall not be obligated to pay the amounts
set forth in the first sentence of this Section 7.5(b) if PCA terminates
this Agreement pursuant to Section 7.1(b) or 7.1(c) or as a result of the
failure of the conditions set forth in Section 6.1 or Section 6.3 to be
satisfied.
(c) Sierra agrees that if PCA terminates this Agreement pursuant to
Section 7.1(b), then on the Payment Date (as defined below), Sierra shall
pay to PCA an amount equal to $3,000,000 plus all of PCA's Expenses,
including PCA's share of the Expenses described in Section 7.5(a), which
sum Sierra and PCA agree is reasonable under the circumstances since it
would be impracticable and extremely difficult to fix the actual damage to
PCA in the case of such a termination. For purposes of this
Section 7.5(c), the "Payment Date" is the date not less than 10 days
following the termination of this Agreement by PCA giving rise to payment
under this Section 7.5(c), and not later than two business days after the
date of delivery of a notice of demand pursuant to Section 7.5(e). Sierra
shall not be obligated to pay the amounts set forth in the first sentence
of this Section 7.5(c) if Sierra terminates this Agreement pursuant to
Section 7.1(b) or 7.1(c) or as a result of the failure of the conditions
set forth in Section 6.1 or Section 6.2 to be satisfied.
(d) PCA and Sierra each agree that (i) except as set forth in clause
(ii) below, the payment provided for in Sections 7.5(b), 7.5(c), 8.2, 8.3
and 8.4 shall be the sole and exclusive remedy of Sierra and PCA upon any
termination of this Agreement as described in such sections and such
remedies shall be limited to the sum stipulated in such sections regardless
of the circumstances (including willful or deliberate conduct) giving rise
to such termination, and (ii) with respect to any termination of this
Agreement pursuant to Section 7.1(b), all remedies available to the other
party either in law or equity shall be preserved and survive the
termination of this Agreement.
(e) Any payment required to be made pursuant to Section 7.5(b) or
7.5(c) shall be made to the party entitled to such payment not later than
two business days after delivery to the party obligated to make such
payment of notice of demand for payment and an itemization setting forth in
reasonable detail all Expenses of such entitled party (which itemization
may be supplemented and updated from time to time by such entitled party
until the 60th day after such entitled party delivers such notice of demand
for payment), and shall be made by wire transfer of immediately available
funds to an account designated by such entitled party in the notice of
demand for payment delivered pursuant to this Section 7.5(e).
-63-
<PAGE>
ARTICLE VIII. SPECIAL PROVISIONS AS TO CERTAIN MATTERS
8.1. TAKEOVER DEFENSES OF PCA AND SIERRA.
(a) No later than the fifth business day after the date of the
announcement of the execution of this Agreement, each of PCA and Sierra
will amend their respective Rights Agreements, as necessary, (i) to prevent
this Agreement or the consummation of the transactions contemplated hereby
from resulting in the distribution of separate rights certificates or the
occurrence of a Distribution Date (as defined therein) or being deemed a
Triggering Event (as defined therein) and (ii) to provide that neither
Sierra, Sierra Sub nor PCA shall be deemed to be an Acquiring Person (as
defined therein) by reason of the transactions contemplated by this
Agreement.
(b) Pursuant to Section 8.1(a), the Board of PCA shall take all
necessary action to amend the PCA Rights Agreement so that (i) none of the
execution or delivery of this Agreement or the exchange of the shares of
PCA Common Stock for the shares of Sierra Common Stock in accordance with
Article II will cause (A) the PCA Rights distributed pursuant to the PCA
Rights Agreement to become exercisable under the PCA Rights Agreement, (B)
Sierra or any of the Sierra Subsidiaries to be deemed an "Acquiring Person"
(as defined in the PCA Rights Agreement), or (C) the "Shares Acquisition
Date" (as defined in the PCA Rights Agreement) to occur upon any such event
and (ii) the "Final Expiration Date" (as defined in the PCA Rights
Agreement) of the PCA Rights shall occur immediately prior to the Effective
Time. PCA agrees to take all necessary action to amend the PCA Rights
Agreement so that the consummation of the Merger, on the terms permitted
hereunder, will not cause any of the effects referred to in Section 3 or 13
of the PCA Rights Agreement to occur; provided, however, that PCA shall not
be required to make such amendments to the PCA Rights Agreement if (i)
Sierra has not performed or complied in all material respects with all
agreements and covenants required by this Agreement to be performed or
complied with by it on or prior to the consummation of the Merger or (ii)
PCA obtains and there is in force from the Delaware Court of Chancery an
order permanently, preliminarily or temporarily declaring that the making
of such amendments to the PCA Rights Agreement would be contrary to the
fiduciary duties of the Board of Directors of PCA.
(c) PCA and Sierra shall each take such action with respect to any
other anti-takeover provisions in their respective charters or afforded
either of them by statute to the extent necessary to consummate the Merger
on the terms set forth in this Agreement.
8.2. NO SOLICITATION.
(a) PCA shall not, nor shall it permit any of its Subsidiaries to,
nor shall it authorize or permit any officer, director or employee of or
any investment banker,
-64-
<PAGE>
attorney or other advisor, agent or representative of PCA or any of its
subsidiaries to, directly or indirectly, (i) solicit, initiate or encourage
the submission of any takeover proposal, (ii) enter into any agreement
(other than confidentiality and standstill agreements in accordance with
the immediately following proviso) with respect to any takeover proposal,
or (iii) participate in any discussions or negotiations regarding, or
furnish to any person any information with respect to, or take any other
action to facilitate any inquiries or the making of any proposal that
constitutes, or may reasonably be expected to lead to, any takeover
proposal; provided, however, in the case of this clause (iii), that prior
to the vote of stockholders of PCA for approval of the Merger (and not
thereafter if the Merger is approved thereby) to the extent required by the
fiduciary obligations of the Board of Directors of PCA, determined in good
faith by a majority of the disinterested members thereof based on the
advice of outside counsel, PCA may, in response to an unsolicited request
therefor, furnish information to any person or "group" (within the meaning
of Section 13(d)(3) of the Exchange Act) pursuant to a confidentiality
agreement on substantially the same terms as provided in Confidentiality
Agreement between PCA and Sierra (the "Confidentiality Agreement"). Without
limiting the foregoing, it is understood that any violation of the
restrictions set forth in the preceding sentence by any officer, director
or employee of PCA or any of its Subsidiaries or any investment banker,
attorney or other advisor, agent or representative of PCA, whether or not
such person is purporting to act on behalf of PCA or otherwise, shall be
deemed to be a material breach of this Agreement by PCA. For purposes of
this Section 8.2, "takeover proposal" means (i) any proposal, other than a
proposal by Sierra or any of its affiliates, for a merger or other business
combination involving PCA, (ii) any proposal or offer, other than a
proposal or offer by Sierra or any of its affiliates, to acquire from PCA
or any of its affiliates in any manner, directly or indirectly, an equity
interest in PCA or any Subsidiary, any voting securities of PCA or any
Subsidiary or a material amount of the assets of PCA and its Subsidiaries,
taken as a whole, or (iii) any proposal or offer, other than a proposal or
offer by Sierra or any of its affiliates, to acquire from the stockholders
of PCA by tender offer, exchange offer or otherwise more than 20% of the
outstanding shares of PCA Common Stock.
(b) Neither the Board of Directors of PCA nor any committee thereof
shall, except in connection with the termination of this Agreement pursuant
to Section 7.1(a), (b), or (f), (i) withdraw or modify, or propose to
withdraw or modify, in a manner adverse to Sierra or Sierra Sub the
approval or recommendation by the Board of Directors of PCA or any such
committee of this Agreement or the Merger or take any action having such
effect, provided, that a statement by the Board of Directors of PCA to its
stockholders as contemplated by Rule 14e-2(a) following Sierra's receipt of
a Notice of Superior Proposal (as defined below) shall not be deemed to
constitute a withdrawal or modification of its recommendation of this
Agreement or the Merger, or (ii) approve or recommend, or propose to
approve or recommend, any takeover proposal. Notwithstanding the
foregoing, in the event the Board of Directors of PCA receives a
-65-
<PAGE>
takeover proposal that, in the exercise of its fiduciary obligations (as
determined in good faith by a majority of the disinterested members thereof
based on the advice of outside counsel), it determines to be a superior
proposal, the Board of Directors may withdraw or modify its approval or
recommendation of this Agreement or the Merger and may (subject to the
following sentence) terminate this Agreement, in each case at any time
after midnight on the next business day following Sierra's receipt of
written notice (a "Notice of Superior Proposal") advising Sierra that the
Board of Directors has received a takeover proposal which it has determined
to be a superior proposal, specifying the material terms and conditions of
such superior proposal (including the proposed financing for such proposal
and a copy of any documents conveying such proposal) and identifying the
person making such superior proposal. PCA may terminate this Agreement
pursuant to the preceding sentence only if the stockholders of PCA shall
not yet have voted upon the Merger and PCA shall have paid to Sierra the
PCA Termination Fee (as defined in Section 8.4(a)). Any of the foregoing
to the contrary notwithstanding, PCA may engage in discussions with any
person or group that has made an unsolicited takeover proposal for the
limited purpose of determining whether such proposal is a superior
proposal. Nothing contained herein shall prohibit PCA from taking and
disclosing to its stockholders a position contemplated by Rule 14e-2(a)
following Sierra's receipt of a Notice of Superior Proposal.
(c) In the event that the Board of Directors of PCA or any committee
thereof shall (i) withdraw or modify, or propose to withdraw or modify, in
a manner adverse to Sierra or Sierra Sub the approval or recommendation by
the Board of Directors of PCA or any such committee of this Agreement or
the Merger or take any action having such effect or (ii) approve or
recommend, or propose to approve or recommend, any takeover proposal,
Sierra may terminate this Agreement.
(d) For purposes of this Section 8.2, a "superior proposal" means any
bona fide takeover proposal to acquire, directly or indirectly, for
consideration consisting of cash, securities or a combination thereof, all
of the shares of PCA Common Stock then outstanding or all or substantially
all the assets of PCA, and otherwise on terms that a majority of the
disinterested members of the Board of Directors of PCA determines in its
good faith reasonable judgment (based on the written advice of a financial
advisor of nationally recognized reputation, a copy of which shall be
provided to Sierra) to be more favorable to PCA's stockholders than the
Merger.
(e) In addition to the obligations of PCA set forth in paragraph (b),
PCA shall promptly advise Sierra orally and in writing of any takeover
proposal or any inquiry with respect to or which could lead to any takeover
proposal, the material terms and conditions of such inquiry or takeover
proposal (including the financing for such proposal and a copy of such
documents conveying such proposal), and the identity of the person
-66-
<PAGE>
making any such takeover proposal or inquiry. PCA will keep Sierra fully
informed of the status and details of any such takeover proposal or
inquiry.
8.3. NO SOLICITATION.
(a) Sierra shall not, nor shall it permit any of its Subsidiaries to,
nor shall it authorize or permit any officer, director or employee of or
any investment banker, attorney or other advisor, agent or representative
of Sierra or any of its subsidiaries to, directly or indirectly,
(i) solicit, initiate or encourage the submission of any takeover proposal,
(ii) enter into any agreement (other than confidentiality and standstill
agreements in accordance with the immediately following proviso) with
respect to any takeover proposal, or (iii) participate in any discussions
or negotiations regarding, or furnish to any person any information with
respect to, or take any other action to facilitate any inquiries or the
making of any proposal that constitutes, or may reasonably be expected to
lead to, any takeover proposal; provided, however, in the case of this
clause (iii), that prior to the vote of shareholders of Sierra for approval
of the Merger (and not thereafter if the Merger is approved thereby) to the
extent required by the fiduciary obligations of the Board of Directors of
Sierra, determined in good faith by a majority of the disinterested members
thereof based on the advice of outside counsel, Sierra may, in response to
an unsolicited request therefor, furnish information to any person or
"group" (within the meaning of Section 13(d)(3) of the Exchange Act)
pursuant to a confidentiality agreement on substantially the same terms as
provided in Confidentiality Agreement. Without limiting the foregoing, it
is understood that any violation of the restrictions set forth in the
preceding sentence by any officer, director or employee of Sierra or any of
its Subsidiaries or any investment banker, attorney or other advisor, agent
or representative of Sierra, whether or not such person is purporting to
act on behalf of Sierra or otherwise, shall be deemed to be a material
breach of this Agreement by Sierra. For purposes of this Section 8.3,
"takeover proposal" means (i) any proposal, other than a proposal by PCA or
any of its affiliates, for a merger or other business combination involving
Sierra, (ii) any proposal or offer, other than a proposal or offer by PCA
or any of its affiliates, to acquire from Sierra or any of its affiliates
in any manner, directly or indirectly, an equity interest in Sierra or any
Subsidiary, any voting securities of Sierra or any Subsidiary or a material
amount of the assets of Sierra and its Subsidiaries, taken as a whole, or
(iii) any proposal or offer, other than a proposal or offer by PCA or any
of its affiliates, to acquire from the shareholders of Sierra by tender
offer, exchange offer or otherwise more than 20% of the outstanding shares
of Sierra Common Stock.
(b) Neither the Board of Directors of Sierra nor any committee
thereof shall, except in connection with the termination of this Agreement
pursuant to Section 7.1(a), (b), or (f), (i) withdraw or modify, or propose
to withdraw or modify, in a manner adverse to PCA the approval or
recommendation by the Board of Directors of Sierra or
-67-
<PAGE>
any such committee of this Agreement or the Merger or take any action
having such effect, provided, that a statement by the Board of Directors of
Sierra to its stockholders as contemplated by Rule 14e-2(a) following PCA's
receipt of a Notice of Superior Proposal (as defined below) shall not be
deemed to constitute a withdrawal or modification of its recommendation of
this Agreement or the Merger, or (ii) approve or recommend, or propose to
approve or recommend, any takeover proposal. Notwithstanding the
foregoing, in the event the Board of Directors of Sierra receives a
takeover proposal that, in the exercise of its fiduciary obligations (as
determined in good faith by a majority of the disinterested members thereof
based on the advice of outside counsel), it determines to be a superior
proposal, the Board of Directors may withdraw or modify its approval or
recommendation of this Agreement or the Merger and may (subject to the
following sentence) terminate this Agreement, in each case at any time
after midnight on the next business day following PCA's receipt of written
notice (a "Notice of Superior Proposal") advising PCA that the Board of
Directors has received a takeover proposal which it has determined to be a
superior proposal, specifying the material terms and conditions of such
superior proposal (including the proposed financing for such proposal and a
copy of any documents conveying such proposal) and identifying the person
making such superior proposal. Sierra may terminate this Agreement
pursuant to the preceding sentence only if the shareholders of Sierra shall
not yet have voted upon the Merger and Sierra shall have paid to PCA the
Sierra Termination Fee (as defined in Section 8.4(b)). Any of the
foregoing to the contrary notwithstanding, Sierra may engage in discussions
with any person or group that has made an unsolicited takeover proposal for
the limited purpose of determining whether such proposal is a superior
proposal. Nothing contained herein shall prohibit Sierra from taking and
disclosing to its stockholders a position contemplated by Rule 14e-2(a)
following PCA's receipt of a Notice of Superior Proposal.
(c) In the event that the Board of Directors of Sierra or any
committee thereof shall (i) withdraw or modify, or propose to withdraw or
modify, in a manner adverse to PCA the approval or recommendation by the
Board of Directors of Sierra or any such committee of this Agreement or the
Merger or take any action having such effect or (ii) approve or recommend,
or propose to approve or recommend, any takeover proposal, PCA may
terminate this Agreement.
(d) For purposes of this Section 8.3, a "superior proposal" means any
bona fide takeover proposal to acquire, directly or indirectly, for
consideration consisting of cash, securities or a combination thereof, all
of the shares of Sierra Common Stock then outstanding or all or
substantially all the assets of Sierra, and otherwise on terms that a
majority of the disinterested members of the Board of Directors of Sierra
determines in its good faith reasonable judgment (based on the written
advice of a financial advisor of nationally recognized reputation, a copy
of which shall be provided to PCA) to be more favorable to Sierra's
shareholders than the Merger.
-68-
<PAGE>
(e) In addition to the obligations of Sierra set forth in
paragraph (b), Sierra shall promptly advise PCA orally and in writing of
any takeover proposal or any inquiry with respect to or which could lead to
any takeover proposal, the material terms and conditions of such inquiry or
takeover proposal (including the financing for such proposal and a copy of
such documents conveying such proposal), and the identity of the person
making any such takeover proposal or inquiry. Sierra will keep PCA fully
informed of the status and details of any such takeover proposal or
inquiry.
8.4. PROVISION FOR ADDITIONAL FEE AND EXPENSE REIMBURSEMENTS.
(a) PCA agrees to pay Sierra a fee in immediately available funds of
$17,000,000 (the "PCA Termination Fee") promptly upon the termination of
this Agreement in the event this Agreement is terminated by (i) Sierra as
permitted by Section 8.2 or (ii) PCA other than as permitted by this
Agreement. In addition to the PCA Termination Fee payable pursuant to
clause (ii) of the immediately preceding sentence, Sierra shall be entitled
to the fees and expenses provided in Section 7.5(b) and any other remedies
including actual damages and specific performance, as permitted by law or
equity. Further, in the event the stockholders of PCA vote upon the Merger
and do not approve the Merger and this Agreement is terminated pursuant to
Section 7.1(d), PCA agrees to pay to Sierra the PCA Termination Fee if
after the date hereof and before such termination of this Agreement or
within six months following the date of such termination of this Agreement
a takeover proposal shall have been made, such payment to be made upon the
consummation of such takeover. In all other instances covered by the
foregoing provisions of this Section 8.4(a), the PCA Termination Fee shall
be payable promptly upon termination of this Agreement.
(b) Sierra agrees to pay PCA a fee in immediately available funds of
$17,000,000 (the "Sierra Termination Fee") promptly upon the termination of
this Agreement in the event this Agreement is terminated by (i) PCA as
permitted by Section 8.3 or (ii) Sierra other than as permitted by this
Agreement. In addition to the Sierra Termination Fee payable pursuant to
clause (ii) of the immediately preceding sentence, PCA shall be entitled to
the fees and expenses provided in Section 7.5(c) and any other remedies,
including actual damages and specific performance, as permitted by law or
equity. Further, in the event the shareholders of Sierra vote upon the
Merger and do not approve the Merger and this Agreement is terminated
pursuant to Section 7.1(d), Sierra agrees to pay to PCA the Sierra
Termination Fee if after the date hereof and before such termination of
this Agreement or within six months following the date of such termination
of this Agreement a takeover proposal shall have been made, such payment to
be made upon the consummation of such takeover. In all other instances
covered by the foregoing provisions of this Section 8.4(b), the Sierra
Termination Fee shall be payable promptly upon termination of this
Agreement.
-69-
<PAGE>
ARTICLE IX. GENERAL PROVISIONS
9.1. NONSURVIVAL OF REPRESENTATIONS, WARRANTIES AND AGREEMENTS. None of
the representations, warranties and agreements in this Agreement or in any
instrument delivered pursuant to this Agreement shall survive the Effective
Time, except for the agreements contained in Sections 2.1, 2.2, 5.6 through
5.17, Section 7.5 and Article IX and the agreements of the "affiliates" of PCA
delivered pursuant to Section 4.1(l).
9.2. NOTICES. All notices and other communications hereunder shall be in
writing and shall be deemed given if delivered personally, telecopied (which is
confirmed) or mailed by registered or certified mail (return receipt requested)
to the parties at the following addresses (or at such other address for a party
as shall be specified by like notice):
(a) if to Sierra or Sierra Sub, to
Sierra
or
Sierra Acquisition Corp.
2724 North Tenaya Way
Las Vegas, NV 89128
(702) 242-7180
Telecopy No. (702) 242-7915
Attention: Chief Executive Officer
with a copy to
2724 North Tenaya Way
Las Vegas, NV 89128
(702) 242-7189
Telecopy No. (702) 242-1532
Attention: General Counsel
-70-
<PAGE>
and to
Morgan, Lewis & Bockius LLP
5300 First Union Financial Center
200 South Biscayne Boulevard
Miami, Florida 33131-2339
(305) 579-0300
Telecopy No. (305) 579-0321
Attention: John S. Fletcher
and
(b) if to PCA, to
5835 Blue Lagoon Drive
Miami, FL 33126
(305) 265-2840
Telecopy No. (305) 264-2771
Attention: Chief Financial Officer
with a copy to
5835 Blue Lagoon Drive
Miami, FL 33126
(305) 265-2920
Telecopy No. (305) 267-4811
Attention: General Counsel
and a copy to
Fulbright & Jaworski L.L.P.
1301 McKinney, Suite 5100
Houston, Texas 77010-3095
(713) 651-5151
Telecopy No. (713) 651-5246
Attention: Robert F. Gray, Jr.
9.3. INTERPRETATION. When a reference is made in this Agreement to
Sections, such reference shall be to a Section of this Agreement unless
otherwise indicated. The table of contents and headings contained in this
Agreement are for reference purposes only and shall not
-71-
<PAGE>
affect in any way the meaning or interpretation of this Agreement. Whenever
the words "include", "includes" or "including" are used in this Agreement,
they shall be deemed to be followed by the words "without limitation". The
phrase "made available" in this Agreement shall mean that the information
referred to has been made available if requested by the party to whom such
information is to be made available. The phrases "the date of this
Agreement", "the date hereof", and terms of similar import, unless the
context otherwise requires, shall be deemed to refer to the date set forth on
the last page of this Agreement.
9.4. SCHEDULES. Any information set forth in any Schedule to this
Agreement shall be responsive to any disclosure required to be provided pursuant
to the terms of any of the Sections of this Agreement and not only the Section
of this Agreement to which such Schedule relates. Any information set forth in
a Schedule that is not required to be provided pursuant to the terms of the
Section of this Agreement to which such Schedule relates is provided for
informational purposes only and shall not be construed as expanding or modifying
the representation, warranty or benchmark contained in such section. The
listing of or reference in a Schedule to any notice, claim, demand, inquiry or
threat shall not be construed as an admission of the truth or accuracy thereof
or an admission of responsibility or liability. The inclusion of a particular
item or matter on a Schedule shall not be construed as an admission by party
delivering such Schedule that such item or matter falls within the scope of any
materiality or other qualifications or limitations to the representation,
warranty, benchmark or matter to which such Schedule relates.
9.5. COUNTERPARTS. This Agreement may be executed in two or more
counterparts, all of which shall be considered one and the same agreement and
shall become effective when two or more counterparts have been signed by each of
the parties and delivered to the other parties, it being understood that all
parties need not sign the same counterpart.
9.6. ENTIRE AGREEMENT; NO THIRD PARTY BENEFICIARIES; RIGHTS OF OWNERSHIP.
This Agreement (including the documents and the instruments referred to herein)
(a) constitutes the entire agreement and supersedes all prior agreements and
understandings, both written and oral, among the parties with respect to the
subject matter hereof, (b) except as provided in Sections 5.6, 5.7, 5.10, 5.11,
5.15, 5.16, 5.17 and 5.19 is not intended to confer upon any person other than
the parties hereto any rights or remedies hereunder. The parties hereby
acknowledge that, except as hereinafter agreed to in writing, no party shall
have the right to acquire or shall be deemed to have acquired shares of common
stock of the other party pursuant to the Merger until consummation thereof.
9.7. GOVERNING LAW. This Agreement, the transactions contemplated hereby
and the rights of the parties hereunder and under statutory and common law with
respect to the transactions contemplated hereby shall be governed and construed
in accordance with the laws of the State of Delaware.
-72-
<PAGE>
9.8. NO REMEDY IN CERTAIN CIRCUMSTANCES. Each party agrees that, should
any court or other competent authority hold any provision of this Agreement or
part hereof or thereof to be null, void or unenforceable, or order any party to
take any action inconsistent herewith or not to take any action required herein,
the other party shall not be entitled to specific performance of such provision
or part hereof or thereof or to any other remedy, including but not limited to
money damages, for breach hereof or thereof or of any other provision of this
Agreement or part hereof or thereof as a result of such holding or order.
9.9. PUBLICITY. Except as otherwise required by law or the rules of the
NYSE and the Nasdaq National Market, so long as this Agreement is in effect,
neither PCA nor Sierra shall, or shall permit any of their respective
Subsidiaries to, issue or cause the publication of any press release or other
public announcement with respect to the transactions contemplated by this
Agreement without reviewing the same with the other party.
9.10. ASSIGNMENT. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned by any of the parties
hereto (whether by operation of law or otherwise) without the prior written
consent of the other parties, except that Sierra Sub may assign, in its sole
discretion, any or all of its rights, interests and obligations hereunder to
Sierra or to any direct or indirect wholly owned Subsidiary of Sierra. Subject
to the preceding sentence, this Agreement will be binding upon, inure to the
benefit of and be enforceable by the parties and their respective successors and
assigns.
[signature page follows]
-73-
<PAGE>
IN WITNESS WHEREOF, Sierra, Sierra Sub and PCA have caused this Agreement
to be signed by their respective officers thereunto duly authorized, all as of
the date first set forth above.
SIERRA HEALTH SERVICES, INC.
By: [Signature Illegible]
-----------------------------
Attest:
/s/ Frank E. Collins
- -------------------------------
SECRETARY
SIERRA ACQUISITION CORP.
By: [Signature Illegible]
-----------------------------
Attest:
/s/ Frank E. Collins
- -------------------------------
SECRETARY
PHYSICIAN CORPORATION OF AMERICA
By: [Signature Illegible]
-----------------------------
Attest:
/s/ John Hageman
- -------------------------------
SECRETARY
-74-
<PAGE>
EXHIBIT 10.1
WORKERS' COMPENSATION AND EMPLOYERS LIABILITY
ASSET GUARANTEE AND
INDEMNIFICATION CONTRACT
EFFECTIVE: SEPTEMBER 30, 1996
By and Between
Florida Builders & Employers Mutual Insurance Company,
an Assessable Mutual (a Florida corporation)
Orlando, Florida
And
PCA Property & Casualty Insurance Company
(a Florida corporation)
Longwood, Florida
<PAGE>
TABLE OF CONTENTS
ARTICLE PAGE
Article I - Liabilities Indemnified . . . . . . . . . . . . . . . . . . . 1
Article II - Term . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Article III - Territory . . . . . . . . . . . . . . . . . . . . . . . . . 2
Article IV - Exclusions & Defenses. . . . . . . . . . . . . . . . . . . . 2
Article V - Coverage. . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Article VI - Definitions. . . . . . . . . . . . . . . . . . . . . . . . . 3
Article VII - Loss Notices. . . . . . . . . . . . . . . . . . . . . . . . 6
Article VIII - Salvage and Subrogation. . . . . . . . . . . . . . . . . . 6
Article IX - Reinsurance Consideration & Premium. . . . . . . . . . . . . 6
Article X - Reports, Remittances and Settlements. . . . . . . . . . . . . 7
Article XI - Offset . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Article XII - Conformation of Agreement to Statutes and Regulations . . . 9
Article XIII - Access to Records. . . . . . . . . . . . . . . . . . . . . 10
Article XIV - Net Retained Liability. . . . . . . . . . . . . . . . . . . 10
Article XV - Inuring Contracts. . . . . . . . . . . . . . . . . . . . . . 10
Article XVI - Errors and Omissions. . . . . . . . . . . . . . . . . . . . 11
Article XVII - Taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Article XVIII - Insolvency. . . . . . . . . . . . . . . . . . . . . . . . 11
i
<PAGE>
Article XIX - Arbitration . . . . . . . . . . . . . . . . . . . . . . . . 12
Article XX - Amendments and Alterations . . . . . . . . . . . . . . . . . 14
Article XXI - Currency. . . . . . . . . . . . . . . . . . . . . . . . . . 14
Article XXII - Required Consents. . . . . . . . . . . . . . . . . . . . . 14
Article XXIII - No Third Party Rights . . . . . . . . . . . . . . . . . . 15
Article XXIV - Warranties . . . . . . . . . . . . . . . . . . . . . . . . 15
Article XXV - Assumption of In-Force Policies . . . . . . . . . . . . . . 16
Article XXVI - Approvals. . . . . . . . . . . . . . . . . . . . . . . . . 16
Article XXVI - Counterparts . . . . . . . . . . . . . . . . . . . . . . . 17
Article XXVII - Assignment. . . . . . . . . . . . . . . . . . . . . . . . 17
ii
<PAGE>
WORKERS' COMPENSATION AND EMPLOYERS LIABILITY
ASSET GUARANTEE AND INDEMNIFICATION CONTRACT
EFFECTIVE AS OF SEPTEMBER 30, 1996
(HEREINAFTER REFERRED TO AS THE "Contract")
By and Between
Florida Builders & Employers Mutual Insurance Company,
an Assessable Mutual (a Florida corporation)
Orlando, Florida
(HEREINAFTER REFERRED TO AS THE "Company")
And
PCA Property & Casualty Insurance Company
(a Florida corporation)
Longwood, Florida
(HEREINAFTER REFERRED TO AS THE "Reinsurer")
ARTICLE I - LIABILITIES INDEMNIFIED
Subject to the terms, conditions, and limitations hereinafter set forth, the
Reinsurer hereby agrees and guarantees that the assets and property of the
Company, as augmented by funds or other assets from time to time transferred or
made available to the Company by the Reinsurer pursuant to this Contract, shall
at all times be sufficient to pay or discharge the following liabilities and
obligations of the Company:
A. the Company's liability for Ultimate Net Loss (as defined in Article VI
below) that has accrued or does accrue to the Company under the Company's
policies, indemnity agreements, contracts, binders, and endorsements of
insurance (hereinafter collectively called "policies") that were or are in force
before or on January 1, 1996 (hereinafter referred to as the "Coverage Date")
for the Workers' Compensation and Employers Liability business written by the
Company or by its predecessor self insurance fund (namely, Florida Home Builders
Self Insurers Fund), in respect of both covered losses that first occurred
before the Coverage Date (hereinafter, "Pre-1996 Losses") and covered losses
that first occur or occurred on or after the Coverage Date (hereinafter,
"Post-1995 Losses"); and
B. the Company's Other Liabilities (as defined in Article VI below) that have
accrued or do accrue to the Company in respect of its contracts, obligations, or
liabilities executed, incurred, or arising, or based on events or circumstances
that occurred or existed, prior to the Coverage Date.
1
<PAGE>
ARTICLE II - TERM
This Contract shall become effective as of September 30, 1996 (hereinafter
referred to as the "Effective Date"), and shall remain in force until all
outstanding Ultimate Net Loss and Other Liabilities covered under this Contract
have been paid, settled, or released in accordance with the provisions of this
Contract.
ARTICLE III - TERRITORY
The Reinsurer's liability under this Contract with respect to Ultimate Net Loss
shall follow the territorial limits of the Company's policies.
ARTICLE IV - EXCLUSIONS & DEFENSES
The Reinsurer's liability under this Contract with respect to Ultimate Net Loss
shall be subject to the exclusions, limitations, terms, and conditions set forth
in the respective policies of the Company. The Reinsurer's liability under this
Contract with respect to any Other Liabilities based on or arising from a
contract, agreement, or understanding shall be subject to the terms,
limitations, and conditions thereof. The Reinsurer shall indemnify the Company
for Ultimate Net Loss and Other Liabilities only if and to the extent that the
Company is or otherwise would be liable therefor, and all defenses,
counterclaims, third-party claims, rights of set-off and contribution, and
causes of action that the Company has or comes to have with respect to Ultimate
Net Loss or Other Liabilities shall equally benefit and may be asserted by or on
behalf of the Reinsurer. Except as otherwise specifically provided in Article
VI.B of this Contract in respect of loss in excess of policy limits and
extra-contractual obligations (as defined in Article VI.D), the Reinsurer shall
in no event be liable for any illegal or unlawful act, conduct, or practice of
the Company or for any penalty, fine, or damages (whether consequential,
incidental, compensatory, punitive, or otherwise) imposed on or incurred by the
Company because of or based on any such act, conduct, or practice.
ARTICLE V - COVERAGE
The Reinsurer shall indemnify the Company for all of the Company's Ultimate Net
Loss and Other Liabilities that are legally valid and enforceable against the
Company, that remain unpaid, and that have not been otherwise satisfied,
settled, discharged, or extinguished after all assets and properties of the
Company, whether owned by the Company on the Effective Date or acquired,
received, or realized by the Company thereafter, have been liquidated (if not
cash) and the proceeds thereof have been used to pay or settle the Company's
Ultimate Net Loss or Other
2
<PAGE>
Liabilities, and no further assets or properties of the Company or proceeds
thereof can be had or realized. In the event and at such time or times that all
assets and properties of the Company that consist of, or that can without undue
delay, loss, or risk be converted into, cash or marketable securities have been
used to pay or settle Ultimate Net Loss and Other Liabilities, then: (a) the
Reinsurer shall, at its election, either (1) itself pay all remaining Ultimate
Net Loss and Other Liabilities in accordance with this Contract or (2) from time
to time convey, transfer, and deliver to the Company cash, marketable
securities, or other liquid assets selected by the Reinsurer in an amount or
amounts sufficient to enable the Company to pay them, and (b) the Company shall
immediately remit to the Reinsurer any and all proceeds of its properties and
assets as and when thereafter received or realized or, at the Reinsurer's
election and request, shall transfer, convey, and assign to the Reinsurer all
right, title, and interest of the Company in and to its assets and properties
then remaining and thereafter acquired.
The Company has delivered, or caused to be delivered, complete and correct
copies of the Company's audited 1995 annual statutory financial statements and
its unaudited statutory statement for the period ended June 30, 1996. The
Company hereby represents and warrants to the Reinsurer that: (1) the financial
statements, the related notes thereto, and the auditor's report thereon fairly
and accurately present the financial condition and results of operation of the
Company as of and for the year ended December 31, 1995, and as of and for the
six months ended June 30, 1996, respectively, in accordance with generally
accepted statutory accounting principles applicable to assessable mutual
workers' compensation insurers, as reported by the Company's auditors; (2) the
Company's loss reserves at December 31, 1995, were established based on and in
accordance with the report and recommendation of the Company's independent
certified actuaries; (3) said financial statements properly and adequately
reflect and record all assets, liabilities, and amounts that the Company then
had any knowledge, notice, or reason to know; and (4) the dollar amount
specified in Article IX.B below is the amount in fact reserved and required to
be reserved in the Company's 1995 year-end statutory financial statements for
total unearned premiums on all policies in force on the Coverage Date.
ARTICLE VI - DEFINITIONS
A. "Claim" as used herein shall mean a request or demand for payment of
workers' compensation and/or employers liability benefits to an injured employee
or his or her beneficiaries or to others entitled to payment in connection
therewith.
B. "Ultimate Net Loss" as used herein is defined as the sum or sums (including
loss in excess of policy limits, extra contractual obligations and all Allocated
Loss
3
<PAGE>
Adjustment Expense, it being understood that in the event a loss settlement,
verdict, judgment, or award is reduced by any process, resulting in an ultimate
saving to the Reinsurer, the expenses incurred in securing such reduction or
reversal shall be incurred by the Reinsurer) paid or payable by the Company on
or after the Coverage Date, in respect of amounts not booked as paid at December
31, 1995, under its policies in settlement of Claims or satisfaction of awards
or judgments rendered on account of Claims, but after deduction of the following
inuring recoveries:
(i) all salvage and subrogation recoveries;
(ii) all recoveries on inuring insurance or reinsurance, including
proceeds from commutation of inuring reinsurances, except for (a) recoveries
collected on or after the Coverage Date on claims booked as paid at December 31,
1995, and (2) recoveries under the annuity contracts reflected on the Company's
December 31, 1995 financial statements;
(iii) all payments or refunds received by the Company from Health Plans
on or after the Coverage Date under the worker's compensation managed care
arrangement agreement dated September 8, 1994, between the Company, PCA
Solutions, Inc., and entities referred to therein as Health Plans (hereinafter
called the "Managed Care Arrangement"); and
(iv) all recoveries on or after the Effective Date from the Special
Disability Trust Fund.
Ultimate Net Loss shall also include any amount payable by Health Plans
under the Managed Care Arrangement on or after the Coverage Date for compensable
services provided or arranged for by Health Plans thereunder in excess of the
amounts reserved therefor on the financial statements of Health Plans at
December 31, 1995.
However, Ultimate Net Loss shall exclude any distributions or dividends to
members or former members of the Company or its predecessor self insurers' fund.
Nothing herein shall be construed to mean that losses under this Contract are
not recoverable until the Company's Ultimate Net Loss has been ascertained.
C. "Allocated Loss Adjustment Expenses" shall mean legal expenses and other
expenses (including interest accruing before and/or after entry of judgment)
incurred by the Company in connection with the investigation, adjustment,
settlement, litigation or arbitration of Claims. Allocated Loss Adjustment
Expenses shall not include costs (hereinafter collectively referred to as
"ULAE") of "in-house" counsel, claims staff or other overhead or general
expenses of the Company or its agents or
4
<PAGE>
subcontractors, including the claims services provided by PCA Solutions, Inc.
(or any other third party replacing, or performing functions agreed to be
performed by, PCA Solutions, Inc.).
D. "Loss in excess of policy limits" and "extra contractual obligations" as
used herein shall be defined as follows:
1. "Loss in excess of policy limits" shall mean any amount paid or
payable by the Company in excess of its policy limits, but otherwise within the
terms of its policy, as a result of an action against it by its insured or its
insured's assignee or beneficiary to recover damages the insured is legally
obligated to pay to a third party claimant because of the Company's alleged or
actual negligence or bad faith in rejecting a settlement offer, or in
discharging its duty to defend or prepare the defense in the trial of an action
against its insured, or in discharging its duty to prepare or prosecute an
appeal consequent upon such an action.
2. "Extra contractual obligations" shall mean any punitive, exemplary,
compensatory or consequential damages, other than loss in excess of policy
limits, paid or payable by the Company as a result of an action against it by
its insured, its insured's assignee or beneficiary or a third party claimant,
which action alleges negligence, malfeasance, or bad faith on the part of the
Company or its administrator in handling a claim under a policy subject to this
Contract. An extra contractual obligation shall be deemed to have occurred on
the same date as the loss covered or alleged to be covered under the policy.
Notwithstanding anything stated herein, this Contract shall not apply to
any loss in excess of policy limits or any extra contractual obligation incurred
by the Company, or any fine or penalty imposed by or paid to a governmental
authority, as a result of or based on any actual or alleged fraudulent, illegal,
unlawful, or criminal conduct of the Company or of any employee, officer,
director, or agent of the Company, whether acting individually or collectively
or in collusion with any individual or corporation or any other organization or
party involved in the presentation, defense or settlement of any claim or matter
covered hereunder.
E. "Other Liabilities" as used herein is defined as the amounts paid or
payable on or after the Coverage Date but not booked as paid by the Company at
December 31, 1995, for valid and legally enforceable liabilities of the Company,
other than Ultimate Net Loss and ULAE. In addition, any amounts required to be
distributed or refunded to former policyholders of the Company or its
predecessor self insurance fund under and in accordance with the terms of the
Safety Incentive Preferred Payment Plans previously underwritten and issued by
either of them shall be deemed Other Liabilities if but only if either (a) a
court of competent jurisdiction rules
5
<PAGE>
in a final judgment binding on the Company or Reinsurer, not appealed or subject
to no further appeal, that payment of such amounts is an enforceable contractual
obligation of the Company or such fund or (b) it is subsequently determined to
the Reinsurer's reasonable satisfaction that the Company has or will have a
surplus remaining after payment or settlement or all Ultimate Net Loss and Other
Liabilities, which surplus is adequate and available for paying such amounts and
is applied to pay such amounts or to reimburse the Reinsurer for doing so.
ARTICLE VII - LOSS NOTICES
Losses shall be reported as provided in Article X, except that the Company shall
promptly notify the Reinsurer (or shall cause its administrator to do so) of any
unusual or unanticipated circumstances that are or become known to the Company
or its administrator and that may materially or adversely affect the Reinsurer's
liability hereunder.
ARTICLE VIII - SALVAGE AND SUBROGATION
The Reinsurer shall be credited with salvage or subrogation (i.e., reimbursement
obtained or recovery made by the Company, less Allocated Loss Adjustment
Expenses incurred in obtaining such reimbursement or making such recovery) on
account of Claims and settlements involving reinsurance hereunder. Salvage
thereon shall always be used to reimburse the excess carriers in the reverse
order of their priority according to their participation before being used in
any way to reimburse the Company for its primary loss. The Company hereby
agrees, directly or through its administrator, to enforce its rights to salvage
or subrogation relating to any loss, a part of which loss was or will be
sustained by the Reinsurer, and to prosecute all claims arising out of such
rights to the fullest extent practicable and productive. The Company shall not
relinquish, abandon, waive, or compromise any material salvage or subrogation
right without the Reinsurer's consent.
ARTICLE IX - REINSURANCE CONSIDERATION & PREMIUM
A. The Reinsurer shall pay to the Company an amount equal to one-half (or such
larger fraction as the Reinsurer may in its discretion elect to pay) of the
Company's deficit surplus as to policyholders that is reported on the Company's
statutory financial statements filed with the Florida Department of Insurance
(the "Department") as of and for the period ended on the Effective Date, taking
into account the results of the independent actuarial report respecting the
Company's reserves delivered during the fourth quarter of 1996, payable in any
combination of cash and securities that the Reinsurer selects and due within
thirty (30) days after the latest of (a) the filing of such financial statement,
(b) execution and delivery of
6
<PAGE>
this Contract, and (c) written approval of this Contract by said Department. In
the event that such financial statement reports a positive or zero surplus as to
policyholders as of the Effective Date, no payment by the Reinsurer shall be due
or payable under this Article IX.A.
B. The Company shall remit to the Reinsurer, as of the Coverage Date,
unearned premium of $33,047,154 in consideration of the Reinsurer's assumption
of liability in accordance with Article XXV of this Contract for Ultimate Net
Loss in respect of Post-1995 Losses, plus all policyholder deposits relating to
the Company's policies reinsured or assumed hereunder.
C. In addition, from and after the time that the Reinsurer first pays Ultimate
Net Loss or Other Liabilities or advances, transfers, or makes available to the
Company assets in accordance with Article V (paragraph first) above, the Company
shall pay, transfer, and deliver to the Reinsurer, as and when collected or
received by or on behalf of the Company, the following sums and amounts:
(a) all proceeds of and amounts realized through collection, enforcement,
or disposition on or after the Effective Date of all other intangible assets,
properties, rights, and chooses in action, including without limitation,
reinsurance recoverable on claims booked as paid on December 31, 1995, agent
balances, receivables, uncollected or retrospective premiums, accrued interest
and dividends receivable, recoveries from annuity contracts, and federal income
taxes or other taxes receivable or refunded;
(b) all proceeds and amounts realized through collection of all inuring
reinsurance or any other inuring recoveries of the Company, including without
limitation all proceeds from commutation of inuring reinsurance, any refunds
received from Health Plans under the Managed Care Arrangement, reinsurance
recoverable on claims booked as unpaid on December 31, 1995, salvage and
subrogation, and recoveries from the special disability trust fund; and
(c) all other assets, proceeds, or amounts received or realized by the
Company on or after the Effective Date.
ARTICLE X - REPORTS, REMITTANCES AND SETTLEMENTS
A. Within thirty (30) days after the end of each month (commencing with the
first full month after the Effective Date) during the term of this Contract, the
Company or its administrator shall report to the Reinsurer the following:
7
<PAGE>
(a) Summary of paid losses, Allocated Loss Adjustment Expenses paid, and
Other Liabilities paid during the month;
(b) Summary of case outstanding losses and Allocated Loss Adjustment
Expenses as of the end of the month, including a report of the carried incurred
but not reported amounts;
(c) Summary of amounts referred to in Article IX.C collected during the
month;
(d) Summary of Revolving Fund (as hereinafter defined) activities during
the month;
(e) Any other information specifically requested by the Reinsurer to
evaluate the Contract which is reasonably available to the Company.
The loss information shall be segregated by accident (report) year and by
class of business. The parties shall confer regarding the suitable format of
such summaries and any desired changes therein.
B. With respect to all Ultimate Net Loss and Other Liabilities that become due
and payable by the Company, the Reinsurer agrees that settlement of such
Ultimate Net Loss and Other Liabilities covered under this Contract shall be
payable by the Reinsurer concurrently with payment by the Company. The
Reinsurer and the Company therefore agree that all such payables under this
Contract may be settled by the Company or its administrator through a revolving
fund (the "Revolving Fund") provided by the Reinsurer. The amount of the
Revolving Fund is to be determined from time to time by the parties and adjusted
based on the average Ultimate Net Loss and Other Liabilities paid through the
Revolving Fund during the preceding quarter. The Reinsurer is to maintain the
amount in the Revolving Fund at the agreed level and restore disbursements from
the Revolving Fund no less frequently than monthly. The Reinsurer is to remit
by wire transfer to the Company's administer at the end of each month an amount
equal to the amount by which the agreed amount exceeds the actual amount in the
Revolving Fund.
In the event a payment due to be made by the Company and the Reinsurer
under this Contract would (together with other such payments by then paid or due
to be paid) exceed the funds then available in the Revolving Fund, the Company
or its administrator may request, and the Reinsurer shall thereupon immediately
make, payment of such required funds into the Revolving Fund. In the event that
the Company or its administrator, without the written consent of the Reinsurer,
applies money in the Revolving Fund for payment of any amount or item other than
Ultimate
8
<PAGE>
Net Loss or Other Liabilities for which the Reinsurer is liable under this
Contract (an "Unauthorized Withdrawal"), then (a) the Company shall, or shall
cause its administrator to, immediately restore such Unauthorized Withdrawal to
the Revolving Fund, plus interest thereon, and (b) if the amount or frequency of
any Unauthorized Withdrawals is such as to leave the Reinsurer insecure in its
reasonable judgment, taking into account the circumstances and their amount, the
Reinsurer may suspend payments or transfers to the Revolving Fund until the
Company or its administrator has established enhanced controls reasonably
satisfactory to the Reinsurer.
The Company may also establish a zero balance account or similar checking
account (the "Account") with a commercial bank satisfactory to the Company's
administrator. The Company's administrator shall have signature authority for
disbursing payments against the Account in respect of Ultimate Net Loss and
Other Liabilities as and when due. The Account may be linked with the Revolving
Fund so that (a) adequate funds are automatically transferred from the Revolving
Fund to the Account to pay checks drawn against the Account as they are
presented and (b) any excess or unused funds or deposits into the Account are
automatically transferred to the Revolving Fund. The Company shall notify the
Reinsurer from time to time of the authorized signatories for this purpose and
any changes therein. The Reinsurer shall be entitled to receive copies of
statements and notices of activities in the Account.
C. All Claims settlements made by the Company or its administrator shall be
binding upon the Reinsurer, provided, however, that such Claims are within the
terms, conditions and limitations of the Company's policies or otherwise
required by applicable Florida worker's compensation law or by a final judgment
of a court or tribunal binding on the Company, and within the terms, conditions
and limitations of this Contract.
ARTICLE XI - OFFSET
Both the Company and the Reinsurer shall have, and may exercise, at any time the
right to offset any balance or balances due to the other party under this
Contract against any balance or balances then owed by such other party under
this Contract or under any other reinsurance agreement between the parties; it
being the parties' intention to take and allow offset based upon any
debtor/creditor relationship arising under this Contract against any balance or
balances then due under this Contract or under any other such agreement,
regardless of whether such balances are in respect of premiums, fees, losses, or
otherwise, and regardless of the capacity of any party.
9
<PAGE>
ARTICLE XII - CONFORMATION OF AGREEMENT TO STATUTES AND REGULATIONS
A. If any separable provision hereof shall be held to be invalid or
unenforceable in a final, binding order or judgment of a court, administrative
body, or any other governmental authority under the laws or Insurance Department
regulations or any other regulations or rulings now or hereafter in effect in
the state governing this Contract or any other state or commonwealth with any
form of jurisdiction over this Contract, such invalidity or unenforceability
shall not affect any other provisions of this Contract which will remain in full
force and effect.
B. The parties shall negotiate in good faith to amend any terms and conditions
of this Contract which violate or are in conflict with such laws, Insurance
Department regulations, or any other applicable regulations or rulings, with the
aims of eliminating such violation or conflict while preserving the initial
allocation of risks, benefits, rights, and duties under this Contract.
ARTICLE XIII - ACCESS TO RECORDS
The Reinsurer or its duly appointed representatives shall upon request have
access at any reasonable time to records of the Company which pertain in any
way to this reinsurance, but without unduly burdening or disrupting the
operations of the Company or its administrator, and excluding legally privileged
materials. The Reinsurer shall use information and records of or furnished by
the Company or its administrator only for purposes of implementing this Contract
and shall not, except as may be required by applicable law or as consented to by
the Company or its administrator, disclose to any third party any non-public
confidential or proprietary information or records of the Company or its
administrator.
ARTICLE XIV - NET RETAINED LIABILITY
This Contract shall apply only to that portion of any insurance that the Company
retains net for its own account, and in calculating the amount of any loss
hereunder, only loss or losses with respect to that portion of any insurance or
reinsurance the Company retains net for its own account shall be included.
ARTICLE XV - INURING CONTRACTS
A. Any specific and/or aggregate excess coverage purchased by the Company
shall inure to the benefit of the Reinsurer. Any subrogation, special
disability trust fund, refunds or recoveries becoming payable to the Company
under the Managed Care Arrangement, and other recoveries shall also benefit the
Reinsurer.
10
<PAGE>
B. In consideration of the coverage provided under this Contract, the
Reinsurer shall have the irrevocable and unconditional authority to negotiate on
behalf of the Company with any reinsurers of any reinsurance contracts that
inure to the benefit of this Contract to commute such contracts. Without
limiting the generality of the foregoing, the Company hereby consents and agrees
to the commutation as of the Effective Date of the reinsurance contracts
heretofore identified by the Reinsurer for immediate commutation.
ARTICLE XVI - ERRORS AND OMISSIONS
Inadvertent delays, errors or omissions made in connection with this Contract or
any transaction hereunder shall not relieve either party from any liability
which would have attached had such delay, error or omission not occurred,
provided always that such error or omission is rectified promptly after
discovery. Each party shall promptly notify the other of any such delays,
errors, or omissions of which it becomes aware in its conduct pertaining to this
Contract.
ARTICLE XVII - TAXES
In consideration of the terms under which this Contract is issued, the Company
will not claim a deduction in respect of the premium or consideration payable
hereunder when making tax returns, other than income or profits tax returns, to
any state or territory of the United States of America or the District of
Columbia.
ARTICLE XVIII - INSOLVENCY
A. In the event of the future insolvency of the Company, reinsurance under
this Contract shall be payable by the Reinsurer on the basis of the liability of
the Company under its policies reinsured without diminution because of the
insolvency of the Company, subject to all terms, conditions, and limitations of
this Contract, directly to the Company or, if one is appointed, to its duly
appointed liquidator, receiver, or statutory successor except as otherwise
provided by Chapter 631, Part I, Florida Statutes, or other applicable law
governing insurer delinquency proceedings, or except when this Contract
specifically provides another payee of such reinsurance in the event of the
insolvency of the Company or when the Reinsurer with the consent of the direct
insured or insureds has assumed such policy obligations of the Company as direct
obligations of the Reinsurer to the payees under the In-Force Policies (as
defined in Article XXV below) and in substitution for the obligations of the
Company to such payees.
B. The liquidator or receiver or statutory successor of the insolvent Company,
if one is hereafter appointed, shall give written notice to the Reinsurer of the
pendency
11
<PAGE>
of a claim against the insolvent Company on the policy or policies reinsured
within a reasonable time after such claim is filed in the insolvency proceeding,
and during the pendency of such claim, the Reinsurer may investigate such claim
and may interpose in the proceeding when such claim is to be adjudicated, any
defense, counterclaim, third-party claim, cause of action, or right which it may
deem available to the Company or its liquidator or receiver or statutory
successor. The expense thus incurred by the Reinsurer shall be chargeable,
subject to court approval, against the insolvent Company as part of the expense
of liquidation to the extent of a proportionate share of the benefit which may
accrue to the Company as a result of the defense undertaken by the Reinsurer.
C. When two or more reinsurers are involved in the same claim and a majority
in interest elect to interpose a defense or the like to such claim, the expense
shall be apportioned in accordance with the terms of this Contract as though
such expense had been incurred by the insolvent Company.
D. Should any party hereto be placed in rehabilitation or liquidation or
should a rehabilitator, liquidator, receiver, conservator or other person or
entity of similar capacity be appointed as respects such party, all amounts due
any of the parties hereto, whether by reason of premiums, losses,
indemnification, or otherwise under this Contract or any other contract(s)
heretofore or hereafter entered into between the parties (whether or not any
such contract(s) be assumed or ceded), shall at all times be subject to the
right of offset at any time and from time to time, and upon the exercise of
same, only the net balance shall be due and payable, in accordance with Section
631.281 of the Florida Insurance Code to the extent such statute or other
applicable law, statute or regulation governing such offset shall apply. All
amounts payable by the Company under Article IX of this Contract shall be deemed
to have been incurred within the meaning of said Section 631.281 as of the
Coverage Date.
ARTICLE XIX - ARBITRATION
A. As condition precedent to any right of action hereunder, except an action
for a temporary, immediate, or emergency injunction or restraining order, any
dispute arising out of the interpretation, performance or breach of this
Contract, including the formation or validity thereof, shall be submitted for
decision to a panel of three arbitrators. Notice requesting arbitration must be
in writing and sent certified or registered mail, return receipt requested.
B. One arbitrator shall be chosen by each party and the two arbitrators shall,
before instituting the hearing, choose an impartial third arbitrator (the
"Umpire") who shall preside at the hearing. If either party fails to appoint
its arbitrator within thirty (30) days after being requested to do so by the
other party, the latter, after ten (10)
12
<PAGE>
days notice by certified or registered mail of its intention to do so, may
appoint the second arbitrator.
C. If the two arbitrators are unable to agree upon the Umpire within thirty
(30) days of their appointment, the two arbitrators shall, unless the parties
agree upon the third arbitrator, request the United States District Court having
general jurisdiction where the Company is domiciled to appoint an Umpire with
those qualifications, or if the Federal Court declines to act, any State Court
having general jurisdiction in such area. The Umpire shall promptly notify in
writing all parties to the arbitration of his selection.
D. Unless the parties otherwise agree in writing, all arbitrators shall be
disinterested active or former executive officers of insurance or reinsurance
companies or Underwriters at Lloyd's, London. Each party shall furnish to the
other information about the qualifications of the arbitrator that the former
selects.
E. Within thirty (30) days after notice of appointment of all arbitrators, the
panel shall meet and determine timely periods for briefs, discovery procedures
and schedules for hearings. The parties shall have adequate opportunity to
depose, present, examine, and cross-examine witnesses, discover and proffer
other evidence including (without limitation) documents and expert testimony,
and submit written legal arguments and authorities. A party has the right to be
represented by an attorney at any hearing or proceeding. A wavier thereof prior
to the proceeding or hearing is ineffective.
F. The panel shall be relieved of all judicial formality and shall not be
bound by the strict rules of procedure and evidence. Unless the parties agree
otherwise, any arbitration shall take place in Orlando, Florida, but the venue
may be changed upon written request when deemed by the panel to be in the best
interest of the arbitration proceeding and not prejudicial to either party.
Insofar as the arbitration panel looks to substantive law, it shall apply the
law of the State of Florida. The decision of any two arbitrators when rendered
in writing shall be final and binding. The panel is empowered to grant interim
relief as it may deem appropriate. The panel may issue subpoenas for the taking
of depositions, attendance of witnesses and the production of books, records,
documents and other evidence and shall have the power, to administer oaths.
Subpoenas so issued shall be served, and upon application to a court of
competent jurisdiction by a party to the arbitration or by the panel, enforced
in the manner provided by law for service and enforcement of subpoenas in a
civil action.
G. To the extent, and only to the extent, that the provisions of this Contract
are ambiguous or unclear, the panel shall make its decision considering the
parties'
13
<PAGE>
course of dealings and the custom and practice of the applicable insurance and
reinsurance business. The panel shall render its decision within sixty (60)
days following the termination of hearings, which decision shall be in writing,
stating the reasons therefore.
H. Judgment upon the award may be entered in any court having jurisdiction
thereof. Each party shall bear the expense of its own arbitrator and shall
jointly and equally bear with other party the cost of the third arbitrator. The
remaining costs of the arbitration shall be allocated by the panel. The panel
may, at its discretion, award such further costs and expenses as it considers
appropriate, including but not limited to attorneys fees, to the extent
permitted by law.
ARTICLE XX - AMENDMENTS AND ALTERATIONS
This Contract, together with any and all other documents or instruments
expressly consented to and exchanged by the parties in connection with executing
and delivering this Contract, embodies the complete agreement of the parties
with respect to the subject matter hereof and supersedes any prior such
agreement or understanding, whether written or oral. Without limiting the
generality of the foregoing, this Contract supersedes and replaces that certain
"Excess Insurance Policy For Self-Insurer Of Workers' Compensation and Employers
Liability" previously issued by the Reinsurer to the Company, dated December 15,
1995 but effective as of January 1, 1996, which shall no longer have any force
or effect. This Contract shall be deemed to have effected a novation of said
"Excess Insurance Policy" as of the Coverage Date.
This Contract may be changed, altered or amended as the parties may hereafter
agree, provided such change, alteration or amendment is evidenced in writing or
by endorsement executed by the Company and the Reinsurer.
ARTICLE XXI - CURRENCY
Whenever the word "Dollars" or the "$" sign appears in this Contract, they shall
be construed to mean United States Dollars, and all transactions under this
Contract shall be in United States Dollars.
ARTICLE XXII - REQUIRED CONSENTS
A. The Company shall not enter into any new inuring reinsurance contract or
any amendment, modification, or termination of an existing such contract, or
agree to do so, without the Reinsurer's express written consent. The Reinsurer
shall not unreasonably withhold or delay its consent to any such action that the
Company or
14
<PAGE>
its administrator recommends in good faith, but a material adverse effect on the
Reinsurer's liability or risks under this Contract shall be sufficient basis to
withhold its consent. For purposes of this paragraph, the Managed Care
Arrangement, any successor thereto or similar such arrangement, and annuity
contracts used to fund Claims or settlements thereof shall be deemed inuring
reinsurance contracts.
B. Except as the Reinsurer may hereafter agree, the Company shall not settle
any Claim for a lump-sum payment, or for a series of agreed upon future payments
or installments with a present value, in excess of $750,000 without the
Reinsurer's express written consent. The Company shall advise the Reinsurer of
any proposed settlement requiring the Reinsurer's consent and any schedule or
deadline within which such consent must be given or withheld and shall furnish
the Reinsurer with pertinent loss information, including case reserves and any
outstanding judgment or offer of settlement or judgment, when requesting such
consent. The Reinsurer shall respond in a timely manner to requests for its
consent to proposed or recommended settlements, in keeping with the terms and
deadlines of settlement offers or proposals and with the schedule of any
litigation or proceeding relating thereto. In deciding whether to consent to a
settlement, the Reinsurer shall consider any recommendations or advice conveyed
to it of counsel representing the Company or its insured regarding the matter.
The Reinsurer may withhold its consent to a proposed or recommended settlement
of a Claim if in its reasonable business judgment the costs of the settlement
will likely exceed the Company's Ultimate Net Loss for the Claim if not settled.
The Company may treat a failure of the Reinsurer to notify the Company in
writing that it does not consent to a settlement within ten (10) business days
after its receipt of a written request therefor, or within such other schedule
or deadline to which the parties may agree at the time, as consent to the
settlement.
C. The Company shall use or cause its administrator to use at all times
prudent Claims administration, adjustment, and settlement techniques and
practices, consistent with evolving practices and norms within the Florida
workers' compensation insurance industry. At the Reinsurer's request, the
Company shall furnish to the Reinsurer information regarding such techniques and
practices employed by the Company or its administrator from time to time,
including any internal written manuals or guidelines, and shall consult with the
Reinsurer regarding such techniques and practices, their implementation as to
particular Claims, classes of Claims, or Claims generally, and any changes
therein.
ARTICLE XXIII - NO THIRD PARTY RIGHTS
15
<PAGE>
Nothing herein shall in any manner create any obligations or establish any
rights against the Reinsurer, the Company, or its administrator in favor of any
third parties or any persons not parties to this Contract.
ARTICLE XXIV - WARRANTIES
The Company represents and warrants to the Reinsurer that PCA Solutions, Inc. is
the duly appointed agent and administrator of the Company and is authorized to
act on behalf of the Company for purposes of sending and receiving notices,
administering and adjusting Claims, receiving loss payments and any other
payment due the Company under this Contract, marshaling, collecting, and
liquidating on behalf of the Company its assets and properties (including
without limitation those described in Article IX.C above), managing the run-off
of Pre-1996 Losses, and implementing this Contract on the Company's behalf.
Further, any notice received by the Reinsurer from PCA Solutions, Inc., or
payments made or notice given to PCA Solutions, Inc. by the Reinsurer under this
Contract shall be deemed to be notice received from the Company, or payment made
or notice given to the Company. The Company also warrants and undertakes to the
Reinsurer that its administrator contract with PCA Solutions, Inc. shall
continue in force until such time as the Reinsurer has discharged its payment
obligations hereunder and that the Company shall not terminate or materially
modify or amend said contract or agree or commit to do so without the
Reinsurer's consent.
ARTICLE XXV - ASSUMPTION OF IN-FORCE POLICIES
As of the Coverage Date, the Reinsurer shall assume, and by entering into this
Contract does assume, the Company's liability for Ultimate Net Loss covered by,
arising from, or attributable to Post-1995 Losses under all policies of the
Company the original one-year terms of which had not expired before the Coverage
Date and that had not lapsed or been canceled before and remained in force on
the Coverage Date (collectively, the "In-Force Policies"). If and to the extent
that the parties hereto have not already done so before the Effective Date: (1)
the Company shall pay and deliver to the Reinsurer, as of the Coverage Date,
cash or marketable investment securities with a fair market value equaling in
aggregate on the date of delivery the dollar amount specified in Article IX.B
above; (2) the Company shall transfer, deliver, and release to the Reinsurer of
the Reinsurer's administrator all documents, books, records, files, and papers
relating to the In-Force Policies, including specifically but without limitation
the original policy and claims files; and (3) the Reinsurer shall issue and
deliver to each record policyholder of an In-Force Policy an assumption
certificate or endorsement in a form approved by or acceptable to the Florida
Department of Insurance, notifying such policyholders that the Reinsurer has
16
<PAGE>
assumed liability for Ultimate Net Loss under the In-Force Policies from and
after the Coverage Date.
ARTICLE XXVI - APPROVALS
This Contract is subject to approval or ratification by the boards of directors
of the parties hereto and written approval by the Florida Department of
Insurance. Neither party shall require or solicit any further or different
approval unless so required by applicable law or so directed by said Department.
By executing and delivering any counterpart of this Contract, each party
represents and warrants to the other that the Contract and its execution and
delivery have been duly approved by all requisite internal action of, and
constitutes a binding obligation of, said party, fully enforceable against such
party in accordance with its terms. In the event that this Contract has not
been approved by said Department, on terms and conditions (including without
limitation the provisions of any order issued or entered by, or agreement
entered into with, said Department that refers to this Contract) satisfactory to
the Reinsurer and the Company within five (5) business days after its execution
by both parties, each party shall be entitled (but not obligated) to cancel this
Contract by written notice to the other party and the Department, in which event
this Contract shall be void and of no force or effect ab initio.
ARTICLE XXVII - COUNTERPARTS
This Contract may be executed in multiple counterparts, each of which shall be
deemed an original and all of which together shall comprise a single legal
instrument. Any party may enter into and become bound by this Contract by
executing and delivering any such counterpart to the other party. Any
counterpart may be delivered by telefacsimile, and a party shall be deemed to
have entered into and become bound by this Contract as soon as a counterpart or
the signature page thereof executed on behalf of such party has been received by
the other party or its authorized representative or counsel, whether in original
form or by telefacsimile. Any party delivering this Contract or its executed
signature page hereof by telefacsimile shall immediately thereafter deliver to
the other party the complete manually signed original.
ARTICLE XXVIII - ASSIGNMENT
Neither party may assign this Contract or any of its rights hereunder, or
delegate any of its duties hereunder, to any other person without the express
written consent of the other, which consent may be withheld or conditioned in
the reasonable discretion of the other; provided, that the parties acknowledge
and agree that PCA Solutions, Inc. has served and may continue to serve as agent
and administrator of and for the
17
<PAGE>
Reinsurer as well as the Company. This Agreement shall inure to the benefit of
and bind the parties' respective successors, permitted assigns, and legal
representatives.
In Witness Whereof, the parties hereto by their respective duly authorized
representatives have executed this Contract on the dates undermentioned at:
Orlando, Florida, this 1st day FLORIDA BUILDERS & EMPLOYERS
of November, 1996 MUTUAL INSURANCE COMPANY, AN
ASSESSABLE MUTUAL
By:
---------------------------
Name:
Title:
Longwood, Florida, this 1st day PCA PROPERTY & CASUALTY
of November, 1996 INSURANCE COMPANY
By:
---------------------------
Name:
Title:
18
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENT OF PHYSICIAN CORPORATION OF AMERICA FOR
THE NINE MONTHS ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> JAN-01-1996
<PERIOD-END> SEP-30-1996
<CASH> 101,307
<SECURITIES> 227,434
<RECEIVABLES> 116,086
<ALLOWANCES> 32,716
<INVENTORY> 960
<CURRENT-ASSETS> 542,290
<PP&E> 71,101
<DEPRECIATION> 20,314
<TOTAL-ASSETS> 1,200,200
<CURRENT-LIABILITIES> 523,136
<BONDS> 10,911
0
0
<COMMON> 388
<OTHER-SE> 116,121
<TOTAL-LIABILITY-AND-EQUITY> 1,200,200
<SALES> 1,071,930
<TOTAL-REVENUES> 1,089,192
<CGS> 891,229
<TOTAL-COSTS> 1,223,541
<OTHER-EXPENSES> 128
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 10,842
<INCOME-PRETAX> (132,967)
<INCOME-TAX> (37,855)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (95,112)
<EPS-PRIMARY> (2.41)
<EPS-DILUTED> (2.41)
</TABLE>
